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Chapter 1 
Mime therapy: rehabilitation of facial expression 
General introduction 
1. Facial nerve paralysis / facial nerve paresis 
A facial nerve paralysis maligns not only the face, but also the life and social environment of the patient. 
Figures 1 and 2 (by permission of the patient) demonstrate how such a paralysis affects the facial display 
of a patient. 
Figures 1. Before the facial nerve paralysis. Figure 2.With left sided facial nerve paralysis. 
The quotation below demonstrates the patient's plight: 
When I woke up that morning and looked in the mirror I was shocked. The left half of my face 
was paralysed and looked awful. My left eye wouldn 't close anymore and the left corner of my 
mouth drooped. Visiting my family doctor gave me some reassurance. He told me I hadn 't 
suffered brain damage, but most probably a Bell's palsy. He prescribed medicine and told me I 
would recover in a few weeks. For the first weeL· following the paralysis I mostly stayed at 
home. My self-confidence was gone and I felt ashamed when people stared at me. When after 3 
weeks there was no recovery, the family doctor sent me to the otolaryngologist, who performed 
additional tests. He came to the same diagnosis and warned me not to hope for complete 
recovery. It turned out in the end that I never got my 'own 'face back and I still feel depressed. 
Λ 
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Figure 3. Jan Bronk. The mimetic musculature is illustrated in red and the facial nerve in yellow, 
(photo: C. de Ruijter, Academic Medical Centre, Amsterdam) 
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In the paragraphs below we provide a brief overview of the medical aspects of facial nerve paralysis, its 
sequelae, treatment strategies, the present Nijmegen Mime Therapy Study (NMTS) and hypotheses. 
1.1 Terminology 
A peripheral facial nerve paralysis is a paralysis of the muscles that are innervated by the seventh cranial 
nerve and is the result of a lesion located in the peripheral part of the nerve ' The peripheral part of the 
nerve is the neural structure commencing from and including the two facial nuclei (lying in the brainstem 
at pons level) and the peripheral nerve branches, the left facial nucleus supplying the left half of the face, 
the right facial nucleus the right half of the face. 
The facial nerve is the seventh of the twelve cranial nerves and supplies motor fibres to the muscles of the 
face (see figure 3) and the jaw. A sensory division of the facial nerve (the ncrvus intermedius) consists of 
sensory fibres for taste in the antenor two-thirds of the tongue and parasympathetic (secretomotor) fibres 
to the submandibular and sublingual salivary and lacrimal glands.2 The facial branches are 
temporofrontal, zygomatic, buccal, ramus marginahs mandibulae and the cervical branch. 
The facial nerve is the most frequently affected nerve of the body leading to paralysis.3 In most cases a 
facial nerve paralysis recovers spontaneously; when there is no complete recovery a facial nerve paresis 
remains. The consequence of a peripheral facial nerve paresis is partial weakness of the muscles that are 
innervated by the seventh cranial nerve. 
The literature is often not consistent in its terminology The terms facial nerve paralysis and facial nerve 
paresis are often used interchangeably In this thesis we will speak of facial nerve paresis and its sequelae, 
indicating incomplete recovery of the facial nerve with partial weakness of the facial musculature 
A neh source of information covering all aspects of the facial nerve is to be found in May and Schaitkin's 
handbook 'The Facial Nerve'.A In the Netherlands a monograph about facial nerve paralysis for 
otolaryngologists has been written by Pieter Devriese5 and a popular description of facial nerve paralysis 
is found in a book edited by Ronald van Gelder.6 
1.2 Peripheral versus central facial nerve paralysis 
A facial nerve paralysis can present in two ways, peripherally and centrally. This study only focuses upon 
peripheral facial nerve paralysis. The difference between peripheral and central facial nerve paralysis is 
that in the latter there is rarely complete paralysis. The muscles in the upper part of the face are less 
affected due to double innervation via crossed and uncrossed corticobulbar nerve fibres. As a central 
facial nerve paralysis is associated with many other problems (hemi-paralysis of the body, aphasia), 
physiotherapy is more focused upon other impairments and health problems in these patients, such as 
mobility of the upper and lower extremities. 
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1.3 Aetiology, incidence and prevalence 
Approximately half of the cases of facial nerve paralysis are Bell's palsies; the incidence being 
20:100.000 adults per year in western countries.7^ For an overview of the other aetiologies of facial nerve 
paralysis see figure 4. The literature does not provide exact figures for all other aetiologies.'° More than 
100 different causes of facial paralysis are described in May and Schaitkin's handbook under the 
classifications: traumatic, neurological, infection, metabolic, neoplastic, toxic, iatrogenic and idiopathic. 
Figure 4. Percentage of causes of facial nerve paralysis in 8509 Dutch patients from 1958-2001 (by 
permission of P.P. Devriese, Academic Medical Centre, Amsterdam)." 
diabetes/ 
hypertension/ 
infection 
12% 
otitis media 
3% 
trauma 
5% 
herpes zoster 
6% 
Bell's palsy 
50% 
operative trauma 
12% 
Complete spontaneous recovery of facial function in Bell's palsy is observed in 70 % of cases.12 
However, complete spontaneous recovery in other cases is described as less than 70 %. Little is known 
regarding the prevalence of peripheral facial nerve paralysis. Of the estimated 8 million adults in the 
Netherlands, approximately 1600 patients a year will be diagnosed with Bell's palsy, of whom 30 % 
(480) will suffer sequelae of facial nerve paralysis varying from mild to very severe. It is generally 
believed that spontaneous recovery of the facial nerve starts within the first weeks, and can continue up to 
until nine months or even longer. When there is no complete recovery after this period of nine months, we 
refer to the affliction as longstanding facial nerve paresis to indicate the chronic phase of the paralysis. 
Wherever the term facial nerve paresis or sequelae of facial nerve paralysis is used in this thesis, 
longstanding or chronic is indicated, unless otherwise mentioned. 
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1.4 Diagnosis 
Diagnosis of an acute facial paralysis is generally made by the general practitioner and reassurance that 
the patient does not have a life-threatening disorder or has had a cerebrovascular accident is important. 
The patient is then often referred to the otolaryngologist or neurologist for a more extensive and 
supplementary examination. May describes in the handbook 'The Facial Νει-νβ'11· 'every effort must be 
made to determine the aetiology because often a treatable cause can be found' Besides the medical 
history and general examination, the clinical examination of the face may consist of. examination of the 
face at rest and during facial movements (eventually with photographs and / or video recording), 
lacrimation test, salivation test, stapedial reflex test, Maximal Stimulation Test (MST), Electromyography 
(EMG), Evoked Electromyography (EEMG), Computed Tomography (CT), Magnetic Resonance 
Imaging (MRI). For detailed information concerning the diagnostics we refer to May and Schaitkin's 
handbook.4 
To classify the severity of the facial nerve paresis several grading systems are available. Two of them, the 
House-Brackmann Facial Grading System13 and the Sunnybrook Facial Grading System14 arc used in this 
thesis and are described later 
2. Sequelae 
Sequelae of facial nerve paresis can be divided into short- and longstanding As mentioned already in this 
study we will only focus on longstanding sequelae, as short-standing sequelae can disappear within a few 
months after onset of the paralysis due to spontaneous recovery. The negative consequences of the 
paralysis can be tremendous as described in the literature.I<"17 
When starting the Nijmegen Mime Therapy Study (NMTS), sequelae of facial nerve paresis were 
described according to the International Classification of Impairments, Disabilities and Handicaps 
(ICIDH) of the World Health Organisation.'8 Nowadays the ICIDH is revised in the International 
Classification of Functioning, Disability and Health (ICF).19 
The most visible sequel is facial asymmetry; asymmetry at rest and during movement. The most notable 
items of asymmetry of the face at rest are differential size of the interpalpebral fissure, absence or change 
in depth of the naso-labial fold and relative level of the mouth comer (up or down), see figure 5 (all 
figures by permission of the patients). Asymmetry of voluntary movement can be observed in one sided 
reduced lifting of the eyebrows, closing the eyes, elevating the upper lip, smiling and pouting, see figures 
6-9. Simultaneously with voluntary movement, the presence of synkineses (involuntary movements in 
one part when another part is moved i.e. associated movements') can be observed. Most synkineses occur 
during eye lid (upper and lower) and mouth movements, see figure 10 and 11. 
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Figure 5. Left-sided facial nerve paresis, face at rest. Note the left eyebrow is lower, the left comer 
of the mouth is pulled up 
Figures 6-9. Voluntary movements, note less range of motion at the right side when lifting eyebrows 
(6), and at the left side when closing eyes (7), smiling (8) and pouting (9). 
Figures 10, 11. Synkineses, note narrowing of the left interpalpebral fissure when pouting (10) and 
pulling up the left comer of the mouth during eye closure (11). 
Facial asymmetry is for the patient an important complaint, justified by the fact that facial symmetry is a 
determinant for facial attractiveness. Evolutionary psychology hypothesises that facial symmetry is a 
marker of (perceived) good health, and therefore relevant to interpersonal attraction.20 
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Although facial asymmetry seems the most important sequel, present in all patients with longstanding 
facial nerve paresis, an extended examination reveals further sequelae Facial expression is a primary 
means of non-verbal communication and it is clear that not only the face is affected. Social isolation, 
feelings of inferiority, communication problems and appearing mentally disabled seriously affect the 
patient's quality of life. 
3. Treatments for patients with longstanding facial nerve paresis 
3.1 Surgical treatments 
Examples of surgical treatments are the implantation of gold weights in the upper eye lid and static or 
dynamic surgical reconstructions.3,4 '5'2'24 Gold weights are implanted in the upper eye lid when the eye 
does not close properly to prevent eye and/or vision problems. Static or dynamic surgical reconstruction 
is performed in cases of absent or minimal facial movement. 
3.2 Non-invasive treatments 
Non-invasive medical treatment possibilities for patients with facial nerve paresis are limited. Examples 
are botulinum toxin injections4'1525 and physiotherapy. Botulinum toxin injections are used to treat facial 
muscles displaying very severe synkinetic (involuntary) movements, inducing these muscles to relax 
whilst other muscles voluntarily contract. These injections cause a (partial) muscular paralysis by 
blocking acetylcholine release. 
For more than fifty years, physiotherapy has been given to patients with facial nerve paresis.26 Although 
there have been several reports indicating the success of physiotherapy, only minimal scientific data from 
well designed studies are available.27 A review of the literature showed a variety of physiotherapeutic 
modalities, four of which were frequently used, exercise therapy, massage, low frequency electrotherapy 
and biofeedback. Exercise therapy was applied with the rationale of improvement of muscular strength 
and co-ordination, and reduction of synkinesis. The conceptual basis of the application of massage to the 
facial muscles was to stimulate the circulation and promote relaxation, and of electrotherapy to achieve a 
more rapid reinnervation of the facial nerve and development of muscular strength. Biofeedback was 
applied to re-educate facial muscles, enhancing facial function. The literature also reveals no consensus 
concerning frequency of treatment, number of treatment sessions and homework programs 2" To date, no 
randomised controlled trial (RCT) has been published showing clear effects of any of the above 
mentioned modalities of physiotherapy. 
As already mentioned, patients with facial nerve paresis often suffer from psychosocial problems 
Although there is no RCT yet showing the effectiveness of psychological treatment in patients with facial 
nerve paresis, this treatment modality would certainly be an option to improve the patient's quality of life. 
Other non-invasive "treatments" are options to enhance appearance by camouflage techniques: 
appropriate hairstyling, facial hair (beard, moustache), tinted eyeglasses, and make-up. Besides these 
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options, specially selected clothing may also help to de-emphasise facial irregularities (May and 
Schaitkin4; chapter 40). One example is that of wearing clothes rich in colour contrasts, which can 
influence the viewer's gaze; the eye will tend to concentrate on the area of greater (darker) colour. 
3.3 Mime therapy 
A new approach in treating sequelae of facial nerve paresis was developed in the 1970's.29 The idea of 
applying Mime was originally conceived in Amsterdam by Jan Bronk and Pieter Devnese in 1974. Jan 
Bronk (t 1985), at that time mime actor, teacher and director of the Dutch Mime Institute, developed 
Mime therapy together with Pieter Devnese, otolaryngologist and specialised in facial nerve paralysis. 
Mime therapy is a non-conventional method of rehabilitation for patients with facial nerve paresis of 
various aetiologies. Mime therapy includes auto-massage, relaxation exercises, co-ordination exercises, 
inhibition of synkinesis and emotional expression exercises. Mime therapy was initially based upon 
principles of mime and at a later stage upon principles of physiotherapy, aiming at rehabilitation of facial 
expression, or in other words improved symmetry of the face. The conceptual basis of Mime therapy is 
that when facial expressions are damaged, it is essential to 'mobilise' the whole body to re-facilitate 
emotional and communicational possibilities. The history and nature of Mime therapy are described in 
detail in chapter 2 of this thesis. 
3.4 Timing of referral of patients with facial nerve paresis for physiotherapy 
As previously stated, approximately 70 % of patients with Bell's palsy recover spontaneously and 
completely. Physiotherapy is not necessary in these patients, but when it is clear that there is degeneration 
of the facial nerve, patients suffering from sequelae, it is necessary to start therapy. In approximately 30 
% of patients with a Bell's palsy, in whom after three weeks there is no sign of recovery, sequelae are 
presumably inevitable The presence of synkinesis indicates nerve degeneration; complete recovery is not 
possible. 
The referral of patients with post-operative and other causes of facial nerve paresis is similar to that of 
patients with Bell's palsy, taking into account that spontaneous recovery can take a longer time. 
Mime therapy is, except for auto-massage, not useful when the paralysis continues to remain complete. 
However, explanation about the course of the paralysis and advice concerning eating, drinking and 
speaking are essential. 
3.5 Nijmegen Mime Therapy Study 
From 1980 to date, more than 1000 patients with sequelae of facial nerve paresis have been treated with 
Mime therapy at the physiotherapy department of the University Medical Centre (UMC), Nijmegen. 
Another, smaller group of patients has been treated by this method in several other university medical 
centres, local hospitals and private practices. Both patients and physiotherapists have reported positive 
results. 
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Increasingly there is a strong conviction within the physiotherapy profession that treatment should be 
evidence based. In order to establish a scientific base for treating patients with sequelae of longstanding 
facial nerve paresis with Mime therapy, a RCT was performed to examine the effectiveness of Mime 
therapy in reducing these sequelae The main purpose of this NMTS study is to determine whether Mime 
therapy as applied in the outpatient department of two university hospitals under controlled conditions, 
has positive effects on the asymmetry of the face and other sequelae in patients with longstanding (more 
than nine months) peripheral facial nerve paresis. The second aim was to investigate the stability of these 
eventual benefits over a penod of one year. 
Our central hypothesis is that facial asymmetry improves as a consequence of Mime therapy in patients 
with longstanding peripheral facial nerve paresis, and that this results in improvements in secondary 
sequelae: facial stiffness, lack of emotional readability, disabilities in eating, drinking, speaking, rinsing, 
lacnmalion, and psychosocial problems. 
4. Overview of the thesis 
This thesis is divided into three sections. 
Parti 
The preparatory studies contain the background of Mime therapy (chapter 2) and results from clinical 
application of Mime therapy in a descriptive study of 175 patients (chapter 3). A review of the literature 
(chapter 4) gives the state of the art concerning physiotherapy and facial nerve paresis, showing that to 
date there is no evidence based physiotherapy treatment available. Chapter 5 descnbes the importance of 
excluding patients with mimetic movements caused by cross-innervation. Chapter 6 describes the 
reliability of the Sunnybrook Facial Grading System, used to measure the primary outcome, asymmetry 
of the face. 
Part II 
The Nijmegen Mime Therapy Study begins with a description of the study design. Next the primary, and 
secondary outcomes on function and disability level of the RCT are given when companng a group of 
patients receiving Mime therapy with a group placed on the waiting list (chapters 7 and 8) The stability 
of these therapy benefits over a time period of one year are desenbed in chapter 9 The impact of Mime 
therapy upon psychosocial sequelae is outlined in chapter 10, and changes in the emotional readability of 
patients are described in chapter 11. 
Part III 
This part gives the summary of the results, the general discussion, a list of conclusions and a 
recommendation for future research and work into the area of care for patients with facial nerve paresis. 
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Chapter 2 
From mime to Mime therapy 
The genesis of a rehabilitation method for patients with facial nerve paresis 
1. Introduction 
The purpose of this article is to comprehensively describe the historical development and clinical 
characteristics of Mime therapy and to give insight into its usefulness as a tool in the treatment of patients 
with facial nerve paresis. The article describes the origin of the therapy, the principles, the present form 
and its practice. 
1.1 The roots of Mime therapy 
In 1975 the Department of Facial Research at the Wilhelmina Gasthuis (WG) in Amsterdam introduced a 
film entitled "Peripheral Facial Paralysis", made by the Foundation for Film and Science in Utrecht Jan 
Bronk (Amsterdam, 1927-1985), director of the Dutch Mime Centre and mime actor (see chapter 1, figure 
3) illustrated in this film the function of the vanous mimetic muscles. For this purpose the facial muscles 
and the facial nerve were drawn on his face. 
Following the section on anatomy and physiology, a scene appears showing the importance of the 
mimetic muscles in human facial expression. This film, aimed at medical students and doctors, 
emphasised the importance of early examination and treatment of patients with facial nerve paralysis. 
During the making of this film Jan Bronk and Pieter Devriese (otolaryngologist, WG, presently Academic 
Medical Centre (AMC), Amsterdam) came into contact with each other. 
1.2 First treatments 
It occurred to Bronk and Devriese that mime might help in rehabilitating patients with an impaired facial 
expression, as a result of Bell's palsy, trauma or other causes. In 1974 they began to explore the 
possibilities of mime with patients at the WG. A treatment plan was devised, consisting of a series of 
exercises, most patients receiving individual treatment. At that time patients started therapy after a 
minimum of one year following onset of the paralysis, the reason for this being that sequelae had to be 
stable. Between 1977 and 1979, 24 patients were treated. 
1.3 Mime therapy in the early years 
Initially Mime therapy consisted of auto-massage of face and neck, breathing and relaxation exercises, 
exercises to facilitate the affected side (including letter and word exercises) and expression exercises. 
The conceptual basis of Mime therapy in the nineteen seventies was that when facial expressions are 
damaged, it is essential to "mobilise" the whole body to re-facilitate emotional and communicational 
possibilities. 
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Massage, breathing and relaxation exercises will relax the whole body, consequently relaxing the face 
which is necessary in expressing emotions and during communication. Co-ordination exercises will result 
in symmetry of the face, while expression exercises are necessary to re-educate expressive possibilities 
1.4 First publications and first courses 
In 1976 a report was given at the Third International Symposium on the Facial Nerve in Zurich on first 
experiences in treating patients with facial nerve paresis.' 1981 saw the publication of a booklet giving 
details of Mime therapy and its conceptual background. This booklet has been revised several times and 
translated into English.2"6 
In 1980, after being trained by Jan Bronk in Mime therapy, two physiotherapists began treating patients at 
the Department of Physiotherapy, Academic Hospital St Radboud Nijmegen, now UMC Nijmegen. The 
following year a group of five physiotherapists was trained by Jan Bronk and all five became motivated to 
learn this form of therapy since results of other treatments for patients with facial nerve paresis were 
dissatisfying or insufficient.7 From then on Mime therapy was given in other Dutch cities: Nijmegen, Oss 
and Groningen. 
On January 1 llh 1985, Jan Bronk died in Wilms at the age of 57. A quotation from the Annual Report of 
the Department of Facial Research": 
"After starting as an actor in 1945, Jan Bronk studied in Pans with Marcel Marceau and went on to 
develop mime along the scientific lines laid down by Etienne Decroux. As an actor he laid the basis for 
the development oj mime in the Netherlands in the fifties He also was director of the Dutch Mime Centre, 
a centre for documentation and information on mime In the early seventies Jan Bronk worked with 
patients with facial nerve paresis, giving them the benefit of his exceptional talent jor expression At the 
WG he developed a completely original rehabilitation program for patients with an impaired jacial 
expression This method, called Mime therapy, proved extremely fruitful; he treated 250 patients in his 
own inimitable way He collaborated on the production of several publications, films and video 
programs Seven physiotherapists were trained by him ". 
Following Jan Bronk's death, courses were continued by the first trained physiotherapists at the AMC 
Amsterdam. A grant from the "Stichting Jan Bronk Fonds" in 1990 made it possible to start a Mime 
therapy course for 18 para-medics, given by eight teachers from vanous disciplines. A second grant in 
1991 was used for a try-out of this treatment for a group of patients with facial nerve paresis. 32 Patients 
took part in this expenment, evaluation showing benefits for half of them, mainly in improved coping 
with the handicap and increased self esteem. 
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2. What is Mime? 
2.1 Definition and background 
Mime is a performance art based on non-verbal expression. The best known form of mime is pantomime; 
the word deriving from 'pan' meaning all (of the body), and "mime" meaning to convey a message 
without words. Pantomime is telling a story without words and may be compared to figurative painting; 
the picture tells the story. Pantomime has repeatedly reappeared in various guises throughout the history 
of theatre, the best known players being: 
the masked players of Greek antiquity known as 'mimoi'; 
the actors of the 16th century Commedia dell'Arte from which, during the 19th century, the famous 
Pierrot developed; 
the great silent film actors, such as Buster Keaton and Charlie Chaplin; 
Marcel Marceau (Strasbourg, 1923), an internationally famous pantomime artist. 
Mime is an abstract form of acting and is based upon three physical aspects: the skeletal, nervous and 
muscular systems. The movements used in mime are distilled from reality; real life is analysed and 
interpreted as new theatrical signs and images. Mime demands a highly refined control of the body, in 
acting the body is the means of expression. 
2.2 Mime Corporel 
A new form of mime, 'mime corporel', was founded by Etienne Decroux (France, 1898-1991), the father 
of modem mime.9 The body and movement analysis in 'mime corporel' is fundamentally different from 
that of the medical world. Whereas practitioners such as physiotherapists analyse the body in terms of its 
anatomical structure and relate movement to function, 'mime corporel' analyses the body and its 
movements entirely in terms of expression possibilities in space. 
The basic principles of 'mime corporei' are: 
movement is rhythm of the body in space and time; 
the essence of a movement is made visible by 'parasite' movements. 
To perform, the mime artist has to leam to 'isolate' and 'articulate', respectively to move and to 
emphasise specific movements. 
The most important training aspects in 'mime corporei' are 
1. Respiration. In mime, movement is linked to and supported by breathing so that the two function 
simultaneously. 
2. Articulation of movement. Every movement, however complex, can be broken down into a senes of 
single movements. 
3. Alertness and awareness of direction. Concentration on that part of the body where movement is 
happening or about to happen is important 
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3. From mime to Mime therapy 
3.1 Development 
Jan Bronk, one of the pioneering Dutch mime artists, took the analysis of Dccroux a step further. As a 
teacher at the mime school (a department of the College of Arts in Amsterdam) he developed the 
analytical principles into a teaching model 
In addition, he adapted mime for a wider social application and was especially interested in its 
possibilities in the area of health care. He was convinced that mime could assist in giving a powerful 
impulse to mental and physical activity in handicapped people He developed a way of working using 
functioning capabilities to assist activation in less well functioning areas Based on 'mime corporei', he 
made an analysis of the face, especially emotional expressions, in order to help patients with facial nerve 
paresis 
3.2 Analysis of the face using the principles of 'mime corporel' 
When analysing the face it is not possible to consider an expression as a separate entity, for in the face 
every movement, however slight, or even an absence of movement, results in an expression of some kind 
Analysis using the principles of'mime corporel' includes: 
1. Respiration. Facial expression is a part of a total 'mood' reflected by the body. The impairment of 
facial expression will be reflected by tension elsewhere in the body. Breathing will reduce tension. 
2. Articulation. Mime teaches the expressive possibilities of movement, normally occurring 
unconsciously For example, the mouth corner can be pulled down extremely fast which gives a 
completely different expression than that caused by allowing the mouth comer to drop gradually. 
Through mime the expressive possibilities of movement, which normally occur unconsciously are 
taught. 
3 Alertness and awareness are not completely directed inwardly: the patient must always bear in mind 
that movements project an expression outwardly. 
4. Expression. Mime is not only the art of movement, but also the art of communication. The body is 
more than just the sum of its various parts; it is an instrument which gives expression to our feelings. 
The expression of the body and face reflect one's mood. The purpose of mime is to deepen and enrich 
the individual's capacity for non-verbal communication. Mime is based upon the abilities of each 
individual and does not portray an ideal. It is an invitation to explore physical possibilities to the 
utmost. 
3.3 Elements of physiotherapy entering Mime therapy 
Considering the fact that in 1980 Jan Bronk trained physiotherapists in Mime therapy, the content of the 
treatment changed from mime to a combination of mime and physiotherapy Specific items were 
elaborated such as stretching of facial muscles, inhibiting synkineses by counteracting movements, and 
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co-ordination exercises between the affected and normal side of the face. The medical history and 
examination were improved by the introduction of standardised intakes and measurements. 
4. Mime therapy in its present form 
4.1 Goals of Mime therapy 
The aim of the treatment is to promote symmetry of the face at rest and dunng movement, the patient 
being simultaneously taught to control synkineses. This will result on a functioning level in increased 
symmetry, reduced stiffness and increased emotional readability; on a disability level, in fewer problems 
with eating, drinking, speaking, rinsing and lacrimation and on a health level in improved weiibeing, self 
confidence, and improved social activities. 
4.2 Content and rationale of Mime therapy 
Mime therapy as applied these days is a combination of stimulation of facial emotional expression and 
functional movements. Furthermore the therapy is on an individual basis, as is the follow-up The present 
form of Mime therapy consists of : 
a. information about treatment and prognosis; 
b. auto-massage of face and neck; 
c. breathing and relaxation exercises; 
d. specific exercises for the face to co-ordinate both halves and to decrease synkineses; 
e. eye and lip closure exercises; 
f. letter and word exercises; 
g. expression exercises. 
A mirror is used as feedback instrument, at the start of treatment it is necessary to see how exercises are 
performed and whether synkineses are present. In the later stage of therapy, patients learn to feel how 
exercises are performed without the use of a mirror, helping them to regain self confidence. 
The average number of treatment sessions is ten, each session lasting approximately 45 minutes, the 
patient attending once weekly or less. Follow-up treatment is usually planned after three or six months. 
The therapy is composed of sequentially structured exercises to align the two facial halves, to control and 
reduce synkineses, and tasks to reintegrate emotional displays. Patients have to execute homework on a 
daily basis, assisted by a 'homework book'. 
a. Information about treatment and prognosis 
Often patients referred for physiotherapy have only received a minimum of information regarding 
prognosis, treatment possibilities and coping with problems. Following an extended medical history and 
examination, the first treatment session is used to explain the cause, course and prognosis. The patient 
also receives information regarding Mime therapy, how it works, the necessity of doing homework and 
the integration of exercises into daily life. 
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Some patients, referred by general practitioners or medical specialists, are incorrectly informed that the 
paralysis will recover completely. This is due to insufficient knowledge or wrong judgement. In our view, 
if synkineses are visible, the therapist should inform the patient about the denervation, and hence 
impossibility of complete recovery. Providing 'bad news' can also play a role in the therapy enabling the 
patient to deal with his handicap in a more realistic manner. 
b. Auto-massage of face and neck 
Patients are taught to massage their face daily for about 10 to 15 minutes, the aims being relaxation of the 
facial musculature and promotion of circulation. Massage involves knowing one's own face and 
discovering in which areas tension is reduced or increased and consists of 'effleurages' and kneading both 
sides of the face. Stretching exercises of the affected side follow to relieve mimetic muscles involved in 
synkinesis. Stretching is performed in a slow manner with the thumb of the hetero-lateral hand placed into 
the mouth on the affected side and opposed to the fingers.10 The direction of the stretching manoeuvre can 
vary from horizontal to vertical (along the nose, ending by the lips). In cases of lagophthalmus (inability 
to close the eyelids fully) the upper eyelid can be stretched for about 15 seconds." 
c. Breathing and relaxation exercises 
As a result of the facial nerve paresis hypertonia can be present not only in the face but in the whole body 
In the presence of synkineses or mass movements muscle tone is increased and stress will only further 
this. From a holistic point of view the mind does not function separately from the body, thus relaxing the 
face also requires relaxation of the whole body. Breathing exercises, specifically expiration, can be used 
to create relaxation 
Patients are taught to recognise tension, and to feel the difference between tension and relaxation in 
general and more specifically in the facial musculature. Relaxation exercises are carried out as described 
by Schultz in a sitting or lying position.12 
d. Specific exercises for the face to co-ordinate both halves and to decrease synkineses 
These exercises consist of: 
basic exercises with variation in amplitude and speed, 
exercises for one side of the face; 
relaxation of jaw musculature; 
exercises for the mouth (smiling, pouting) and eye (closing and opening) with simultaneous inhibition 
of synkinesis (slow, small movements and counteraction), see figures 1 and 2 (by permission of the 
patient). 
These exercises will create an improved co-ordination between the two halves of the face, enabling the 
patient to display facial movements and emotions in a more symmetrical way. 
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Figure 1. Synkinesis of the eye while pouting. Figure 2. Inhibition of synkinesis. 
e. Exercises for eye and lip closure 
Eye exercises are necessary when the eye docs not close properly, preventing an irritated eye and/or 
vision problems. Exercises are performed with variation in speed and force. 
Lip closure exercises are necessary for eating, drinking and rinsing of the mouth and comprise: 
exercises for the cheek (filling the cheeks with differing amounts of air); 
eating and drinking exercises while keeping the eye open (small movements). 
Helping to create a better lip closure enables the patient to feel more comfortable during functional and 
social activities. 
f. Articulation exercises 
These exercises are performed to increase the patient's awareness of lip movements and the position of 
the mouth for various sounds. Vowels as a, e, i, o and u, and consonants such as p, b, m, s and f, are used 
for the position of the lips and words exercises concentrate on the correct mouth position. 
An increased articulation will provide patients with more self-esteem during communication. 
g. Expression exercises 
Throughout the therapy it is essential to try to develop a conscious connection between the use of certain 
muscles and facial emotional expression. Exercises can be performed in two ways: working from the use 
of certain muscles towards a mood expression, or working from a certain mood as a starting point for a 
movement. For example the patient can be asked to raise his eyebrows or the patient is requested to 
perform an expression depicting amazement. 
Various moods may be evoked by asking the patient to knit the brow, open the eyes wide, stick out the 
lower lip, tighten the lips, etc. These expressive exercises can be used throughout the whole Mime 
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therapy program. As expressions and emotions are not only expressed in the face, but throughout the 
whole body, patients arc taught to use their arms, hands and body Learning a more conscious use of the 
facial muscles while expressing emotions can help to cope with the distressing after-effects of the 
paralysis. 
4.3 Indications for Mime therapy 
Indicated for Mime therapy arc patients with peripheral facial nerve paresis of various aetiologies like 
viral infections (e.g Bell's palsy, herpes zoster oticus), operative trauma, traumatic injuries, otitis medis 
Patients with no recovery after facial nerve paralysis are, except for auto-massage, not indicated for Mime 
therapy However, when after a dynamic nerve and/or muscle reconstruction, movement is visible, 
patients can start Mime therapy. Patients with central facial nerve paresis are not treated with Mime 
therapy 
4.4 Present situation in the Netherlands 
In the Netherlands 200 - 250 patients are treated yearly with Mime therapy, of which the most are treated 
in Nijmegen (70 - 100). At this moment there are approximately 30 'mime therapists', physiotherapists 
and more recently speech therapists, working mostly in an academic setting. Mime therapy courses arc 
given at the Physiotherapy Department of the UMC Nijmegen in co-operation with the Physiotherapy 
Department of the "Vrije Universiteit" Medical Centre Amsterdam and the Department of Facial 
Research of the AMC Amsterdam. 
A video tape has been made depicting Mime therapy as demonstration material and it was first presented 
at the International Symposium on the Facial Nerve in Cologne, Germany in 1992. Information regarding 
Mime therapy has also been given during several Facial Nerve Conferences: Rio de Janeiro, Matsuyama 
and San Francisco. 
Nowadays Mime therapy can also be applied in an adapted way for patients after a nerve and/or muscle 
reconstruction.'3 
Besides plastic surgery and psychological guidance, Mime therapy is available as a third modality to treat 
patients with facial nerve paresis. We feel that all three modalities should be available in medical centres 
where patients are referred.1'1 
5. Future prospects 
Mime therapy is used mainly in the Netherlands and is -based upon clinical reports- a promising 
treatment. For an international introduction Mime therapy has to be based on scientific evidence. The 
results of a randomised controlled trial in the effectiveness of Mime therapy will provide evidence for this 
treatment approach. As there is little known about the working mechanisms of Mime therapy, further 
research has to be carried out concerning this aspect. 
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Description of outcomes in patients with facial nerve paresis referred for 
physiotherapy 
1. Introduction 
This report describes the results of the clinical application of a modality of physiotherapy. Mime therapy, 
in patients with peripheral facial nerve paresis. Data, collected over a decade, were systematically 
explored for signals that Mime therapy improves sequelae of patient with facial nerve paresis. Such 
signals form the basis of a randomised controlled trial (RCT), which formally tests the efficacy of Mime 
therapy. 
1.1 Background 
A peripheral facial nerve paralysis is a paralysis of the muscles innervated by the seventh cranial nerve 
due to a lesion located in the peripheral part of the nerve. The cause of the paralysis is in approximately 
50% of cases a Bell's palsy. See chapter 1, figure 4 for other aetiologies of facial paralysis. The incidence 
of Bell's palsy in the Netherlands, as described by Devnese in 1990, is estimated at approximately 
20:100.000 per year.1 In approximately 70% of the patients with a Bell's palsy, the voluntary motor 
function spontaneously normalizes.2'1 The other 30% remain with a paresis with sequelae varying from 
very mild to very severe. 
1.2 Physiotherapy in patients with facial nerve paresis: state of the art 
Although there have been several reports indicating the success of physiotherapy in patients with facial 
nerve paresis, few scientific data seem to be available. In a review from 1958 - \99\4 concerning the 
effects of physiotherapy in patients with peripheral facial nerve paresis, only one RCT was found among 
70 articles 5 This RCT showed no significant advantage of electrotherapy. The non-RCT studies showed 
benefits from exercise therapy, biofeedback, low frequency electrotherapy, and massage. A literature 
search in Medline and Cinahl covering the period 1991 - 2001, revealed two RCTs performed by Ross et 
al. and Segal et al. claiming significant improvements utilising biofeedback and exercise therapy. 
Since 1980, patients with peripheral facial nerve paresis have been treated at the Physiotherapy 
Department, University Medical Centre (UMC) Nijmegen with Mime therapy aimed at the rehabilitation 
of facial expression. This report is based on archive data covenng a decade (1987 - 1997) and consists 
of pre- and post-treatment analyses of 175 patients treated with Mime therapy. 
Mime therapy was developed approximately 25 years ago by the late Jan Bronk, mime actor and Pieter 
Devnese, otolarynologist. Mime therapy is a combination of stimulation of facial expression, functional 
movements, and relaxation techniques including breathing control.10 The aim of the treatment is to 
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promote symmetry of the face at rest and during movement, the patient being taught to simultaneously 
control synkineses or mass movements 
The aims of this investigation are a) to describe sequelae of patients with facial nerve paresis referred for 
physiotherapy, b) to describe their changes and stability while receiving Mime therapy, c) to explore 
predictors for these changes and d) to justify the setting up of a RCT. 
2. Materials and methods 
2.1 Patients' files 
Physiotherapy files were collected from patients with peripheral facial nerve paresis, treated with Mime 
therapy between 1987 and 1998. These files contained: 
- a letter from the general practitioner or referring specialist; 
- general history and state of well-being as reported by the patient, prior to and following treatment; 
- observations made by the physiotherapist, prior to and following treatment. 
2.2 Mime therapy 
Patients were treated with Mime therapy, which consists of. 
- information concerning treatment and prognosis; 
- auto-massage of face and neck, a combination of 'effleurages', kneading and muscle stretching, 
- breathing and relaxation exercises. Relaxing the face requires relaxation of the whole body and 
breathing exercises, specifically expiration can be used to create relaxation; 
- specific exercises for the face to co-ordinate both halves and to decrease synkineses, consisting of 
slow and small movements of the various parts of the face; 
- exercises for eye closure, and lip closure necessary for eating, drinking and rinsing of the mouth; 
- letter and word exercises; 
- emotional expression exercises. 
A mirror is used as a feedback device. The average number of treatment sessions is ten, each session 
lasting approximately 45 minutes, the patient attending once weekly or less. Follow-up treatment is 
usually planned after three or six months. The therapy comprises sequentially structured exercises to align 
the two facial halves, to control and reduce synkineses, and tasks to reintegrate emotional displays 
Patients have to execute homework on a daily basis, assisted by a 'homework book' ' ' 
2.3 Method and analysis 
The files of 203 patients receiving Mime therapy in the past decade 1987 - 1997 were available for 
analysis. Each file contained information collected at the first and last treatment session and the patient 
data were coded into variables and recorded. All data were collected by the same physiotherapist (first 
author), and were coded for quantitative computerized descriptive analysis (SPSS-package). The files 
contained three groups of variables: 
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1. Demographic variables: age (years) and sex. 
2. Medical variables: diagnosis, affected side and previous therapies. 
3. Variables reflecting impairments, disabilities and quality of life' 
3.1.a Impairments (observation of the patients by the physiotherapist): asymmetry at rest 
measured on a 3 point scale, asymmetry during facial movements on a 5 point scale and 
synkineses on a 3 point scale. 
3.1 b Impairments (subjective judgement by the patient): pain (9 point scale), stiffness (5 point 
scale), involuntary movements (5 point scale), secretion of tears (3 point scale), nasal 
obstruction (2 point scale) and sensation (2 point scale). 
3.2 Disabilities (patient judgement) in eating (8 point scale), drinking (5 point scale), 
speaking (5 point scale) and hearing (3 point scale). 
3 3 Quality of life (patient judgement, 10 point scale). 
Aspects of facial asymmetry were detailed according to the parts of the face involved (face at rest 4 
indicators: forehead, eye region, naso-labial fold and mouth region), the type of movement (8 indicators: 
raising forehead, frowning, eye closure, sniffing, smiling, pouting, depressing lower lip and ballooning 
cheeks) and eventually associated synkineses. 
As an overall measure of impairments the House-Brackmann Facial Grading System (HB-FGS)12 was 
used. The HB-FGS classifies facial functioning; grade I is normal functioning, grade VI is a complete 
paralysis. However, the instrument is gross, implying that small changes will not be noticed. 
All analyses were performed with the SPSS-package (version 7.5). Tests for paired samples were used for 
statistical analysis of the pre- and post-treatment comparisons. As the nature of the analyses was 
descriptive and exploratory, statistical tests were performed two-sided.13 If not otherwise mentioned chi-
square tests were used. Stabilities of inter-patient differences were calculated with Pearson correlation 
coefficients. 
3. Results 
Of the 203 collected files of patient who received Mime therapy, 175 complete files were subjected to 
analysis. Firstly, the general characteristics of the patients will be described, subsequently patients' 
sequelae presumably to be affected by Mime therapy will be reported. 
3.1 Patient characteristics 
26% of the patients were referred for facial rehabilitation following a Bell's palsy, 38% following 
surgical removal of an acoustic neuroma, herpes zoster in 8%, trauma in 10%, otitis media in 5% and 
congenital facial nerve paresis in 6%. The remaining 7% of diagnoses was unknown. Diagnosis and sex 
show no relationship (p = 0.14; not significant) and most patients (71%) had received a previous therapy 
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(medication, electrotherapy, exercise therapy, acupuncture, speech therapy). The nght side was 
significantly (right 106, left 69; ρ < 0.001 ) more affected than the lelt side, both for males and females. 
3.2 Age and sex 
The age range was 6 to 85 years. Of the 175 patients, significantly more females (108) than males (67) (p 
< 0.002) were treated. The mean age of all patients was 42 years (SD 18.1), the age distributions being 
the same for males and females (p = 0.50). The mean time between onset of the paralysis and start of the 
treatment was 28,4 months (SD 33,8, range 1 - 99, median 12 months). 
3.3 Patient perceived impairments, disabilities, and quality of life 
Patients' impairments, disabilities and quality of life were assessed directly before the initial (Tl) and 
after the final (T2) treatment session. The mean time between Tl and T2 was 5.5 months (SD 5.2, range: 
1 to 40 months, median = 4.0). The wide range is due to the fact that there were a few patients treated 
who had undergone nerve and/or muscle transplantation, requiring a long range treatment with a low 
session frequency. The average number of therapy sessions was 8, range 2 to 14. Table 1 gives an 
overview of the average seventy of sequelae at intake (Tl) and after the final treatment session (T2). 
Table 1: Patient-reported impairments, disabilities and quality of life among 175 patients receiving Mime 
therapy, and their changes over the therapy period (Tl - T2). 
Impairments: 
Pain 
Stiffness 
Involuntary movements 
Nasal passage 
Sensation 
Disabilities in: 
Eating 
Drinking 
Speaking 
Heanng 
Quality of life 
1 
Tl 
Mean (SD) 
1.5(2,2) 
1.7(1.3) 
1.8(2.8) 
0.2 (0.4) 
0.3 (0.5) 
2,5(1.8) 
1.4(1.4) 
1.4(1.1) 
0.7 (0.9) 
3 0(2.5) 
2 
T2 
Mean (SD) 
0.5(1.5) 
0 6 (0.9) 
0 6 ( 1 6) 
0.2 (0 6) 
0.5(0 5) 
1.0(1.3) 
0.4 (0 7) 
0.4 (0 6) 
0.7 (0.9) 
1.0(1.4) 
3 
Changes in average 
severity Τ1 -T2 t 
** decreased 
** decreased 
** decreased 
improved, ns 
** improved 
** improved 
** improved 
** improved 
no diffcience, ns 
** improved 
4 
Correlation of 
Tl, T2 severity 
0.57* 
0.71 * 
0.52* 
0 56* 
0.98* 
0.55* 
0 58* 
0.50* 
0 98* 
0.59* 
Legend * = ρ < 0 05, ** = ρ < 0.01, t a paired sample t-test was used, ns = not significant 
With regard to the seventy of a complaint on all three levels, the patients improved on average on all 
subjective indices except for heanng problems. Eight of 10 complaints significantly improved dunng 
Mime therapy. Patients differed at intake in the amount and severity of their complaints High correlations 
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between pre- and post-treatment measures reveal that such inter-individual differences are stable over 
time. Column 4 shows that for stiffness, sensation and hearing, the post-test inter-patient differences align 
quite well with pre-existing differences at Tl. The scores at intake regarding the other impairments and 
disabilities only predict to a moderate degree their relative position at discharge. 
3.4 Facial functioning 
3.4.1 Face at rest 
Facial symmetry at rest improved, i.e. asymmetry on all indicators (respectively forehead, eye region, 
naso-labial fold and mouth region) decreased significantly, see table 2. 
Table 2: Observed asymmetry of the face at rest and changes during Mime therapy, Ν = 175. 
Asymmetry in facial areas 
Forehead 
Eye 
Naso-labial fold 
Mouth 
1 
Tl Mean (SD) 
0.7 (0.8) 
1 1 (0 8) 
1.2(0.8) 
17(1 1) 
2 
T2 Mean (SD) 
0.5 (0.7) 
0 6 (0.6) 
0.5 (0 6) 
1.1(1.3) 
3 
Changes Τ 1-T2t 
** improved 
** improved 
** improved 
** improved 
4 
CorTelationTI,T2 
0.74* 
0 52* 
0.58* 
0 19 
Legend: * = ρ < 0.05, ** = ρ < 0.01, t a paired sample t-tesl was used 
3.4.2 Face during voluntary movement 
Both the movements and the synkineses variables indicate the presence and degree of severity of the 
sequelae. Table 3 shows the results 
Table 3: Observed facial functioning during voluntary movement, synkinesis and changes during Mime 
therapy, Ν = 175 Lower scores indicate improved function. 
1 2 3 4 
Voluntary Tl T2 Change Correi 
Movement Mean (SD) Mean (SD) Tl-Tt2t T1,T2 
Raise forehead 4.0(1.4) 3 6(15) ** 0 8 3 * 
Frown 3.8(1.4) 3.2(1.5) ** 0.80* 
Eye closure 3.2(13) 2 3(11) ** 0.65* 
Sniff 3 8(12) 3 0(13) ** 0.75* 
Smile 3.5(1.1) 2.3(0.9) ** 0.71* 
Pout 3.5(1 1) 2.6(1.0) ** 0.66* 
Depress lower 4.2(1.3) 3.3(1.5) ** 0 72* 
Ιφ 
Balloon 3 5(1.2) 2 4(1.0) ** 0.64* 
cheeks 
5 6 7 8 
Synk Tl Synk. T2 Change Correi. 
Mean (SD) Mean (SD) T1-T2 f T1,T2 
0.5(0.7) 0 4(0.5) ** 0 69* 
0.5(0.6) 0.4(0.5) * 0 62* 
0 7(0 7) 0 6(0.5) ns 0.57* 
0.3(0 6) 0 2(0 4) ** 0.55* 
0.5(0.7) 0.4(0 5) ** 0 49* 
0 8 (0.9) 0 7 (0.6) ns 0 55 * 
0 4(0 7) 0.3(0 5) ** 0 62* 
0 6(0 8) 0.5(0.6) * 0.64* 
Legend: * = ρ < 0 05, ** = ρ < 0 01, t a paired sample t-lest was used, ns = not significant 
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Asymmetry in facial movement remains present to a substantial degree (columns 1 & 2), but nevertheless 
the average severity of this asymmetry decreases in all movements (column 3), while intcr-patient 
differences at intake are preserved over time (high correlations between Tl and T2, shown in column 4). 
An increase in the number of patients showing a synkinesis was observed for 3 out of 8 movements (eye 
closure, pouting and ballooning cheeks). Nevertheless, the group average of severity of synkineses 
significantly decreased for 6 movements (column 5-7). Inter-patient differences in degree of synkineses 
tended to persist over time for all movements (column 8). 
3.4.3 Sequelae assessed by the House-Brackmann Facial Grading System 
According to the HB-FGS at T2 most patients had a lower score than at TI, indicating progress. Most 
transitions consist of a 1-level progression between intake and discharge Of the 88 patients functioning at 
intake on HB-FGS level V or higher, only 19 remain at these low function levels at discharge. Analysing 
the average HB-FGS scores, it is shown that patients improved by one grade. The high correlation 
between pre- and post-test (r = 0.77) indicates that although there is change, the relative position of 
patients changes minimally between intake and discharge. HB-FGS level after Mime therapy is rather 
accurately predicted by HB-FGS level at intake. See table 4 for the HB-FGS at pre- and post-test, and the 
transitions between HB-FGS levels. 
Table 4 Transitions between beginning (HB 1 ) and end (HB2) of Mime therapy in levels of House-
Brackmann Facial Grading System. Ν = 175 patients. 
HB1 * HB2 Cross tabulation 
Count 
HB2 
1 
1 A 
HB1 2 
3 
4 
5 
6 
Total 
EN 
3 
1 
4 
0 
30 
2 
v0 
2 0 ^ 
8 
4 
3 
35 
3 
\ 1 
J N 
21 
4 
57 
4 
\ 1 
2 9 \ 
4 
34 
5 6 
^ 7 
iNv^i 
18 1 
Total 
22 
24 
41 
65 
23 
175 
3.5 Predictors of changes 
Improvements have been reported in many aspects of the patients' complaints and observed facial 
functioning. Does the possibility exist to predict these changes on the basis of objective patient 
information available at intake9 Age, sex and affected side of the face might be such predictors. In our 
analysis, changes in scores were assessed by taking residuals from the post - pre test regressions. 
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However there were no significant relations between age, sex or affected side and changes in complaints 
or facial functioning. 
4. Discussion and conclusions 
This study aimed at describing changes in sequelae of facial nerve paresis during a period in which 
physiotherapy was given. For almos' all sequelae of facial nerve paresis on all three levels (impairments, 
disabilities and quality of life) significant improvements were observed. No indications for further 
investigations were found. However, some notes of caution are in order. 
Are the recorded changes present within the patient or in the measurement procedure? Assessment of the 
patients' functioning and therapy were done by the same physiotherapist (C.B.). This could influence the 
validity of the data in an adverse way, especially the change data. This physiotherapist had at the time of 
availability of the first patient records, eight years of expenence working with patients with facial nerve 
paresis; this allows for a stable cognitive frame of reference when assessing patients at intake and 
discharge. In a recent project (unpublished observations, Beurskens 2002) inter-rater agreements were 
assessed concerning facial functiomrg. 25 Patients (mean age 45 years, range 13-74) with a mean seventy 
of III on the HB-FGS, were videotaped. Three raters independently scored the patients using the 
Sunnybrook Facial Grading System.14 The intrarater reliabilities of the composite scale for the observers 
were determined to be intra-class correlation coefficient (ICC) between 0.89 and 0.98. The interrater 
reliabilities varied between ICC 0 90 and 0.95. One of the three raters was the physiotherapist from the 
present study. No information about intcrrater agreement can be given in this study, as no data of a 
second rater was available. Contradicting the hypothetical possibility of therapist/observer bias is the fact 
that there was a considerable convergence in changes based on the reports from two different sources 
(patient and physiotherapist) Assessments of physiotherapy following facial nerve paresis performed by 
the same physiotherapist are also found in the literature in a pre-experimental study from Coulson and 
Croxon.15 In studies from Ross et al.6 and Segal et al.7, the assessments were done by a single therapist, 
but in both prospective studies this therapist was blinded. 
Many patients showed improvement, but is this sample not atypical? 
Our group of patients can be considered as a sample from the patient stream referred to the UMC 
Nijmegen for facial rehabilitation at that time. No indications were found denoting that the composition 
of this patient population has changed over the years. One might speculate that our conclusions are only 
valid for the local situation, as a data set obtained from another Dutch centre for facial rehabilitation in 
Amsterdam (Devnese1) reports for the penod 1973 - 1984 a sex ratio of 1 0 m their group of patients, 
while in this study it was 1 5 'favouring' women. The Amsterdam group only consisted of patients with 
Bell's palsy which is expected to affect both sexes alike, whilst our group included patients with facial 
nerve paresis of other aetiologies. Amongst our Bell's palsy patients, the sex ratio also did not 
significantly differ from 1 0 The Nijmegen hospital apparently seems to attract relatively more women 
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than men for facial rehabilitation. As there is no correlation between sex and the changes observed, we do 
not believe that overrepresentation of women biases the results concerning the changes during the 
physiotherapy episode 
Conclusions concerning changes in facial functioning: 
1. Following a period of 3 to 5 months of Mime therapy a substantial degree of improvement was 
observed in almost all areas investigated: impairments, disabilities and quality of life. 
2. Asymmetry in the face at rest decreased for each of the four facial areas investigated. 
3. All eight aspects of measured voluntary facial movement improved. 
4. Of the eventual synkineses associated with each of these eight facial movements, five synkineses 
decreased and three synkineses increased, one significantly 
5. Patients reported fewer complaints concerning pain, stiffness, involuntary movements, sensation, 
eating, drinking, speaking, and quality of life. 
5. According to the HB-FGS, almost all patients improved on average by one level in 8 to 10 sessions. 
6. Age, sex and affected side were not predictive of any of the observed changes. 
7. A high degree of stability of inter-individual differences was observed. 
8. Mime therapy might be a source of the improvements observed. However, research following a more 
strict design such as a RCT is required. 
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Literature review of evidence based physiotherapy in patients with facial 
nerve paresis 
1. Introduction 
1.1 Incidence 
About half of the incidence of peripheral facial nerve paralysis in western countries is as a consequence of 
Bell's palsy; 20100.000 adults per year '^ This implies that there are 40:200 000 new cases of peripheral 
facial nerve paralysis per year of which approximately 30% will develop a facial nerve paresis with 
sequelae (asymmetry of the face at rest and during movement, problems with speaking, eating and 
drinking and lack of quality of life) varying from very mild to very severe."1 According to an a-selective 
survey (unpublished internal report) among 400 Dutch physiotherapists (response rate 76 %) in 1996, 
25% of them were involved in the treatment of patients with facial nerve paresis. 
1.2 Background of a review until mid 1991 
An earlier review of the international literature of physiotherapy for patients with facial nerve paresis of 
the period 1966 to mid - 1991, was made in 1992.5 This revealed a variety of physiotherapy modalities 
being practised, mainly: exercise therapy, massage, electrotherapy, biofeedback, ultra sound, short-wave 
diathermy, infrared and hot packs. Of the 17 published articles in this review aiming to study the 
effectiveness of physiotherapy in facial nerve paresis, 14 were based on a pre-experimental design, two 
on a quasi-experimental design and only one was a randomised controlled study (RCT). This RCT from 
Mosforth & Tavemer6 did not show differential outcomes for two modalities of physiotherapy 
(electrotherapy + infrared versus massage therapy). The other studies are, when considered according to 
present standards, too weak concerning their design to substantiate the claimed benefits. The present 
medical scientific community demands RCTs as a golden standard7 and therefore only these are 
considered, the objective being to document the further development of evidence based physiotherapy in 
patients with peripheral facial nerve paresis up to the end of 2002. 
2. Material and Method 
2.1 Criteria for considering studies for this review 
Studies included in this review were selected according to the following set of criteria, a) the design being 
a randomised controlled trial; b) all patients involved had a peripheral facial nerve paresis; c) all 
interventions m which any modality of physiotherapy (a combination of modalities was possible) was 
employed were considered, also studies companng physiotherapy with non-physiotherapeutic treatment 
42 
Literature review of evidence based physiotherapy in patients with facial nerve paresis 
were considered for this study; studies containing interventions such as (electro)acupuncture or 
chiropractic methods were not included because we do not consider these as a modality of physiotherapy; 
d) the studies were published in peer-reviewed journals between 1966 - end 2002. The search was not 
only performed out between mid 1991 until the end of 2002, but again between 1966 - mid 1991 to check 
whether articles were missed, the search strategies nowadays being more sophisticated. 
2.2 Search strategy for identification of studies 
A search was performed using computerised bibliographic databases [Medline, Chinai, Excerpta Medica 
(part Rehabilitation & Physical Medicine), PEDro, Current Contents and the Cochrane Library] in the 
period from 1966 - end 2002 by the Dutch National Institute of Allied Health Professions (S. van de 
Heuvel) and the first author to identify randomised controlled trials.8 This was combined with the medical 
subject heading 'facial paralysis' and other keywords pertaining to facial nerve disorders and 
physiotherapy (e.g. Bell's palsy, facial paresis, asymmetry, synkinesis, physical therapy, rehabilitation, 
biofeedback). No language restriction was made. References of identified articles, relevant conference 
proceedings and textbooks were checked by CB. Any additional study that seemed eligible was retrieved 
and assessed according to title, abstract and keywords. The last search for randomised trials was 
performed on December 31st 2002. 
Table 1. The PEDro scale (lasl modified March, 1999) 
1. Eligibility criteria were specified. 
2. Subjects were randomly allocated to groups (in a crossover study, subjects were 
randomly allocated an order in which treatments were received). 
3. Allocation was concealed. 
4. The groups were similar at baseline regarding the most important prognostic indicators 
5. There was blinding of all subjects 
6. There was blinding of all therapists who administered the therapy. 
7 There was blinding of all assessors who measured at least one key outcome. 
8. Measures of at least one key outcome were obtained from more than 85% of the subjects 
initially allocated to groups 
9. All subjects for whom outcome measures were available received the treatment or control 
condition as allocated or, where this was not the case, data for at least one key outcome was 
analysed by "intention to treat". 
10. The results of between-group statistical comparisons are reported for at least one key 
outcome. 
11. The study provides both point measures and measures of variability for at least one key 
outcome. 
no / yes 
no /yes* 
no / yes 
no / yes 
no / yes 
no / yes 
no / yes 
no / yes 
no / yes 
no / yes 
no / yes 
Legend: * No indicates 0 point, yes 1 point for the numbers 2-11 
43 
Chapter 4 
2.3 Methodological quality assessment of the studies 
Trials included in this review were rated using a checklist called the PEDro scale, see table 1. The PEDro 
scale is based on the Delphi list, a validated quality assessment tool.910 This scale considers the following 
aspects of trial quality: a) the internal validity of the trial and b) whether or not the trial contains sufficient 
statistical information to be interprétable. 
In total the PEDro scale contains 11 items, of which 10 items assess internal validity. In judging the 
studies we omitted criterion one (eligibility criteria) because it refers to the generalisation of the results. 
The maximum score by using the PEDro scale is therefore 10. Two reviewers (CB, IB) independently 
assessed each of the eligible studies. In case of disagreement a consensus method was used and a third 
reviewer (RO) was consulted to resolve this disagreement. For each study a total score ranging between 0 
and 10 was calculated by summing the dichotomised scores of 2-11 of the PEDro scale. 
3. Results 
Three randomised controlled trials involving patients with peripheral facial nerve paresis and 
physiotherapy were identified (A: Mosforth & Tavemer6, B' Ross et al ", C: Segal et al.12). See table 2 
for characteristics of these studies. 
Table 2. Characteristics of the included studies. 
Study 
Mosforth 
& 
Tavemer 
1958 
Ross, 
Nedzelski 
& McLean 
1991 
Segal, 
Hunter, 
Danys, 
Freedman 
& Black 
1995 
Method 
-RCT 
- blinding of assessor 
- loss to follow-up 3 
- no intention to 
treat analysis 
- RCT, two 
experimental groups 
randomised, the 
control group nol 
randomised 
- blinding of assessor 
- loss to follow-up: 1 
- no intention to treat 
analysis 
-RCT 
- blinding of assessor 
- no loss to follow-up 
Participants 
-N = 83 
- Age: 3-79 (M=37,5) 
-Sex M 40; F 43 
- Cause: Bell's palsy < 
14 days 
-N = 31 
-Age: 25-71 (M=49) 
- Sex: M. 15, F 16 
- Cause: 
postoperative, Bell's 
palsy, herpes zoster 
- Duration of paresis: 
18 months-10 years 
(M=46 months) 
- N = 10 
- Age. 16-78 years 
- Duration of facial 
nerve paresis 0 5 - 27 
years 
- Cause· 9 Bell's 
palsy, one unknown 
Intervention 
- Experimental group: 
massage + infrared + 
electrotherapy 
- Control group- massage 
- Daily (max 6 months) 
- Exp. group 1 : biofeedback 
+ mirror feedback 
- Exp. group 2: mirror 
feedback 
- Control group: no 
treatment 
- From 2 sessions a week to 
2 per month (total 26), 
duration 1 year 
- Exp Group· small-
movement (anti-
synkinesis) therapy 
- Control group: standard 
therapy (education, 
relaxation, face-tapping, 
biofeedback and exercises) 
- 3 times a week for 4 
weeks 
Outcomes 
No significant 
differences were 
found on any 
outcomes 
No significant 
difference between 
the two randomised 
groups 
No significant 
differences were 
found on any 
outcomes 
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3.1 Results of the design and the methodological quality of the studies 
The overall methodological quality of the studies, assessed by using the PEDro scale, is shown in table 3 
The third reviewer was consulted three times to solve disagreement concerning items 2, 9 and 10. 
Table 3 The methodological quality of the studies as measured by the PEDro scale. 
Author 
Mosforth and 
Tavemer 
Ross et al. 
Segal et al. 
Year 
1958 
1991 
1995 
1 
Y 
Y 
Ν 
2 
1 
1 
1 
3 
0 
0 
0 
4 
1 
1 
1 
5 
0 
0 
0 
6 
0 
0 
0 
7 
0 
1 
1 
8 
1 
1 
1 
9 
0 
1 
1 
10 
1 
1 
1 
11 
0 
1 
1 
SUM 
4/10 
7/10 
7/10 
Each of the three studies was classified as a randomised controlled trial, however the report of Ross 
showed that randomisation was only used to assign patients to the two experimental groups, the control 
group was not formed out of the previous random assignment process. The control group is apparently a 
non-equivalent group and therefore comparison of any of the experimental groups with the non-
equivalent control group is liable to a vanety of internal validity threats. 
The concealment of the randomisation was not mentioned in any of the studies The patients in the 
experimental and control group were comparable for age, sex, and duration of the paresis in study A and 
C, in C also for severity of the paresis. In study Β the experimental groups and the control group were 
comparable for age, besides this the two experimental groups were also comparable for duration and 
severity of the paresis. Patients and therapists were not blinded in the studies, assessors were blinded in 
studies Β and C. Loss to follow-up was reported in study A; two patients because of failure to rc-attend 
and one because of failure to complete treatment due to illness. Study Β lost one patient in the control 
group by attrition; in study C there was no loss to follow-up. None of the studies mentioned an intention 
to treat analysis, however all patients (ten) were analysed m study C. 
Results of physiotherapy as shown by the outcome 'asymmetry of the face' were mentioned in two 
studies, Β and C, study A assessed the final degree of voluntary power. The studies Β and C reported 
means, standard deviation, and Β also the standard error of the results. Besides these measures, outcomes 
in both studies were provided graphically. 
3.2 Characteristics of the participants 
All patients in the studies had a peripheral facial nerve paresis; in study A the cause of the facial nerve 
paresis in all patients was a Bell's palsy, in study Β the causes were postoperative (mainly acoustic 
neuroma), Bell's palsy and herpes zoster and in C all patients except one, had a Bell's palsy. The duration 
of the paresis/paralysis was in study A less than 14 days, ranged in Β from 18 months to 10 years (mean 
46 months) and in C from 0.5 to 27 years (no mean score mentioned). The severity of the paresis was not 
specified in study A and C, in study Β it ranged from House Facial Nerve Grading System I to IV (mean 
III) and the degree of synkinesis ranged from 0 to III (mean 1). 
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The mean age in study A was 37,5 years (3-79), in Β 49 years (25-71 ) and in C a range was given from 16 
to 78 years. 
3.3 Physiotherapeutic interventions in the identified studies 
The interventions in study A were for the expenmental group massage, infrared and electrotherapy, for 
the control group massage alone. Patients were instructed to massage their face daily. Infrared was 
applied to the affected side at 60 cm distance for 10 minutes followed by electrotherapy, each muscle in 
turn stimulated to 30 minimal contractions with a pulse of 100 msec duration and repeated three times. 
Treatment was given daily until active contractions returned and then thrice weekly until recovery was 
virtually complete or the condition seemed stationary (two to six months). 
Interventions in study Β were for the experimental groups EMG biofeedback with mirror feedback or 
mirror training alone, the control group receiving no treatment. EMG biofeedback was carried out for 30 
minutes in combination with structured supervised therapy consisted of relaxation, small graded isolated 
movements and inhibition of synkinesis Besides these exercises patients had to carry out a homework 
program for a minimum of half an hour to one hour daily. The training schedule varied from 2 sessions 
per week to 2 sessions a month with total treatment duration of one year. 
Study C compared a "small-movement" therapy with standard therapy. The standard therapy comprised 
patient education, relaxation, face tapping, biofeedback and "specific actions" (e.g. smiling). The "small-
movement" group received the standard therapy with the difference that subjects had to cease exercises 
when synkinesis occurred, a single maximal movement was then made, the subsequent movement limited 
to half of this maximal movement. All patients received treatments three times a week for a duration of 
four weeks. 
3.4 Effects of the interventions 
None of the studies showed a significant effect of the interventions. Study A reports scores of the same 
level concerning "estimated voluntary power" of the facial muscles in both experimental and control 
groups. Results of the intervention in study Β seem to be beneficial for patients. Significant 
improvements between pre- and post-test were noted concerning linear measures of facial movement and 
visual assessment of voluntary movement. However, the control group was not equivalent to the 
expenmental groups as it was not formed from the random assignment procedure; therefore we can not 
accept their conclusions. Study C showed no significant reduction in synkinesis when the experimental 
group was compared with the control group. 
4. Discussion 
Only three randomised controlled trials were identified over a time period of more than forty years, these 
trials showing diversity in many aspects: heterogeneous patient groups, interventions and outcome 
measures. The quality of the studies ranged from low to moderate/good. 
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Despite the fact that many patients with peripheral facial nerve paresis are referred for physiotherapy, 
little is known about the evidence of the vanous modalities of physiotherapy. However, it has to be taken 
into account that the earliest study is from 1958; at that time guidelines for RCTs such as the CONSORT 
statement (Consolidated Standards of Reporting Trials) were not available." As shown in the many 
descriptive reports in the review of 1996, there was a need to establish information. Reasons for the small 
number of RCTs could be that the percentage of physiotherapists treating patients with facial nerve 
paresis is small, or that specialists are not well informed about the treatment possibilities of 
physiotherapy. Another reason could be that it was difficult to generate groups with sufficient numbers of 
homogenous patients (patients are referred one by one), and therapists are not familiar with a randomised 
waiting list design. 
With three RCTs we were unable to perform a meta-analysis Applying the PEDro scale also gave 
considerations/objections, a disadvantage of the scale being the extended blinding. In physiotherapeutic 
research it is often not possible to blind both patients and therapists for a specific intervention, giving a 
substantially lower score on the PEDro scale 
A further disadvantage is that the number of patients is not categorised in the PEDro scale. The number of 
participants ranged from 10 to 83; none of the studies used a power calculation to detect the number of 
patients needed in the trial. An incorrect number of patients can influence the results in an adverse 
manner. 
Bell's palsy was the cause in most cases and duration of the paralysis varied from less than 14 days to 27 
years. It is generally believed that spontaneous recovery of the facial nerve occurs in the first weeks and 
can continue until approximately nine months. It has to be taken into account that if patients are treated 
within this period of time, positive results could contribute to this spontaneous recovery and not the 
applied therapy. 
The intervention differed in all studies, two studies applying biofeedback (Ross et al." and Segal et al.12) 
and both studies used a variety of exercises Combining several modalities of physiotherapy further 
complicates the discovery of which intervention is effective. 
The main outcome measures were asymmetry of the face measured in three different ways: estimated 
voluntary movement, linear measurement of facial movement and symmetry as a percentage of the 
normal side. Segal et al.12 studied another aspect of asymmetry: synkinesis. None of the studies examined 
disabilities such as eating, drinking and speaking or quality of life. Not known in the studies is whether 
these disabilities decreased or whether patients had an improved well-being due to therapy. 
5. Conclusion 
The conclusions of this review are the following: 
in companson to physiotherapy for other disorders, there is only a small number of RCTs concerning 
physiotherapy and peripheral facial nerve paresis; 
the number of RCTs has hardly increased since mid - 1991; 
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the methodological quality of the included trials is low to moderate; 
none of the included trials showed a significant treatment effect when the experimental group was 
compared with the control group. 
Well designed randomised controlled trials have to be conducted in order to validate physiotherapy for 
patients with facial nerve paresis. 
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Introduction to chapter 5 
Asymmetry of the face is the most striking characteristic of patients with facial paralysis after 
degeneration of the facial nerve Contralateral reinnervation in facial paralysis is a phenomenon 
unknown to most clinicians Knowledge regarding this phenomenon is relevant for the interpretation 
of the mechanisms underlying renewed facial muscle activity and consequently for the prognosis and 
treatment possibilities. 
Prior to commencing treatment of patients with a very severe facial paralysis, physiotherapists are 
advised to gain information regarding electromyography. 
The following article describes a case study of a patient with recovery of the affected side through 
contralateral reinnervation: 
Contralateral remnervation of midline muscles in facial paralysis 
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Contralateral reinnervation of midline muscles in facial paralysis 
We report a patient with activity of the ipsilateral orbiculans oris and nasalis muscles after a complete left 
facial palsy. An electromyogram (EMG) determined that these muscles were innervated by the 
contralateral facial nerve. Contralateral reinnervation in facial palsy is a phenomenon unknown to most 
clinicians and has received little attention in the literature in recent years. ' 1 ' ' 6 7 1 0 · " · 1 4 Knowledge about 
this phenomenon is relevant for the interpretation of the mechanisms underlying renewed facial muscles 
activity and, consequently, the prognosis after a complete facial palsy. Whether the activity evoked either 
by voluntary efforts or by stimulation of the unaffected nerve is due to conduction along nerve fibers or 
muscle fibers crossing the midline is a matter of controversy.12 
Case Report 
Our patient, a 37-year-old man, underwent a resection of a vestibular schwannoma of the left 
cerebellopontine angle. Although the facial nerve was not sacrificed during surgery, the patient had a 
complete paralysis of the muscles of facial expression on the left postoperatively. Three months after the 
operation, the patient was able to perform some voluntary contractions at the left angle of the mouth. As 
this was interpreted as reinnervation of the muscles by the left facial nerve, a jump anastomosis operation 
between the facial and hypoglossal nerves in order to reinnervate the left facial muscles was postponed. 
The patient reported no further progress in the following year. 
One year after the operation, neurologic examination showed a clear asymmetry of the face due to 
flaccidity and weakness of the left facial muscles. The left eye could not be closed entirely. The patient 
was unable to move his left brow but could wrinkle his nose on both sides by contracting the nasalis 
muscles. Upon showing his teeth, the patient was able to produce some voluntary contraction of the 
orbiculans oris muscle at the angle of the mouth on the left. 
Table 1. EMG results. 
Muscles 
(left) 
Obncularis 
oris 
Nasalis 
Spontaneous 
activity 
+++ 
-
Recruitment 
single unit 
Poor 
MUAP characteristics 
Duration 
(ms) 
3-8 
Ν 
Amplitude 
(uV) 
500-1000 
500-1000 
Polyphasia 
+++ 
-
Right facial 
nerve conduction* 
Latency 
(ms) 
13.00 
12 56 
Amplitude 
(uV) 
32 
07 
Legend: * Preauricular stimulation 
Note: +++ = markedly increased; - = absent 
Electrodiagnostic studies of both facial nerves were performed according to standard techniques.2 
Stimulation of the affected (left) facial nerve preauncularly evoked no responses. Stimulation of the right 
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facial nerve evoked responses in both right and left facial muscles. The responses of the right nasalis and 
orbicularis oris muscles consisted of compound motor action potentials (CMAP) of normal configuration 
and latency, whereas the contralateral (left) nasalis and orbicularis ons muscles showed polyphasic 
responses with very long latencies as recorded with needle electrodes (Table 1 and Figure 1) Needle 
EMG revealed fibrillation potentials (3+) and positive spikes (3+) in the left orbicularis oris muscle The 
recruitment patterns of the left orbicularis oris, mentalis, and nasalis muscles were poor; no motor units 
were present in the left orbicularis ocuh, frontalis, and corrugator glabellae muscles. The motor unit 
action potentials (MUAP) on the left side of the face could be recruited only during intense contraction of 
the corresponding muscles on the right and were of low voltage and polyphasic ("nascent potentials"). 
Figure 1. Stimulation of the right facial nerve showing polyphasic responses with very long latencies in 
the left nasalis muscle (A) and the left orbicularis ons muscle (B) recorded with a concentnc EMG 
needle. 
Discussion 
The appearance of movements in the left orbicularis oris muscle 3 months after a complete left facial 
palsy and the delayed response of the left nasalis and orbicularis oris muscles after stimulation of the right 
facial nerve suggest conduction along fibers of this nerve across the midline. This is very likely due to 
sprouting of terminal branches crossing the midline of the face and innervating bundles of muscle fibers 
on the affected side. The long latencies of the responses are compatible with slow conduction in recently 
sprouted nerve branches that are unmyelinated or barely myelinated.' Also, the markedly polyphasic 
response can be explained by different conduction velocities in the reinnervated nerve branches. Possibly, 
the unique properties of the muscles of facial expression lying subcutaneously and the lack of a clear 
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fascia is a prerequisite for such reinnervation by a different nerve. For sensory nerves, such reinnervation 
at the borders of hypesthesia via different nerves is well known.2 
Contralateral nerve innervation has been reported frequently in the past. '34·6·7·'0 " l4 However, no recent 
literature is available, and the phenomenon seems unknown to most clinicians. Contralateral reinnervation 
in patients with a peripheral paralysis of the facial nerve was found in 8 of 17 patients by Kilimov7 and in 
all 10 patients by Gambi and Tonali.4 The orbicularis ons muscle was the most frequently reinnervated, 
followed by the corrugator glabellae and the mentalis muscles. One patient had contralateral reinnervation 
of the nasalis muscle and none had contralateral reirmervation of the orbicularis oculi muscles. Passerini 
et al.10 found contralateral reinnervation for chin muscles in 11 of 23 patients. 
Trojaborg12 suggested that the contralateral response is due to conduction along muscle fibers crossing the 
midline rather than to cross-innervation. This was interpreted as indicating extension of the motor 
endplates across the midline. However, in that case, one would expect voluntary contractions directly 
after a complete facial palsy and not after a delay of 3 months, as in our patient Gambi and Tonali found 
a contralateral response at a maximum of 2 cm from the midline of the orbicularis oris muscle in normal 
subjects. The authors attributed this to the fact that the motor endplates extend somewhat over the 
midline.4 According to Latham and Deaton,8 most fibers continue towards the median plane and cross 
some 5 mm into the opposite half-lip; at that point, the fibers from the two sides interlace on their way to 
their dermal insertions, creating the ridges of the philtrum of the upper lip and the less marked depression 
in the lower lip. Others, however, have found facial nerve supply strictly limited to the ipsilateral side, 
and no muscle responses could be detected beyond the midline frontier.10 
Facial muscle motor endplates are found in the immediate vicinity of the entrance points of the nerves and 
are located eccentrically. This is different from skeletal muscles where the motor endplates form a narrow 
band stretching across the central zone.5 This may explain why the phenomenon of contralateral 
reinnervation is probably seen only in facial muscles close to the midline. Apart from the contralateral 
facial nerve, reinnervation by the ipsilateral trigeminal nerve and terminal branches of the mandibular 
nerve has also been reported in humans.'13 
What determines the extent of contralateral cross-innervation? Roth" suggested that it was the way in 
which the paralysis was established. When this is acute, the reinnervation remains limited, even after 
several years. Other have stated that there is no relation between the severity of damage and the extent of 
contralateral nerve reinnervation nor between illness duration and reinnervation patterns.10 
Clinically, the renewed activity of some left facial muscles was misinterpreted as regeneration of the 
damaged (left) facial nerve, and, consequently, a hypoglossal-facial anastomosis was postponed for Wi 
years. We, therefore, strongly recommend EMG testing after a complete facial palsy, not only to monitor 
reinnervation but also to determine the ongin of the reinnervation, as this may have consequences for 
further treatment 
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Quantification of the sequelae of facial nerve paresis is a major achievement in obtaining scientific 
understanding. 
Patients with facial nerve paresis suffer from a wide variety of sequelae The literature, as well as 
reports by patients, clinicians and own experiences shows that asymmetry of the face is the most 
obvious sequel. 
When measuring asymmetry of the face as a central outcome variable in the evaluation of effects of 
Mime therapy, it is necessary to have a reliable instrument. Although the House-Brackmann Facial 
Grading System is the most widely accepted grading system, this instrument was found not to be 
sufficiently sensitive in measuring small treatment effects. The Sunnybrook Facial Grading System, 
developed by Ross et al. in Canada is a more appropriate measurement instrument. 
In the following article we describe testing the feasibility of the SB-FGS and the inter and intrarater 
reliability: 
Reliability of the Sunnybrook Facial Grading System when performing optimal facial movements 
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Reliability of the Sunnybrook Facial Grading System when performing 
optimal facial movements 
1. Introduction 
Human facial expressions are the result of muscular activity in the face and are not only under voluntary 
control, but also controlled involuntarily through our emotions ' The face displays our emotions. At the 
University Medical Centre (UMC) Nijmegen, rehabilitation of facial expression is named Mime therapy 
which is based upon a combination of mime and physiotherapy, respectively emotions and functional 
movements.2,3 This treatment has been developed for patients with facial nerve paresis i.e. asymmetry of 
the face at rest and dunng movement, problems with drinking, eating, speaking, expressing emotion and 
synkinesis (involuntary or abnormal movement that is associated with a desired movement or motion). 
The aim of Mime therapy is to promote symmetry of the face at rest and during movement and to 
stimulate movement in facial muscles separately whilst avoiding synkinesis. Psychosocial aspects of 
facial nerve paresis and the patient's quality of life are also indirectly focused upon during Mime therapy 
Facial expression is an integral part of human communication and it is through accurate grading of an 
impairment and functional mobility that treatment can be assessed for its effectiveness. Due to the vanety 
of facial expressions and the small yet essential movements which an expression entails, only a trained 
observer can perceive and interpret facial movements of patients with facial nerve paresis Many grading 
systems for facial nerve paresis show variability in interobserver ratings.5 6 The House-Brackmann Facial 
Grading System (HB-FGS) is one of the most widely used and accepted scales today, developed by 
House and Brackmann in 1985.7 It is a gross scale that divides patients' impairments into six categones, 
ranging from grade I being normal function, to grade VI being a complete paralysis, and has shown to 
have good interrater reliability.8 However, the responsiveness is low, meaning it does not distinguish very 
well between the changes made by treatment or between differences in patients.'10 
The HB-FGS is inadequate in that synkineses are not scored separately, thus changes in synkineses 
following treatment can not be measured. A more recently developed facial grading scale in Canada by 
Ross, Fradet and Nedzelski in 1996 is the Sunnybrook Facial Grading System (SB-FGS), which measures 
facial impairments in individuals with facial neuromuscular dysfunction." Ross et al. compared the HB-
FGS to the SB-FGS and found that the SB-FGS was simple and quick to administer and succeeds in a 
wider response range when reporting results compared to HB-FGS. It is essential that clinicians have an 
objective standard and an easy to use tool for interpreting facial nerve paresis. The evaluation 
measurement must be reliable, valid and responsive to neuro-motor changes secondary to treatment. 
The purpose of this study was to examine the subscales and the composite scale of the SB-FGS Dutch 
Language Version (SB-FGS-DLV) for its intra and interrater reliability, enabling the SB-FGS to be used 
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to accurately measure sequelae of facial nerve paresis in our patient population. Studying the subscales of 
the SB-FGS-DLV demonstrates differentiation between the situation at rest and during voluntary 
movements, the presence of synkineses and the composite score. Besides this, we wished to investigate 
the reliability of the SB-FGS-DLV when patients perform optimal symmetrical movements, other than 
maximal movements with respect to synkinesis. 
2. Method 
2.1 Subjects 
During a period of six months, those patients referred to the Department of Physiotherapy at the UMC 
Nijmegen, with a diagnosis of peripheral facial nerve paresis and meeting the inclusion criteria were 
included in this study. In order to participate in the study, the subjects had to have a unilateral peripheral 
facial nerve paresis with absence of nerve and / or muscle transplantation, be 18 years or older, have the 
ability to follow instructions, and to have given written informed consent to take part in this study. 
2.2 Description of the Sunnybrook Facial Grading System 
Figure 1. The Sunnybrook Facial Grading System (by permission of Ross et al.). 
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The SB-FGS (see figure 1, repnnted with permission of Ross et al.), consists of three sections: resting 
symmetry, symmetry of voluntary movement, and synkinesis. 
The scores for the three sections are combined into a composite score by subtracting the resting and the 
synkinesis score from the voluntary movement score. A composite score of 100 would represent normal 
facial function and 0 would indicate complete facial nerve paralysis. The SB-FGS was translated into 
Dutch by the first author (CB), thereafter being translated back into English by a native speaker to test the 
correctness of the translation. In the event of differences, these were discussed until consensus was 
reached (the SB-FGS-DLV is available from the first author). 
The SB-FGS-DLV does not require specialised equipment and can be easily understood by clinicians 
without specialised training in facial rehabilitation. Besides this, the SB-FGS-DLV does not require a 
maximal movement in order for the evaluation to be scored. Brach et al. reported an intraclass correlation 
coefficient (ICC) for mterrater reliability of the SB-FGS to be 0.90 for 15 patients having a HB-FGS of 
III or higher.'2 The intrarater reliability using ICC was 0.94 for both physiotherapy raters Although Brach 
and co-workers have shown good interrater and intrarater reliability scores for the SB-FGS, it is also 
imperative that the SB-FGS be shown to be reliable with various patient samples e g. patients with a HB-
FGS of II or higher, and when used by therapists with little expenence in the field of facial nerve paresis. 
The major difference with Brach and Ross' study is that patients in these studies were requested to 
perform maximal voluntary facial movements The here undertaken study requested patients to perform 
an optimal symmetrical movement keeping the rest of the face as relaxed as possible, so producing a 
more natural movement. Requesting patients with facial nerve paresis to perform maximal movements, 
reveals obvious synkineses. Furthermore, the study by Brach et al. only used two physiotherapists whose 
previous expenence in facial paresis was not mentioned, therefore a continued study is required with a 
greater number of raters and a different patient sample. 
2.3 Instruction in the use of the SB-FGS-DLV 
The SB-FGS-DLV evaluations were performed independently by two physiotherapists and one 
physiotherapy student. The two physiotherapists have had many years of experience in treating patients 
with facial nerve paresis and one of them (CB) was already familiar with the SB-FGS-DLV. The student 
and one of the physiotherapists (MH) were familiarised with the SB-FGS-DLV by means of observing 
previously recorded videos of patients with facial nerve paresis together with a protocol. The student and 
one of the experienced physiotherapists scored eight patients using the SB-FGS-DLV, compared their 
results, and discussed the differences between the scores. These eight patients did not participate in this 
study. 
2.4 Procedure 
The videos of the patients were recorded by a physiotherapist not participating in the study following the 
items on the SB-FGS-DLV and using a standard method for positioning the patient, lighting, and distance 
of the camera from the subject. The patients were asked to maintain their face in a central position and to 
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relax the face, neck, and shoulders, looking straight ahead with their back against the wall and feet flat on 
the floor. This position was held for two minutes to record the face at rest. The subject was asked to 
perform each movement slowly and to hold the position for two seconds and then relax. This was 
repeated three times and all three trials were reviewed. 
3. Statistics 
For interrater reliability of the SB-FGS-DLV, two physiotherapists and one physiotherapy student 
independently scored the SB-FGS-DLV using videotapes of the previously recorded facial examinations 
consisting of a demonstration of each item on the SB-FGS-DLV. Intrarater reliability for each of the 
raters was calculated from an initial scoring and subsequently from a second scoring one week later. The 
videos were presented to each rater in a random order. The ICC was used for statistical analysis of the 
interrater and intrarater reliability of all three raters.13 
4. Results 
Twenty-five patients with unilateral facial nerve paresis took part in the study; 13 with Bell's palsy, six 
following surgery for acoustic neuroma, two with herpes zoster oticus, two with tumor removal other than 
acoustic neuroma, and two patients with trauma. Of the patients, 11 were male and 14 female (mean age 
45 years, range-18-74). The mean duration of facial nerve paresis was 31.8 months (range: 2-156). The 
mean severity of the facial nerve paresis as measured using the HB-FGS was III (range: II - V), measured 
using the SB-FGS-DLV composite score 57 (range. 17 - 92). 
Table I. Intra and interrater reliability (Intraclass Correlation Coefficient [ICC]) 
of the Sunnybrook Facial Grading System-Dutch Language Version (N=25). 
Rater 1 (CB) 
Rater 2 (MH) 
Rater 3 (MM) 
Rater 1 - Rater 2 
Rater 1 - Rater 3 
Rater 2 - Rater 3 
Intrarater reliability 
Rest1 Move2 Synk3 Sum4 
99 
.97 
.98 
.96 
.91 
.93 
.95 
.81 
.83 
.98 
.89 
.95 
Interrater reliability 
Rest1 Move2 Synk' Sum" 
.97 
.96 
.97 
.96 
.94 
.92 
.92 
.82 
87 
.95 
.90 
.93 
Legend. 1. Rest = resting symmetry 2. Move = symmetry of voluntary movement 
3. Synk = synkinesis 4. Sum = composite score 
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The results of this study (see table 1) indicate that the SB-FGS-DLV has an excellent interrater and 
intrarater reliability. The intrarater reliabilities of the composite score for the observers (CB, MH, MM) 
were determined to be ICC = .98, .89 and .95. The interrater reliabilities of the composite score were ICC 
= .95 (rater 1-2), .90 (rater 1-3), and .93 (rater 2-3) respectively. Intrarater reliabilities for the subscales 
vaned between 81 and .99, interrater reliabilities between .82 and .97. For both the intra- and interrater 
reliability the ICC showed the lowest values for the synkinesis subscale. 
5. Discussion 
We believe that the SDB-FGS-DLV as an impairment specific assessment instrument, plays an important 
role in the evaluation of patients with facial nerve paresis. It has demonstrated reliability not only 
amongst expenenced physiotherapists, but also amongst physiotherapists inexperienced in the field of 
facial rehabilitation. The information gathered from the composite score of the SB-FGS-DLV gives a 
concise quantifiable score to rate patients, and improves communication together with other health 
professionals. When considering the various parts of the SB-FGS-DLV, one notices that synkinesis scores 
display the lowest reliability both for the intra- and the interrater measurements. Synkinesis, as an 
involuntary movement, is the most difficult section to score; the difference between slight and moderate 
synkineses especially caused confusion. 
The SB-FGS-DLV is easy to administer, is reliable with short instruction and requires no specialised 
equipment. The difference in reliability between the physiotherapist (MH) and the student can be 
explained by the fact that the student received a longer training in the use of the SB-FGS-DLV than the 
physiotherapist. 
The results show that when the patient performs facial movements which are not maximal, the intra- and 
interrater reliability is excellent, unlike those of Brach et al and Ross et al who used maximal voluntary 
movements. It is important that normal optimal voluntary movement is performed when using the SB-
FGS-DLV due to the fact that information gained from an evaluation should be equivalent to the 
treatment technique administered This is essential when producing accurate clinical outcome measures in 
the evaluation of patients following Mime therapy. 
When considering the framework developed by the World Health Organization's International 
Classification of Functioning, Disability and Health, the SB-FGS-DLV is only part of the complete 
picture of facial function.14 The SB-FGS-DLV as a tool is a functional measurement instrument and does 
not measure disabilities and handicaps These must therefore be separately evaluated, for example using 
the Facial Disability Index as suggested by VanSweanngen and Brach '5 
This study could form the basis for continued research on the effects of physiotherapy in patients with 
facial nerve paresis. Future research should investigate the SB-FGS-DLV's ability to detect changes in a 
patient's condition after e.g. Mime therapy. 
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6. Conclusion 
The results of this study show that the Dutch version of the Canadian Facial Grading System has a very 
good intra- and interrater reliability for patients with facial nerve paresis referred to the physiotherapy 
department at the UMC Nijmegen. The SB-FGS-DLV is also reliable when no maximal movements, but 
op/ima/-symmetrical movements are requested in respect to synkineses. The SB-FGS-DLV is not only a 
very reliable tool for experienced physiotherapists, a short training was sufficient for a physiotherapy 
student to be able to measure in a reliable manner. As the synkinesis score showed lowest reliability, it is 
to be recommended that the scoring protocol be improved. 
Further study specifically involving Mime therapy for patients with facial nerve paresis and the SB-FGS-
DLV's sensitivity to clinically important change is essential in the future. The SB-FGS-DLV will be used 
as one of the outcome measures in a prospective randomised controlled study of the effectiveness of 
Mime therapy on patients with longstanding facial nerve paresis 
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Conclusions of the preparatory studies 
The following conclusions were drawn from the preparatory studies' 
Patients with peripheral facial nerve paresis show a wide range of sequelae, asymmetry of the face 
being the most important one. 
Evidence based physiotherapy of patients with facial nerve paresis is minimal. The literature 
reveals no treatment effects of physiotherapy in the treatment of facial nerve paresis. 
Clinical practice shows that Mime therapy is a valuable treatment and has the potential to be an 
effective therapy. 
A randomised controlled trial into the effectiveness of Mime therapy could substantially enlarge 
and support evidence based physiotherapy of patients with facial nerve paresis 
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Introduction to chapters 7-11 
This introduction is a bridge between the preparatory studies reported in chapters 1 - 6 and the efforts 
to generate an evidence basis for Mime therapy in the chapters 7 - 1 1 . 
The Nijmegen Mime Therapy Study 
The aim of the Nijmegen Mime Therapy Study (NMTS) is to assess the effectiveness of Mime therapy 
in improving facial disfigurements and other sequelae of facial nerve paresis. The results of the 
preparatory studies indicate that a) Mime therapy might be an effective treatment, b) at the moment no 
other efficacious treatment is described in the scientific literature. 
In the field of physiotherapy there is a growing need for evidence based treatments. These 
considerations legitimise the burden of designing and executing a randomised controlled trial in the 
outpatient department where patients with facial nerve paresis are usually treated. The design is 
described according to the guidelines of the CONSORT (Consolidated Standards of Reporting Trials) 
statement on randomised controlled trials.'2 
The design of the NMTS has as its core a two-group RCT, with pre- and post-tests. Added to this core 
are two occasions for follow-up measurements at three and twelve months post-therapy. To evaluate 
the effectiveness of Mime therapy in patients with peripheral facial nerve paresis a randomised 
controlled trial was started April 1st 1999, the treatment group receiving Mime therapy for three 
months, the control group forming a waiting list. The recruitment ended November 30th 2001 Follow-
ups took place between October 1999 and April 2003. See table 1 for the design and measurements 
schema. 
Assignment of patients to treatment or control groups is done within pairs of patients. Although the 
'design-time' in table 1 is the same for all participants in the RCT, the events on the time line of table 
1 occur at the same calendar time only for the members of the same pair. In this way eventual seasonal 
influences are the same in both groups. 
In the section of the design investigating stability, repeated measurements are performed to see 
whether the achievements of Mime therapy at immediate post-test (T2) are stable over a time penod of 
three months (T3) and one year (T4) 
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Table 1. Design of the Nijmegen Mime Therapy Study and measurement schema. 
/ 
Random assignment to 
control and treatment 
group within pairs of 
patients . 
X 
Control group 
Treatment group 
3 months 3 months 3 months 
Wailing Therapy 
| J | J 
T0t Tl c T2C T3C 
3 months 3 months 
Therapy 
I I— I—-
Tl, T2, T3, 
9 months 
9 months 
] 
T4C 
1 
T4, 
Legend: T0C = Pre-test control group, Tl c = post-test control group, T2L = immediate post-test control group, 
Tl|= pre-test experimental group, T2, = immediate post-test experimental group, T3C, Τ4ς, T3|, T4, = follow-ups 
To assess the effectiveness of Mime therapy a comparison is made between the treatment (T2) and 
control group (Tl) at immediate post-test to investigate whether there is a sequelae difference in the 
expected direction, see table 2 (line in bold); the other line between TO (beginning of the waiting 
period) of the control group and Τ1 (beginning of the therapy) of the treatment group, shows the 
comparison done to check whether the random assignment of patients has indeed created equivalent 
groups at pre-test. 
Table 2. Comparison of the control and treatment group of the NMTS at post-test. 
Control group 
Treatment 
group 
Waiting 
1-^ - 1^- I 
Τ θ \ Τ ΐ Τ \ ^ T2, 
Pre-tesK Post-test \ ^ 
\ Therapy \ ^ 
Tl, T2, 
Pre-test Post-test 
Legend: see table 1 
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Background 
Physiotherapy in the Netherlands is often prescribed for patients with peripheral facial nerve paresis, 
even though the evidence for its effectiveness is limited A variety of physiotherapy modalities have 
been applied during the past two decades to alleviate the plight of patients. Intervention tnals using 
randomised control groups have found no evidence in favour of any therapy. We wished to assess the 
effectiveness of Mime therapy, a therapy combining mime and physiotherapy for patients with 
sequelae of longstanding, unilateral, peripheral facial nerve paresis and to give this treatment a 
scientific base 
Participants 
Inclusion criteria were: a) 18 years or older, b) unilateral peripheral facial nerve paresis, c) facial nerve 
paresis existing for more than nine months, d) reinnervation visible on the affected side (no 
contralateral cross-innervation), e) absence of dynamic correction (nerve or muscle reconstruction), f) 
absence of congenital facial nerve paresis, and g) sufficient knowledge of the Dutch language 
All patients were informed by letter about the research project and written consent had to be obtained 
prior to participation. The study was approved by the Advisory Committee on Ethics in Human 
Experimentation at the University Medical Centre (UMC) Nijmegen. Participants in this RCT were 
patients treated at the physiotherapy outpatient departments of the UMC Nijmegen or "Vrije 
Universiteit" Medical Centre Amsterdam. The Physiotherapy Department of the UMC Groningen was 
also willing to participate, but no patients met the inclusion cntena while the time window was open. 
Intervention 
The therapy group received Mime therapy for three months. Mime therapy consists of auto-massage of 
face and neck, breathing and relaxation exercises, specific exercises to co-ordinate both halves of the 
face and to decrease synkineses, exercises in lip closure, letter and word pronunciation exercises, and 
emotional expression exercises. Five trained physiotherapists administered Mime therapy, each patient 
having his/her 'own' therapist. 
The control group was a non-treatment group placed on a waiting list. The waiting period commenced 
directly after the pre-test and ended after three months when the intake for Mime therapy took place 
Objective 
The main purpose of the study is to determine the effectiveness of Mime therapy, more specifically to 
determine whether Mime therapy has positive effects on the asymmetry of the face and other sequelae 
in patients with long-standing (more than nine months) peripheral facial nerve paresis. An additional 
purpose is to assess the stability of eventual benefits of Mime therapy over a one year period 
As there is often confusion concerning efficacy and effectiveness, both definitions are given here. 
Efficacy, the extent to which a specific intervention, procedure, regimen or service produces a 
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beneficial result under ideal conditions? Effectiveness: the extent to which a specific intervention, 
procedure, regimen or service when deployed in the fields in routine circumstances, does what it is 
intended to do for a specified population."1 
Our central hypothesis is that facial asymmetry improves as a consequence of Mime therapy in 
patients with longstanding peripheral facial nerve paresis, and that this results in improvements in 
secondary sequelae: facial stiffness, reduced emotional readability, dysfunctions in eating, drinking, 
rinsing, speaking and lacnmation and psychosocial problems. 
Outcomes variables 
The primary outcome variable is asymmetry of the face: asymmetry at rest, during voluntary 
movement and synkinesis. 
Table 3. Sequelae of facial nerve paresis and the measurement instruments used to asses the sequel. 
Sequel Measurement instrument Data >ource* 
Functioning (impairment) level 
Asymmetry at rest 
Asymmetry during voluntary movements 
Synkinesis 
Stiffness of the face 
Decreased emotional readability 
Sunnybrook Facial Grading System 
(SB-FGS; 1-20) 
House-Brackmann FGS (HB-FGS,1-VI) 
Lip-length / pout index 
SB-FGS (20-100) 
HB-FGS 
Lip-length / pout index 
SB-FGS (0-15) 
Stiffness scale 
Emotional readability matrix 
OR 
OR 
TR 
OR 
OR 
TR 
OR 
PR 
OR 
Disability level 
Problems in eating, drinking, rinsing 
Problems in speaking 
Lacnmation problems 
Facial Disability Index (FDl-physical) 
FDl-physical 
FDI-physical 
PR 
PR 
PR 
Health level 
Non-wellbeing in past month 
Depressivity past 3 months/24hrs 
Tension in social interactions 
Moods in past week 
Coping styles 
Avoidance of social contacts 
Difficulties in social contacts 
Well-being scale 
Depnscope 
Tension / relaxation scale 
State of mind scale 
Utrecht Coping List 
Behavioural tendencies Questionnaire 
FDI-social 
PR 
PR 
PR 
PR 
PR 
PR 
PR 
*OR observer recorded videotaped facial performances, TR: therapist reported, PR: patient reported 
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All primary and secondary sequelae of facial nerve paresis can be described according to the 
International Classification of Functioning, Disability and Health of the World Health Organisation5, 
see table 3. 
This classification distinguishes three levels: functioning (impairment), disability, and health 
(handicap) level. The first column of table 3 shows the sequel, the second column contains the 
measurement instrument used in this study to assess this sequel and the third column contains the data 
source. 
Sample size 
Considerations of power and desired minimal effect size assisted in the choice of the number of 
patients to be assigned in equal numbers to treatment or control group. To guarantee the clinical 
significance of the efficacy of Mime therapy we were only interested in large effects, i.e. standardised 
mean differences (d) at post-test of at least d = 0.80 Consultation of Woodward's table B7 indicated 
that, with our two-group design with a directional hypothesis, 48 patients, equally divided over both 
groups, are sufficient to detect an effect size of d = 0.85 with a significance level set at 5% and power 
of the test at 90%.6 With some protection against eventual dropouts the sample was fixed at 50 
patients, 25 in each group 
This sample of 50 patients was drawn from the population of patients with facial nerve paresis referred 
for physiotherapy at two academic hospitals (UMC Nijmegen and "Vrije Universiteit", MC 
Amsterdam) This population is in fact a continuous stream of patients whose composition has not 
changed during the last ten years. 
The eligibility-window was open between April 1st 1999 and November SO"1 2001. 
Randomisation, sequence generation, implementation 
A coin tossed by an independent administrative employee assigned the patient to the treatment or 
control group for the first member of a pair as patients became available over time. A list of random 
assignment was available before patients appeared in person at the outpatient department. 
The allocation was concealed as only the administrative employee was informed about the random 
allocation sequence. Patients were called up for the first measurement / treatment by this person, at 
this moment the concealment was lifted for the patient. 
Referral files were checked against the exclusion criteria by the main investigator (CB). Immediately 
after pre-test data collection, patients were directed by the administrative employee to the first 
treatment session or to make an appointment for treatment in three months, according to the pre-set 
table of random allocation. 
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Blinding 
As treatment was an active process in comparison to waiting, blinding of the patients to the treatment 
condition was not possible after the pre-test. The same was true for the therapists. At pre- and post-
tests and follow-ups, facial performances of the patient were recorded on video by the therapist and 
assessed by the researcher, blind to the group condition and measurement phase 
Statistical methods 
The equivalence of experimental and control group at pre-test is tested with two-tailed t-tests and chi-
square tests. Group differences at post-test provide the basis for conclusions about treatment 
effectiveness. For the target variable HB-FGS, mean values are reported in accordance with other 
publications, although stnctly speaking HB-FGS scores are rank numbers and group differences were 
analysed by a non-parametric test, i.e Mann-Whitney test. Multivariate analysis of variance is 
performed on the other outcome variables Moreover, pre-test sequelae were entered as covanates to 
adjust for pre-existing between-patient differences. Effect sizes are estimated in those cases where 
group differences were significant (p<0 05). The (in)dependence of the treatment effect from sex, age 
and duration of the paresis was examined by inspecting the interaction terms in three two-way 
analyses of variance (sex by treatment, age by treatment, duration by treatment). 
Demonstration of the absence of mean differences and of trends at follow-up measurements are 
inspected by repeated measures (M)AN(C)OVAs. Moreover, levels of individual lime courses are 
inspected and categorised for patterns of change. Finally, stability of inter-patient differences in 
sequelae over time is analysed by inter-time correlations. 
Flow of participants 
See figure 1 for an overview of the trial profile of participants in the NMTS. 
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Figure 1 Tnal profile of Nijmegen Mime Therapy Study. 
Assessment for eligibility, period 
April 1st 1999-November 30th 2001, 
in Nijmegen and Amsterdam (n=162) 
Allocated to Mime therapy (n=25) 
Received allocated 
intervention (n=24) 
Did not receive allocated 
intervention (n=l) 
Reason: pregnancy, bed rest 
Immediate 
post-therapy 
Randomised (n=50) 
Analysed (n=24) 
Excluded from 
analysis (n=l). 
Reason: dropout 
not related to 
group condition 
3 months 
follow-up 
12 months 
follow-up 
| 
Analysed (n = 23) 
Excluded from 
analysis (n=l). 
Reason dropout: 
heart attack 
Analysed (n = 23) 
Did not meet inclusion criteria 
(n=112), reasons. 
refused to participate (n=6) 
too young (n=21) 
too early referral (n=55) 
complete paralysis (n=5) 
muscle/nerve reconstruction (n=23) 
bilateral facial nerve paresis (n=2) 
Allocated to waiting list (n=25) 
Received allocated 
intervention (n=24) 
Did not receive allocated 
intervention (n= 1 ) 
Reason: terminally ill husband 
Analysed (n=24) 
Excluded from 
analysis (n=l) 
Reason: dropout 
not related to 
group condition 
Analysed (n = 23) 
Excluded from 
analysis (n=l). 
Reason dropout: 
severe car accident 
Analysed (n = 23) 
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Effectiveness of Mime therapy: improvement of facial disfigurement in 
patients with facial nerve paresis 
1. Introduction 
There is a striking contrast between knowledge about the facial nerve and the availability of evidence-
based physiotherapy for patients with facial nerve paresis. Approximately half of the incidence of 
peripheral facial nerve paralyses are cases of Bell's palsy; 20:100 000 adults per year in western 
countries.1'3 The other cases have a variety of aetiologies, mostly trauma, operative-trauma, herpes zoster, 
diabetes mellitus or otitis. Complete recovery of facial function in Bell's palsy is observed in most 
patients within three months.'1 About 30% suffer sequelae, distinct asymmetry of the face at rest and in 
movement, and synkinesis The literature does not provide exact figures for the other aetiologies.5 It is 
generally believed that spontaneous recovery of the facial nerve occurs in the first weeks and can 
continue until about nine months. This study concerns patients with a facial nerve paresis lasting more 
than nine months. 
Associated with asymmetry, problems in drinking, eating and speaking, and of a psychosocial nature are 
frequently observed as longstanding sequelae.6 The focus on facial symmetry is justified by the fact that 
facial symmetry is a determinant for facial attractiveness Evolutionary psychology hypothesizes that 
facial symmetry is a marker of good health, and therefore relevant to interpersonal attraction.7 
Patients suffering from sequelae are often referred to physiotherapists since the medical practitioner's 
options are limited to invasive treatments A vanety of physiotherapeutic approaches have been tried out 
during the past two decades to alleviate the plight of patients with facial nerve paresis.8 Intervention trials 
using randomised control groups9 ' ' have found no evidence in favour of any therapy (Mosforth & 
Tavemer9· electrotherapy vs. massage; Ross et al.10 EMG-biofeedback vs. mirror-feedback, Segal et al."· 
'small-movement'-therapy vs. exercise therapy). Beginning around 1980, Mime therapy was developed in 
the Netherlands specifically for patients with facial nerve paresis through a collaboration between medical 
clinicians and mime-actors.12 Two decades of positive experiences in several Dutch university medical 
centres (UMCs) have shaped Mime therapy into its present form.13 At present. Mime therapy consists of a 
combination of auto-massage, relaxation exercises, and exercises to inhibit synkineses and enhance facial 
expression. 
In order to establish a scientific underpinning for giving Mime therapy to patients with facial nerve 
paresis, a randomised, controlled trial was performed to examine the effectiveness of Mime therapy in 
reducing facial asymmetry. The main purpose of the study was to determine whether Mime therapy, 
under controlled conditions, had positive effects on the asymmetry of the face in patients with sequelae of 
longstanding peripheral facial nerve paresis. 
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2. Methods 
2.1 Participants 
Only patients with penpheral facial nerve paresis, referred to the physiotherapy outpatient departments of 
the UMC Nijmegen, or the "Vnje Universiteit" Medical Centre Amsterdam were considered Referrals 
were made by a general practitioner, ENT specialist, plastic surgeon or neurologist Inclusion criteria 
were: a) 18 years or older, b) unilateral peripheral facial nerve paresis, c) facial nerve paresis existing 
more than nine months, d) some reinnervation visible on the affected side (no contralateral cross-
innervation''1), e) absence of dynamic correction (nerve or muscle reconstruction), f) absence of 
congenital facial nerve paresis, and g) sufficient knowledge of the Dutch language. The study was 
approved by the Advisory Committee on Ethics in Human Experimentation at the UMC Nijmegen. All 
patients were informed by letter about the research project and written consent had to be obtained prior to 
participation. 
2.2 Study design, randomisation and sample size 
The effectiveness of Mime therapy was assessed on the basis of a prospective randomised control group 
design with pre- and post-tests. The first author checked referral files against the inclusion criteria. A coin 
flip, by an independent administrative worker, designated the assignment to the treatment or control 
group for the first member of a pair as patients became available over time. Directly after pre-test, 
patients were invited by the administration to begin treatment, or to make an appointment for treatment in 
three months. The treatment group received Mime therapy for three months The control group was a 
non-treatment group placed on a waiting list. Considerations of power and effect size assisted in the 
choice of the number of patients to be assigned in equal numbers to treatment or control group. To 
guarantee the clinical significance of the efficacy of Mime therapy we were only interested in large 
effects, i.e. a standardised mean difference of at least d = 0.80. Consultation of Woodward's15 table B7 
indicated that, with our two-group design with a directional hypothesis, 48 patients, equally divided over 
both groups, are sufficient to detect an effect size of d = 0.85 with a significance level set at 5% and 
power of the test at 90%. As protection against dropouts the sample is fixed at 50 patients, 25 in each 
group. 
2.3 Treatment 
Mime therapy commenced with the intake after the pre-test on the same day. Five trained physiotherapists 
administered Mime therapy, with each patient having his/her 'own' therapist. Mime therapy is a 
combination of mime and physiotherapy and consists of facial emotional expression exercises and 
functional movements.16 The aims of the treatment are to promote symmetry of the face at rest and during 
movement and to control synkineses, resulting in a better handling of the handicap. Ten treatment 
sessions are given at the outpatient department, each weekly session including sequentially structured 
exercises lasting approximately 45 minutes. Patients also have to perform daily exercises at home. In 
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addition to providing regular information concerning treatment and prognosis, the therapy consists of 
auto-massage of face and neck, breathing and relaxation exercises, specific exercises to co-ordinate both 
halves of the face and to decrease synkineses, exercises in lip closure, letter and word pronunciation 
exercises, and emotional expression exercises. 
The control group was a non-treatment group placed on a waiting list. This was chosen as control, since 
non-treatment is the usual fate for patients with facial nerve paresis and since an evidence-supported 
treatment is lacking. The waiting period started directly after the pre-test and ended after three months, 
when the intake for Mime therapy took place. 
2.4 Measurements 
At pre- and post-test video-recordings of the patients were made by their physiotherapists using 
standardised positioning, facial tasks and instructions. As part of the standard procedure the therapists 
scored their patients in-vivo using both the Sunnybrook Facial Grading System (SB-FGS)17 and the 
House-Brackmann Facial Grading System (HB-FGS)18. This allows for a comparison between scorings 
from in-vivo and from video recorded data. The video tapes were scored by the first author after all data 
had been collected. To ensure that this scorer remained blind to the test times and treatment condition of 
the patients, the tapes were arranged and scored in randomised order For a detailed evaluation of facial 
asymmetry the 13 items of the Sunnybrook Facial Grading System (SB-FGS) were used. The SB-FGS, 
developed by Ross et al. in 1992 measures three components of facial asymmetry: resting asymmetry 
(RAS) (ranging 0 - 4), facial symmetry in voluntary movement (SVM) (ranging 5 - 25), and synkinesis 
(SYN) (ranging 0 - 15). RAS consist of asymmetry of the eye, cheek (naso-labial fold) and mouth, SVM 
and SYN are based on forehead wrinkle, gentle eye closure, smile, snarl and lip pucker. An overall facial 
symmetry score, the composite score, can also be computed. The composite score is calculated as: [4 χ 
SVM - (5 χ RAS + 1 χ SYN)], with 100 representing normal facial function and 0 indicating complete 
facial paralysis. The reliability of the SB-FGS is reported to be high.1920 The SB-FGS gives the primary 
outcome measures. 
As secondary outcome measure the HB-FGS was scored. The HB-FGS, one of the most widely used 
scales, classifies patients' impairments into six general categones, ranging from grade I (normal 
function), to grade VI (complete paralysis). HB-FGS has been shown to have good interrater reliability; 
however, its sensitivity to change in facial symmetry is low.21"23 
Hypothesis 
Our central hypothesis is that facial asymmetry improves as a result of Mime therapy in patients with 
longstanding peripheral facial nerve paresis. More specifically, when comparing the treatment with the 
control group at post-test we expected a higher composite score on the SB-FGS resulting from a) 
increased symmetry of voluntary movements (SVM), b) decreased resting asymmetry (RAS) and c) a 
decrease of synkineses (SYN). We also expected an improved score on the HB-FGS. 
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2.5 Analyses 
The equivalence of experimental and control group at pre-test was tested with two-tailed t-tests and chi-
square tests. Group differences at post-test provide the basis for conclusions about treatment 
effectiveness. For the target variable HB-FGS, mean values are reported in accordance with other 
publications, although strictly speaking HB-FGS scores are rank numbers and group differences were 
analysed by a non-parametric test, i.e. Mann-Whitney test. For the group of primary target variables SB-
FGS, a multivariate analysis of variance was performed on the three SB components, followed by single 
variable F tests. This was done to avoid an undue inflation of type 1 error rate. Moreover, the three pre-
test SB-FGS components were entered as covariates to adjust for pre-existing between-patient 
differences. Effect sizes (Hedges's g24) were then estimated in those cases where group differences were 
significant (p < 0.05) The (in)dependence of the treatment effect from sex, age and duration of the 
paralysis was examined by inspecting the interaction terms in three by two-way analyses of variance (sex 
by treatment, age by treatment, duration by treatment). Finally, a detailed analysis of the treatment effect 
at the item level was carried out with a multivariate analysis of co-variance, with the pre-test scores as co-
variates 
3. Results 
3.1 Recruitment of participants 
Recruitment in both physiotherapy departments started in April 1999. It ended in November 2001 when 
50 patients (21 males and 29 females) met the inclusion criteria and consented to participate in the study, 
see figure 1 in 'Introduction chapters 7 - 11 ' for a trial profile. 
Twenty-five patients were administered Mime therapy for three months, the other 25 patients being 
placed on a waiting list for three months. There was one dropout in each group: one patient was pregnant 
and obliged to maintain bed rest (after five treatment sessions), the other (on the waiting list) because of 
nursing her terminally ill husband. 
3.2 Group equivalence 
There was no evidence that the two groups were not equivalent at pre-test. Baseline characteristics of the 
patient groups are given in table 1. Groups did not differ significantly in sex, age, referral, cause of 
paresis, severity of paresis, affected side, and time interval between the paralysis and the referral. The 
groups also did not differ significantly at pre-test with regard to the target variables (table 2, columns 1 -
4). In our opinion group equivalence is not attenuated by the loss of one patient from each group, as the 
reasons for drop-out are unrelated to the trial. As outcome information on the dropouts is not available a 
full intention-to-treat (itt) analysis cannot be done. However, the sensitivity of the results to drop-out is 
tested by a 'worst-case' scenario, in which the dropout in the treatment group was assigned the worst 
observed outcome, and the dropout in the control group the best observed outcome in their group. 
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Table 1. Composition of the waiting list (WL) and Mime therapy (MT) group at pre-test, Ν = 50. 
Ν (% VU- UMCN)* 
Gender 
Age (mean in years) 
Referred by 
Cause 
Seventy of paresis 
HB-FGS§(mean) 
Sunnybrook-FGS (mean) 
Time between onset and 
intake (median in months) 
Affected side 
Waiting list 
25 (48, 52) 
Male: 10, Female: 15 
43 (SD 15; 20-73) 
General practitioner: 
ENT 
Plastic Surgeon 
Neurologist: 
Bell: 
Acoustic neuroma 
Herpes Zoster. 
Borrelia: 
Traumatic injury: 
Operative trauma. 
3 8 (SD 0.8, median 4, 
36 (SD 18,6-74) 
14(Q3-Q1:20-12) 
Right 9; left: 16 
3 
19 
1 
2 
18 
4 
2 
1 
0 
0 
2-5) 
Mime therapy 
25 (40, 60) 
Male: 11, Female: 14 
44 (SD 14; 20-66) 
General practitioner: 
ENT: 
Plastic Surgeon: 
Neurologist 
Bell 
Acoustic neuroma: 
Herpes Zoster: 
Borrelia. 
Traumatic injury: 
Operative trauma: 
4.2 (SD 0.8; median 4, 
35 (SD 19; 8-70) 
13(Q3-Q1: 18-12) 
Right 13, left 12 
3 
19 
3 
0 
16 
2 
3 
0 
3 
1 
2-5) 
Sig.* 
ns* 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
Legend. * Sig. = significant difference (p < 0.05), VU = Vnje Universiteit Amsterdam, UMCN = University 
Medical Centre Nijmegen; * ns = not significant; * HB-FGS = House-Brackmann Facial Grading System 
3.3 Reliability of measures 
At pre-test two independent evaluations were made for both the HB-FGS and the three components of the 
SB-FGS. One scoring was made by the therapist at intake, the second scoring was obtained from video 
recordings by the first author (C.B.), blind to the group condition and measurement phase. Both sconngs 
were correlated to estimate inter-rater reliability, which turned out to be high (SB resting asymmetry 0.77, 
SB-FGS symmetry of voluntary movement 0.91, SB synkinesis 0.88, SB composite score 0.93, HB-FGS 
Spearman correlation 0.84). The analyses below are all based on the blinded scorings. 
3.4 Treatment effects 
The mean values of the target variables for all conditions can be found in table 2. All target variables at 
the post-test show mean group differences consistent with our hypothesis concerning positive effects of 
Mime therapy Therefore it makes sense to test whether these differences are statistically significant. To 
evaluate the effects of Mime therapy, the mean scores of the treatment group at post-test were compared 
with those of the control group. 
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Table 2. Results of comparison of waiting list (WL) (N = 24) and Mime therapy (MT) group (N = 24) 
respectively at pre and post-test concerning the House-Brackmann Facial Grading System (HB-FGS) and 
the Sunnybrook-FGS (SB-FGS), assessed by blinded scoring of video tapes. 
HB-FGS (mean) 
(median) 
Resting asymmetry 
l.Eye 
2. Cheek 
3 Mouth 
SVM' 
4. Forehead wrinkle 
5 Gentle eye closure 
6. Open mouth smile 
7. Snarl 
8. Lip pucker 
Synkinesis 
9 Forehead wnnkle 
lO.Genlle eye closure 
11 .Open mouth smile 
12.Snarl 
13.Lip pucker 
Composite score 
Pre-test 
WL 
Mean (SD) 
3.8 (0.8) 
4 
11.2(5.2) 
0.80 (0.40) 
0.80 (0.50) 
0.76 (0.44) 
55.4 (14.5) 
2 5(1.3) 
3.6 (0.9) 
2.6(1.0) 
2 2 (0.9) 
2 8 (0.8) 
7.8(3.1) 
1.6(0 8) 
1.3(0.8) 
1 3 (0.9) 
1.6(0 7) 
2.0 (0 9) 
35.9 (17.5) 
MT 
Mean (SD) 
4.2 (0.9) 
4 
12.2 (3.3) 
0.68 (0 48) 
0.71 (0 47) 
0.88(0 33) 
54.7(17.4) 
2.4(14) 
3.6(0 8) 
2.5(10) 
26(1.1) 
26(1.0) 
7.6 (2.6) 
1.5(0 9) 
1.2(0.7) 
1.3(0.8 ) 
1 5 (0 7) 
2 0(0.8) 
35.1 (19.2) 
Sig.· 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
Post-test 
WL 
Mean (SD) 
3.9 (0.8) 
4 
11.9(4.9) 
0.71 (0.46) 
0 79(0.51) 
0 88 (0.34) 
54.8 (14.2) 
2.4(1.3) 
3.7 (0.9 ) 
2.6 (0.9) 
2 3 (0.9) 
2 8 (0.8) 
8.0 (3.5) 
1 7 (0 9) 
1.4(0 7) 
1.7(0.9) 
16(0 8) 
2.1 (0 9) 
34.5 (16.2) 
MT 
Mean (SD) 
3.3 (0.8) 
3 
7.1 (3.9) 
0 71 (0.46) 
0 46(0.51) 
0 25 (0.44) 
66.7(15.3) 
2.6(15) 
4 0(0 7) 
3.5(0 9) 
3 2(10) 
3 4 (0 8) 
4.9(1.8) 
1.0(0.6) 
0 8(0 5) 
0.8 (0.5) 
0 8 (0.6) 
1 4(0.7) 
54.9 (18.2) 
Ρ* 
p < 0 0 1 
ρ < 0.01 
ns 
p < 0 05 
p < 0 0 1 
ρ < 0.01 
ns 
ns 
p < 0 0 1 
ρ < 0.01 
p < 0 0 1 
ρ < 0.01 
p < 0 0 1 
p < 0 0 1 
ρ < 0.01 
ρ < 0.01 
ρ < 0.01 
ρ < 0.01 
* Sig = significant difference (ρ < 0.05); two-sided t-test; ns = nol significant; ρ = probability; one-sided t-test; not 
adjusted for pre-test; 'SVM = Symmetry of Voluntary Movement 
For the HB-FGS the treatment group scored significantly better than the control group (Mann-Whitney 
test, ρ < 0.01) For the SB-FGS the overall multivariate test showed a significant difference between the 
Mime therapy and the control group (Wilk's Lambda = 0.57, F = 10.89, ρ < 0 01). This overall difference 
turned out to be based upon significant between-group differences for each of the three SB-FGS 
components (resting asymmetry· F = 14.3, ρ < 0.01; voluntary movement symmetry: F = 7.7, ρ < 0.01, 
synkinesis: F = 15.3, ρ < 0.01). This pattern of results was the same for analyses including dropout scores 
estimated according to the worst-case scenario. Hedges's g coefficient indicates, just as Cohen's d 
coefficient25, effect size as a kind of standardised difference between the means of the treatment and 
control groups. The difference between the two coefficients is that g is an estimate of effect size observed 
in the sample, while d is an estimate of the population effect size; both coefficients can be transformed 
back and forth (see endnote *). After adjustment for pre-test between-patient differences, the effect sizes 
of Mime therapy are substantial: g = 1.80 for resting asymmetry (RAS), g = 2.54 for voluntary movement 
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symmetry (VMS), g = 1.50 for synkinesis (SYN), and g = 3.64 for the composite score. To facilitate 
comparisons with other research the last column of table 2 contains the probability of the t statistic 
without correction for pre-test between-patient differences. 
Generalisation of treatment effects over sex, age, and duration of paresis 
Patients differ in sex, age and duration of paresis. The age variable was tnchotomised (below 35, 35-50, 
above 50 years). Duration of paresis was dichotomised at the median (13 months); note that duration of 
nine months or less was excluded. For SB-FGS and its three components, no significant interactions of 
treatment with sex, age, or duration of paresis were found. The effects of Mime therapy appear to be 
similar in the sexes, all three age groups, and both duration groups. 
Treatment effects at SB-FGS item level 
The overall multivariate analysis of variance (Wilk's Lambda) on all 13 pre-test item scores of SB-FGS 
did not reveal significant differences between groups. The same overall test at post-test, with correction 
for pre-test differences on all 13 items revealed significant group differences for 12 out of 13 items in 
favour of the Mime therapy group. Eye asymmetry was not affected by Mime therapy 
Adverse events 
No important adverse events were reported. 
4. Discussion 
The main goal of this research was to determine whether Mime therapy would reduce facial asymmetry. 
The results support our hypothesis that Mime therapy substantially improves facial symmetry in patients 
with facial nerve paresis. The Sunnybrook scale revealed improvements in all three components of facial 
symmetry in the treatment group as compared to the control group at post-test. The House-Brackmann 
scale also showed an analogous result. After having undergone Mime therapy, patients' facial asymmetry 
at rest as well as during movement significantly and substantially decreased, as did synkineses. Moreover, 
the effect sizes are large and therefore clinically relevant. Positive effects of Mime therapy were inferred 
from the existence of post-test differences between two randomly assigned groups. Obviously, receiving 
Mime therapy (or not) is a major component of this treatment differential. It might be argued that control 
group resentment for being on a waiting list could also have had an effect. However, as waiting lists in the 
Dutch health care system are ubiquitous, patients considered this as 'normal'. We have no indications that 
patients in the waiting list groups felt 'disadvantaged', nor that patients in the treatment group felt 
'elected' 
Although we found that the therapy effect can be generalised over sex, age and duration of the paresis, it 
is necessary to caution that this conclusion is based on analyses with relatively low power. 
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Our sample can be considered as a random sample from a stream of patients with facial nerve paresis 
attending both outpatient departments for more than ten years. There are indications that this stream of 
patients has a constant composition and we assume our results to be valid for future patients. 
In contrast to other non-RCT studies using the HB-FGS (Coulson and Croxon22; Segal et al.26), we found 
a significant pre-post treatment difference of nearly one grade, which is considered clinically significant. 
There was also a pre-post difference on the composite SB-FGS of more than 10 points, which is 
considered clinically significant. However, not all facial aspects improved. Resting asymmetry of the eye 
was not affected by Mime therapy. It seems that eye asymmetry in most patients is caused by a hypertonic 
orbicular oris muscle (64 % of the patients had a smaller interpalpebral fissure) Apparently, it is more 
difficult for patients to concentrate on their eye when trying to relax it during exercises, than on the 
mouth/cheek region where there are several muscles to focus upon. 
Future research into Mime therapy can address several topics. In addition to attempting replication of the 
present results, the stability of the effects of Mime therapy has to be assessed, as well as its dose-response 
curve. One could even consider giving Mime therapy in an early stage (< ten months after paralysis) of 
the paresis We expect that improving facial asymmetry reduces psycho-social handicaps (impaired 
communication and quahty-of-life, depression); this can now be investigated Finally, a study of the 
processes responsible for the effectiveness of Mime therapy (including an eventual placebo component) is 
recommended. 
5. Conclusion 
This is the first study that demonstrates the effectiveness of physiotherapy for patients with facial nerve 
paresis. Patients benefit from Mime therapy with respect to resting asymmetry, asymmetry of voluntary 
movement and synkinesis, as expressed in a higher composite score of the SB-FGS and a lower HB-FGS. 
The effects are not dependent on age, sex and duration of the paresis (at least nine months). The clinical 
implication is that Mime therapy is a good treatment choice for such patients The costs of the therapy are 
relatively low, treatment time short and physiotherapists and speech therapists can be easily trained to 
give this treatment. 
* Cohen's d and Hedges's g are measures of effect size that can be transformed back and forth according 
to the formula d = g.(N/dfWiihin)'/2- This formula implies that d is always larger than g. 
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Positive effects of Mime therapy on sequelae of facial nerve paresis: stiffness, 
lip mobility and social & physical aspects of facial disability 
1. Introduction 
Since 1980 Mime therapy, a combination of mime and physiotherapy, has been offered in the Netherlands 
to patients with facial nerve paresis. Although Mime therapy has shown satisfying results, there is no 
research to validate this claim. Many reports document that various therapies giving good results are used 
in the treatment of patients with facial nerve paresis.1 However, only a few randomised controlled trials 
are reported concerning effects of EMG biofeedback in combination with exercise therapy.23 
The aim of Mime therapy is to improve symmetry of the face both at rest and during movement, 
simultaneously controlling synkineses; in the process, patients will look and feel better and have fewer 
problems with eating, drinking, speaking and social integration. The treatment consists of a combination 
of (auto)massage, relaxation exercises and exercises to inhibit synkineses, enhance facial expression and 
improve functional movements. To evaluate the effects of Mime therapy, a randomised controlled trial 
(RCT) was started at the Physiotherapy Department of the University Medical Centre (UMC) in April 
1999, patients taking part in this research project being treated at two centres. The study has been 
approved by the Advisory Committee on Ethics in Human Expcnmentation at the UMC. The central 
question in this research is. does Mime therapy have positive effects on the functioning (impairment), 
disability and health (handicap) level of patients with sequelae of longstanding peripheral facial nerve 
paresis?4 In this report, impairment is indicated by stiffness and lip (im)mobility, disability and handicap 
being indicated by the physical and social aspects of the Facial Disability Index (FDI).5 
2. Methods 
2.1 Design 
The effectiveness of Mime therapy or rehabilitation of facial expression is assessed in a prospective study 
by comparing two groups of patients randomly assigned to receive Mime therapy (treatment group) or to 
be on a waiting list (control group). 
2.2 Patient population 
Patients with longstanding peripheral facial nerve paresis who are referred to the physiotherapy 
departments by a general practitioner, ENT specialist, plastic surgeon or neurologist were considered for 
the study. The patients had to meet the following criteria a) 18 years or older, b) unilateral peripheral 
facial nerve paresis existing for more than nine months, c) reinnervation must be visible on the affected 
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side (no contralateral cross-innervation6), d) absence of dynamic correction (nerve or muscle 
reconstruction), e) absence of congenital facial nerve paresis, 0 sufficient knowledge of the Dutch 
language All patients were informed by letter about the research project and a written consent for 
participation was requested 
2.3 Randomisation 
Patients who met the inclusion criteria and signed the consent letter were randomly assigned to one of two 
groups the control group which received no therapy or the treatment group which received Mime 
therapy Random assignment was performed within pairs of patients as they become available If one 
patient was randomly assigned to the Mime therapy group, the next patient of this pair automatically 
entered the control group and vice versa For the first patient of a pair, a coin tossed by an independent 
assistant of the administration department decided the assignment 
2.4 Mime therapy 
Mime therapy has been developed from the components mime and physiotherapy in treating patients with 
facial nerve paresis 7 * It consists of a combination of stimulation of facial emotional expression and 
functional movements The aims of the treatment are to promote symmetry of the face at rest and during 
movement, enabling the patient to control synkineses or mass movements resulting in a better handling of 
the handicap In the present research project, the number of treatment sessions is ten, each weekly session 
lasting approximately 45 minutes The therapy is composed of sequentially structured exercises to align 
the two facial halves, to control and to reduce synkineses, and tasks to reintegrate emotions with 
expressions Patients have to perform the exercises daily at home, assisted by a homework-manual9 
Besides providing information concerning treatment and prognosis, the therapy consists of 
(auto)massage of face and neck, 
breathing and relaxation exercises, 
specific exercises for the face to co-ordinate both halves and to decrease synkineses, 
exercises for eye and lip closure, 
letter and word articulation exercises, 
emotional expression exercises and guidance in communication possibilities 
2.5 Measurement instruments 
Data were collected concerning the level of impairment, disability and handicap of the patient in pre- and 
post-test measures in both the treatment and the control group At the impairment level, stiffness and lip 
(im)mobility were measured, disability was indicated by the physical subscale of the FDI, the social 
subscale of the FDI indicating the degree of handicap 
* Stiffness 
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To measure stiffness of the face, patients were asked to indicate the expenenced stiffness on a five point 
scale (1 = no stiffness at all, 5 = very stiff). 
* Lip (im)mobility 
To assess the functioning of the pen-oral muscles indicating mouth mobility, the length of the lips can be 
measured in two ways; pulling the comers of the mouth apart as far as possible and pulling the comers 
together. Both movements were quantified by calculating the lip-length (LL) and pout (P) indices.10'" 
'Pout' is used in this context as a technical description of protrusion of the lips. Usually the word 'pout' 
suggests an expression of annoyance or pique. In earlier references, the term 'snout-index' has been used. 
Since the word 'snout' has different connotations in English as compared to Dutch and German (nose of 
an animal as opposed to the mouth), the term 'pout-index' is be used. 
The LL-index was assessed by the physiotherapist using a sliding caliper and following a standard 
protocol proposed by Jansen et al. The LL-index indicates the ratio between the intercommissural 
distance (ICD) in a resting position and the ICD during contraction of the buccinator, risorius and 
zygomaticus muscles. Higher scores indicate greater mobility. The P-index indicates the ratio between the 
ICD in a resting position and the ICD during contraction of the orbicularis oris muscle Jansen et al. 
report that interobserver variations are negligible and intra-observer variations are moderate on repeated 
measurements. 
* Facial Disability Index Questionnaire 
All patients completed the questionnaire (10 items) comprising the FDI. The FDI is a disease-specific, 
self-report instrument developed by VanSwearmgen & Brach in 19965 for the assessment of patients with 
facial nerve paresis. The FDI results in two indices, the level of physical disability (FDI-physical) and the 
level of social handicap (FDI-social). Both indices use a 100 point scale, higher scores indicating less 
impairment and less handicap. Research performed by VanSwearmgen and Brach5 showed that the FDI 
subscales produce reliable and valid measurements in patients with facial nerve paresis. 
Hypothesis 
Mime therapy results in improvement in patients with facial nerve paresis, indicated by a lower score on 
stiffhess and a higher score on lip mobility, FDI-physical and FDI-social indices. 
3. Results 
3.1 Patients 
Between April 1 1999 and November 1 2001, 162 patients were referred to the physiotherapy outpatient 
departments of the UMC Nijmegen or the "Vrije Universiteit" MC Amsterdam. Of these 162 patients, 50 
patients (21 men and 29 women, mean House Brackmann12 grade IV) met the inclusion criteria and 
consented. Reasons for not being included were that patients were too young, had received nerve or 
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muscle reconstruction after complete paralysis, or were referred earlier than the ten months following the 
onset of paralysis 
Twenty-five patients received Mime therapy for three months, the other 25 patients were on a waiting list 
for three months Because waiting lists in Dutch health care are ubiquitous phenomena, patients accepted 
this waiting period. For details of the patient groups see table 1 chapter 7. Groups did not differ 
significantly in gender, age, referral, cause, severity of paresis (measured with the House-Brackmann 
Facial Nerve Grading System), affected side, and the time interval between onset of paralysis and referral. 
There were two dropouts, one in each group, reasons for dropping out were not related to the treatment. 
3.2 Analysis 
The analysis was performed on the basis of data of 48 patients in several steps. 
3.2.1 Analysis step 1, control of equivalence of groups on pre-test 
To check the results of the random assignment procedure, the mean scores of the experimental and the 
waiting list group were compared (two-sided t-test). When the two groups did not show significant 
differences, they were considered to be equivalent. 
Concerning stiffness, the comparison of the two groups at pre-test showed that the mean scores did not 
differ significantly (t-test, ρ = 0.86). For the LL index this comparison of the two groups at pre-test 
showed that the mean LL scores did not differ significantly (t-test, ρ = 0.07), similar results were found 
for the Ρ index (t-test, ρ = 0.35). 
Table 2. Mean scores and standard deviation (SD) of stiffness, lip mobility, FDI-physical and FDl-social 
at pre and post-test for patients in the waiting list (WL) and Mime therapy (MT) group (N = 48) 
Impairment level 
Stiffness 
Lip (im)mobility 
LL-index 
P-index 
Disability level 
FDI-physical 
Participation level 
FDI-social 
Pre-test Mean (SD) 
WL 
3.68 (0.75) 
21 6(8.4) 
16.3(6.2) 
63 2(17.9) 
72.6(17.3) 
MT 
3.72 (0.84) 
17.6(6.7) 
14.7(5.7) 
56 8 (20 7) 
686(14.1) 
Sig* 
ns 
ns 
ns 
ns 
ns 
Post-test Mean (SD) 
WL 
3.54 (0.66) 
19 6(7 7) 
15.7(5 7) 
59 6(17.8) 
66.2(16.4) 
MT 
2 37(0.71) 
23.7(7.3) 
21 (7.3) 
73.5(16 8) 
80 7(12.2) 
Ρ " 
ρ < 0.00 
ρ < 0.03 
ρ < 0.00 
ρ < 0 .02 
ρ < 0.01 
Legend: * Sig. = significanl difference (ρ < 0.05); two-sided l-test; ns = not significant; ** ρ = probability; 
one-sided t-test 
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For both Facial Disability Indices (FDI-physical and FDI-social) the comparison of the two groups at pre­
test showed that both indices did not differ significantly (t-test, ρ = 0.24, ρ = 0.37, respectively). Table 2 
lists the mean scores for all indices in the pre-test in both groups. 
The above reported absence of significant differences between the treatment and control group does not 
depend on gender or age of the patients (ANOVA, no significant interactions). 
The results listed in table 1 and 2 support the assumption of the equivalence of the treatment and waiting 
list group before treatment. This is a precondition for attributing an eventual difference at post-test to an 
effect of Mime therapy. 
3.2.2 Analysis step 2, determination of effects 
To determine the effects of Mime therapy, two sub-steps were performed; (a) the mean scores at post-test 
were inspected to evaluate whether the treatment group differ in the hypothesized direction from the mean 
scores in the waiting list group. Only when this condition is met, does it make sense (b) to use a statistical 
test to determine whether this difference is significantly different from zero (one-sided test). In the case of 
this condition not being met, the data would already contradict the hypothesis of a positive effect of Mime 
therapy. 
Analysis step 2a, control of data consistency with hypothesis 
As can be seen from table 2, all indices at the post-test in the treatment group compared with the waiting 
list group show a difference that is consistent with the hypothesis of positive effects of Mime therapy for 
patients with sequelae of facial paralysis (degree of stiffness is lower for the treatment group, the other 
three indices are higher). 
Analysis step 2b, statistical analysis of post-test differences 
To determine whether the observed differences at post-test are statistically significant, one sided t-tests 
were performed for each of the indices. The results are shown on the right side of table 2. For all indices, 
patients in the treatment group score significantly more favourably compared with the waiting list group. 
3.2.3 Analysis step 3, correction for inter-patient differences 
To evaluate the effects of the treatment more precisely at post-test, i.e. without the blur evoked by pre­
existing inter-individual differences, analyses of covanance were performed on all post-test indices, with 
the corresponding pre-test score as co-variable. The results are listed in table 3. 
After statistical correction for pre-existing differences, significant (p < 0.05) and substantial (Hedges's g 
> 0.813) effects of Mime therapy on all outcome variables are listed in table 3. 
Patients differ also in sex and age. To assess the generalisation of the above results across gender and age, 
these variables were included as additional factors in the ANOVA design. The age variable was 
tnchotomised (below 35 years, 35-50 years and above 50 years) and no significant interactions of gender 
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by treatment, or age by treatment were found. The effects of Mime therapy apparently do not differ 
between the sexes or the three age groups 
Table 3. Effects of Mime therapy versus waiting list condition. Results of ANCOVA after correction for 
inter-individual differences at pre-test (n=48). 
Impairment level 
Stiffness 
Lip (im)mobility 
LL-index 
P-index 
Disability level 
FBI-physical 
Participation level 
FBI-social 
Effects of Mime 
P* 
p < 0 0 0 
ρ < 0.00 
ρ < 0.00 
p < 0 0 0 
ρ < 0.00 
therapy 
(eta2) 
(0.49) 
(0 69) 
(0 60) 
(0.64) 
(0.74) 
Hedges's g 
1.92 
2 78 
2 50 
2.35 
3.02 
Legend: * ρ = probability 
4. Discussion 
Patients with sequelae of longstanding facial nerve paresis who had received ten weeks of Mime therapy, 
showed in comparison to a randomised waiting list control group significantly and substantially 
favourable scores on indices of facial stiffness, lip immobility and the physical and social aspects of the 
FDI. Similar beneficial aspects of Mime therapy were found in a retrospective study often year archive 
data of 175 patients. 
How do our results compare to other RCT studies on facial paralysis patients? 
A search in the English, French and German literature (Medline, Cinahl, Pedro, DocOnline, Excerpta 
Medica and Cochrane) in the period 1975 - 2001 concerning physiotherapy in patients with sequelae of 
facial nerve paresis revealed only two reports of studies with a RCT design. They are discussed below. 
Ross et al.2 studied the efficacy of feedback training in 25 patients with longstanding facial nerve paresis 
in a RCT. They compared electromyographic feedback plus mirror to mirror feedback alone. A third 
group used as a comparison group received no therapy. The designation "RCT" is based on the formation 
of the two treatment groups by random assignment. There was no significant difference between these 
two treatment groups on any of the outcome measures. We do not subscribe to the conclusion of Ross et 
al. that they have provided proof that feedback training was efficacious, because their conclusion is based 
upon the comparison of two treatment groups with a third group receiving no treatment, the latter group 
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not being formed by random assignment. In our study, positive differences were found between the 
treatment and the control group, both being formed by a single random assignment procedure. 
Segal et al.3 reported a RCT comparing "standard" therapy with a new therapy ("small movement") 
intended to reduce synkinesis. They did not find significant differences in the outcome measures between 
both groups, which consisted of a total of 10 patients with a history of facial nerve paresis of five months 
duration or longer. The study of Segal et al. also differs from ours in that they used a very small number 
of patients with a short history of facial nerve paresis. In our study, which includes 50 patients with a 
history of facial nerve paresis of more than nine months, we found significant differences between the 
treatment and control group in all four variables. Although reduction of synkineses was not one of these 
four outcome variables, improved lip mobility and less stiffness could indicate inhibition of synkinesis 
Ongoing data analysis in this Mime therapy study will investigate this hypothesis. 
Strength of the design 
Positive effects of Mime therapy were inferred from the existence of post-test differences between two 
randomly assigned groups. Patients in the treatment group entered directly (after the pre-test) a ten week 
treatment program. Patients in the control group (after the pre-test) were told that the start of their 
treatment was scheduled for three months later The random assignment procedure ensures that the groups 
were equivalent directly after assignment. The differences between the two groups at post-test can only be 
attributed to differences arising after assignment. Obviously, receiving Mime therapy (or not) is one of 
the relevant differences, but are there other factors that are relevant? 
Patients were not blinded as to whether they were on the waiting list or not and, because waiting lists in 
the Dutch health care system are ubiquitous, patients considered this 'normal'. We have no indications 
that patients in the waiting list groups felt 'disadvantaged', or that patients in the treatment group felt 
'privileged'. Stiffness and both FDI-indices are based on patient report- at pre-test no significant 
differences between the groups were found. Physiotherapists performed the lip mobility measurements 
and were not blinded to the patients' group, as they had to make appointments for the ensuing next visit. 
The absence of group differences in lip mobility at pre-test does not support the hypothesis of biased 
measurements. We assume that the therapist's knowledge regarding the patients' condition did not 
differentially influence the lip mobility measurements at post-test In general, physiotherapists did not 
have access to the pre-test data when collecting data at post-test. 
Spontaneous recovery in the three months between pre and post-test is the same in both groups, because 
the groups are formed by random assignment within patient pairs. Differential patient expectancies in 
both groups (part of a placebo effect) could be held responsible for (part of) the observed post-test 
differences. We consider such effects as part of the complex set of mechanisms called upon by 'Mime 
therapy'. Theoretical work has to be carried out in conjunction with process studies to reveal which 
components underlie the positive effects. 
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Conclusion 
This research shows that Mime therapy has positive and substantial effects on four outcome variables 
corresponding to the WHO's classification of functioning, impairment and health. Physiotherapy (in 
particular exercise therapy) when treating patients with sequelae of facial paralysis is not yet evidence 
based, and therefore this research could form a starting point for further development of rehabilitation for 
this group. 
Given the substantial size of the effects, Mime therapy seems to be an important treatment option for 
patients with facial nerve paresis. 
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Stability of benefits of Mime therapy in sequelae of facial nerve paresis over 
a one year period 
1. Introduction 
Mime therapy is a form of physiotherapy offered in the Netherlands for more than 20 years to patients 
with peripheral facial nerve paresis.'2 Mime therapy includes massage, relaxation exercises, inhibition 
of synkinesis and emotional expression exercises. 
A peripheral facial nerve paralysis is a paralysis of the muscles that are innervated by the seventh 
cranial nerve due to a lesion located in the peripheral part of the nerve. Approximately half of the 
cases of penpheral facial nerve para'ysis are Bell's palsies, the incidence being 20.100.000 adults per 
year in western countries.3"5 Other cases have a variety of aetiologies, mostly traumatic injury, 
operative trauma, herpes zoster, diabetes mellitus or otitis media. Complete recovery of facial function 
in Bell's palsy is observed in 70 % of the patients6, however about 30 % of the patients suffer 
sequelae: distinct asymmetry of the face at rest and in movement, and synkinesis. It is generally 
believed that spontaneous recovery of the facial nerve occurs within approximately nine months. This 
study concerns patients with sequelae of unilateral peripheral facial nerve paresis lasting more than 
nine months. 
According to the International Classification of Functioning, Disability and Health (ICF) of the World 
Health Organisation (WHO), sequelae in patients with peripheral facial nerve paresis can be described 
on three levels.7 On a functioning (impairment) level the sequelae are: asymmetry and stiffness of the 
face, on a disability level: problems with eating, drinking, speaking, nnsing the mouth and 
lacrimation, and on a health level psycho-social problems. 
In a randomised controlled trial (RCT), started at the outpatient department of physiotherapy, at the 
University Medical Centre (UMC) Nijmegen and "Vrije Universiteit" Medical Centre Amsterdam in 
April 1999, Mime therapy has been shown to be effective in reducing sequelae in patients with 
longstanding facial nerve paresis. The RCT involved comparing two groups of 25 patients randomly 
assigned to receive Mime therapy (treatment group) or to be put on a waiting list (control group). 
Sequelae on a functioning level concerning asymmetry were measured using the House Brackmann 
Facial Nerve Grading System (HB-FGS)8, the Sunnybrook Facial Grading System (SB-FGS)9, the 
stiffness-scale, and a sliding calliper.10 On a disability level, the sequelae were measured using the 
Facial Disability Index (FDI)" Questionnaire (FDI-physical) and on a health level with the social 
index of the FDI. The SB-FGS, developed by Ross et al. in 1992, measures three components of facial 
asymmetry: resting asymmetry, facial symmetry in voluntary movement, and synkinesis. 
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The conclusion of this RCT was that patients with sequelae of longstanding peripheral facial nerve 
paresis who received ten weeks of Mime therapy, showed significantly and substantially more 
favourable scores on indices of facial asymmetry, stiffness, lip mobility and the physical and social 
aspects of the FDI in companson to a randomised waiting list control group.1213 With this evidence of 
the short-term benefits of Mime therapy the question arose as to the stability of the gains achieved. 
A review of the literature provided us with only one study describing the long-term follow-up after 
rehabilitation (biofeedback) in patients with facial nerve paresis.14 The conclusion of this study was 
that unsupervised, post-therapy, home exercise programs may be detrimental. 
The main purpose of our study is to assess the stability of benefits from Mime therapy over time 
periods of three months and one year. 
2. Methods 
2.1 Design 
The design was a prospective follow-up which was based upon a RCT in which a treatment group was 
compared with a waiting list control group. The follow-up consisted of three measurement occasions 
within one year; immediately after therapy (T2) and three (T3) and twelve months (T4) post-therapy, 
see table 1. Follow-up measurements took place between October 1999 and April 2003. 
Table 1. Schema of the measurements of the Nijmegen Mime Therapy Study. 
/ 
/ 
Random assignment to 
control and treatment 
group within pairs of 
patients 
^N*. 
Control group 
Treatment group 
3 months 3 months 3 months 
Waiting Therapy 
T0C * l t T2C T3C 
3 months 3 months 
Thera^j 
1 1
 Λ k \ Λ 
Tl, T2, T3, 
9 months 
9 months 
— • ι 
Τ4
ς 
fc, ι 
w • 
Τ4, 
Legend' T0C = Pre-test control group, Tlc = post-test control group; T2t= immediate post-test control group; 
Tl,^ pre-test experimental group; T2, = immediate post-test experimental group; T3C, T4C, T3t, T4, = follow-ups 
2.2 Participants 
Forty-eight patients completed the RCT and were available for follow-up. There were two drop-outs, 
one in each group for reasons unrelated to group condition. 
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The wish to demonstrate with a sufficient power (> 85 %) a minimum effect size of at least Cohen's d 
= 0.80, led to the choice of 48 participants in the original RCT. To anticipate eventual drop-outs the 
RCT started with η = 50; one dropout in each group reduced the sample to 48. All patients had given 
informed consent to participate in the RCT including the follow-up. The Advisory Committee on 
Ethics in Human Experimentation at the UMC Nijmegen had given its approval. 
2.3 Measurements of sequelae of facial nerve paresis 
Sequelae of facial nerve paresis were measured during the follow-ups using the same measurement 
instruments as used in the RCT, described in the introduction See 'Introduction chapters 7-11' table 3, 
which contains an overview of measurements 
To measure asymmetry, video-recordings of the patients were made by their physiotherapists at pre-
and post-test and at the two follow-ups, using standardised positioning, facial tasks and instructions. 
The video tapes were scored by the first author on the SB-FGS and the HB-FGS after all data had been 
collected. To ensure that the scorer remained blind to the test times and treatment condition of the 
patients, the tapes were arranged and scored in randomised order. The hp-length (LL) and pout-indices 
(P) were assessed by the physiotherapist using a sliding calliper following a standard protocol 
proposed by Jansen et al.10 The LL-index indicates the ratio between the inter-commissural distance 
(ICD) in a resting position and the ICD during contraction of the buccinator, risonus and zygomatic 
muscles. The stiffness-scale and the FDI questionnaire were completed by the patients themselves. 
2.4 Analyses of stability 
Two types of stability will be analysed: stability of outcome level (A), and stability of inter-patient 
differences in outcomes (B). 
Stability of outcome level 
Stability of outcome level (A) will be analysed primanly (A 1 ) as absence of changes over time in the 
average scores of the three post therapy measurements, and secondly (A2) by inspection of the change 
profiles of all individual patients for all sequelae. 
A.l Absence of post-therapy trends in group averages 
Group-level analysis of absence of changes over time is performed by applying repeated measures 
analysis of variance (ANOVA) and testing for trends. To test whether the differential pre-therapy 
history of our RCT participants influenced the course of post-therapy outcomes the group condition 
was added as a factor in the resulting time (3) by group (2) ANCOVA design. 
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Presence of mean level stability will be inferred by the absence of significant (p < 0.05) trends (linear 
or quadratic) in the three post-therapy measurements. Significant trends will be inspected for 
remission or continued improvement. 
From the RCT analysis it was known that inter-patient differences at pre-test sometimes confounded 
the post-test. To overcome this confounding, ANCOVA's will be performed with the respective 
immediate pre-therapy (Tl) score as covariate. All dependent variables are subjected in this analysis 
procedure, except HB-FGS scores as HB-FGS scores are rank orders, indicating stages. Individual 
patient's HB-FGS time courses will be classified into patterns (covering the whole period Tl to T4). 
A2- Change profiles of individual patients 
The analysis of stability of averaged outcomes (as presented above) fits the framework of evidence 
based medicine. However, the clinical practitioner is focussed on the individual patient. Therefore we 
checked all individual time courses of sequelae in patients with facial nerve paresis for the presence of 
patterns of change in the period T1-T4. For a classification of change patterns see table 2. Patterns that 
are considered to considerate long-term stability (12 months) after therapy have to fall within the 
range (T2 ± 2.SE, SE = Standard Error of the mean). Expressed otherwise, when the condition (T2 -
2.SE) < T3, T4 < (T2 + 2.SE) is met, the change pattern T2 -» T3 -> T4 is classified as stable. 
Table 2. Overview of change patterns from pre-therapy to one year after Mime therapy (Tl to T4). 
Pattern 
1. Deterioration during therapy (T1-T2) 
2 No achievements of therapy (T1-T2) 
2.1 No achievements 
2 2 "Hyper" stability (T1=T2=T3=T4) 
3. Improvement during therapy 
(T1-T2) 
3 1 Improvement continues 
3.2 Improvement continues at T3, 
achieved level at T3 still present at 
T4 
3.3 Achieved level at T2 still present at 
T3 and T4 
3.4 Achieved level at T2 still present at 
T3 and changes at T4 
3 5 Achieved level at T2 still present at 
T4 and changes at T3 
3.6 Deterioration after therapy 
Specification 
Detenoration at T2, T2 < (Tl - 2 SE) 
T1=T2, changes thereafter at T3 and/or T4 
Stable pattern Tl -»T4, including no changes during therapy and 
thereafter, differences at T2, T3 or T4 < (Tl ± 2 SE) 
T4 supenor to T3 [T4 > (T3 + 2.SE)], T3 superior lo T2 [T3 > (T2 + 
2.SE)] 
T3 supenor to T2 [> (T2 + 2.SE)], T3 = T4 [T4 < (T3 ± 2 SE)] 
T2 = T3 = T4 [< (T2 ± 2.SE)] 
a. T2 = T3 [T3 < (T2 ± 2.SE)], improvement at T4 [T4 > (T2 + 2.SE)] 
b. T2 = T3 [T3 < (T2 ± 2 SE)], deterioration at T4 [T4 < (T2 + 2.SE)] 
a. T2 = T4 [T4 < (T2 ± 2 SE)], improvement at T3 [T3 > (T2 + 2.SE)] 
b. T2 = T4 [T4 < (T2 ± 2 SE)], detcnoralion at T3 [T3 < (T2 + 2 SE)] 
Deterioration at T3 and T4 [T3, T4 < (T2 + 2.SE)] 
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Β. Analysis of stability of inter-patient differences 
Pearsons' correlations between time points are calculated for all sequelae of facial nerve paresis except 
for HB-FGS, for which Spearman rank order correlations are calculated. 
3. Results 
In the follow-up of 48 patients there were two dropouts, one patient was involved in a car accident 
(ex-waiting list group), the other suffered a severe heart attack (ex-Mime therapy group). Data were 
available at three and twelve months following treatment from 46 patients. 
3.1 Stability of group outcome levels on SB-FGS, lip mobility, stiffness and FDI 
Except for the pout index and FDI-social, repeated measures analyses of co-variance (ANCOVA, with 
immediate pre-therapy score as covanate) showed no significant differences (p > 0.05) in the average 
scores, nor were there significant trends in the three post-therapy measurements (T2, T3, T4). The 
pout index showed a post-therapy improvement with a linear trend (adjusted means are 12=22.2; 
T3=23.5; T4=24.2). The FDI-social also showed a post-therapy improvement with a linear trend 
(adjusted means are T2= 81.6; T3=83.6; T4= 85.3). These results show group averaged level stabilities 
for all sequelae except for the pout index and the FDI-social, which continue to improve. 
The differential pre-therapy history of our RCT participants did not influence the course of any of the 
post-therapy outcomes when the group condition (waiting list / Mime therapy) was added as a factor in 
the resulting time (3) by group (2) ANCOVA design. This time by group interaction was found to be 
not significant. 
3.2 Stability of levels of individual patients 
Individual time courses of sequelae of patients with facial nerve paresis are classified as to their 
Patient Sequelae Change Pattern (PSCP) during the period T1-T4. Each PSCP is an occasion for 
observing non-stability of therapy benefits. In all there are 9 (sequelae) χ 46 (patients) = 414 PSCPs. 
The results of the classification of PSCPs are listed in table 3. 
Twenty-eight of the 414 PSCPs are not relevant for answenng our question regarding stability of 
benefits, there being no benefits of therapy; PSCP category 1,2 1 and 2.2 in table 3. 
Of the remaining 386 PSCPs, 28 showed repeated deterioration after therapy, both at 3 and 12 months 
(pattern 3.6). 12 months stability was absent in 8 of the 386 PSCPs (pattern 3.4b), 19 PSCPs (pattern 
3.5b) showed a deterioration dip only at 3 months 
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Table 3. Overview of individual Patient Change Patterns over time of Sequelae (PSCP) of facial nerve 
paresis from pre-therapy (Tl) to post-test (T2), three months (T3) and one year (T4) after Mime 
therapy. Cells containing numbers of patients (N = 46). 
Time pattern of PSCP 
1. Deterioration during therapy 
T2<T1 
2.1 No achievements (Tl = T2) 
2.2 "Hyper" stability 
(T1=T2=T3=T4) 
SB-
FGS 
total 
0 
0 
0 
SB-
FGS 
at rest 
1 
3 
9 
SB-FGS 
Move-
ment 
0 
0 
1 
SB-FGS 
Synki-
nesis 
1 
2 
1 
Stiff-
ness 
0 
2 
1 
Lip-
length 
Index 
1 
0 
0 
Pout 
index 
0 
1 
0 
FDI 
PhyM-
cal 
0 
3 
0 
FDI 
Social 
1 
1 
0 
Total 
4 
12 
12 
Improvements during therapy 
3.1 Improvement continues 
T2<T3<T4* 
3.2 Improvement continues at 
T3, T2 < T3=T4 
3.3 Achieved level T2 present at 
T3, T4 (T2=T3=T4) 
3.4 Achieved level ·* 
T2=T3 change T4 
3.5 Achieved level 
T2=T4 change T3 
a.T4t 
b.T4>L 
a T 3 Î 
b T 3 l 
3.6 Deterioration after therapy 
T3 and T4 < T2 
Total 
3 
2 
30 
4 
0 
1 
1 
5 
46 
0 
1 
30 
1 
0 
0 
1 
0 
46 
0 
4 
31 
0 
0 
4 
1 
5 
46 
3 
7 
8 
3 
4 
5 
3 
9 
46 
0 
5 
30 
5 
1 
0 
1 
1 
46 
11 
7 
20 
2 
1 
3 
1 
0 
46 
6 
10 
19 
4 
0 
3 
2 
1 
46 
3 
16 
10 
5 
1 
1 
2 
5 
46 
4 
7 
9 
9 
1 
5 
7 
2 
46 
30 
59 
187 
33 
8 
22 
19 
28 
414 
Legend: * <: detenoration ** Î: improvement 
>: improvement 4: detenoration 
All other PSCPs (386-28-8-19=331) of the relevant 386 PSCPs showed either perfect stability (187) or 
even improvements. 
See figure 1 for an example of improvement at T3 and stability at T4 (pattern 3.2) of the SB-FGS 
composite score of patient number 7. 
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Figure 1. Partial stability of the Sunnybrook - Facial Grading System (SB) composite score, 
demonstrated in patient number 7 [T2 = 56 (2 SE = 2.7)]. PCSP-pattem 3.2. 
T2 + 2 SE 
T2-2.SE 
TO Tl Therapy T2 T3 T4 
Whether only a few patients generated the deterioration was investigated and no systematic patient 
connected detenoration of a group of sequelae was found. 
3.3 Stability of outcome level on HB-FGS 
HB-FGS scores of individual time courses of patients are shown in table 4. 
Table 4. Patients with a specific course on the House-Brackmann Facial Grading System, Ν = 46. 
1 
1.1 
1.2 
1.3 
2 
2.1 
Category 
No achievements of therapy (T1-T2) 
"Hyper" stability 
Stable pattern (T1=T2=T3=T4) 
No achievements during therapy (T1=T2), 1 grade improvement at 
T3, achieved level at T3 still present at T4 
No achievements during therapy, T1=T2=T3, 1 grade 
improvement al T4 
Improvements during therapy (T1-T2) 
1 grade improvement during therapy (T1-T2) and T2=T3=T4 
Total 
Number of patients 
10 
1 
1 
34 
46 
Table 4 demonstrates that 12 patients did not benefit from therapy. 34 Patients improved during 
therapy and the achieved level at T2 was still present at the two follow-up measurements. 
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3.4 Stability of inter-patient differences in sequelae of facial nerve paresis 
Correlations of sequelae seventy immediately post-therapy (T2), and at three months (T3) and twelve 
months (T4) follow-up are shown in table 5. 
Table 5. Stability of inter-patient differences in sequelae severity Pearson correlations between the 
severity of sequelae at immediate post-therapy (T2), and at three months (T3) and twelve months (T4) 
following therapy. Between brackets correlation of follow-ups and pre-thcrapy (ΤΙ), Ν = 46 patients. 
All correlations are significant (p < 0.05). 
Sequelae* 
SB-FGS total 
SB-FGS at rest 
SB-FGS dunng movement 
SB-FGS synkinesis 
HB-FGS** 
Stiffness 
Lip mobility Lip Length index 
Lip mobility Pout index 
FDI-physical 
FDI-social 
T3 
0.96 (0.89) 
0 95 (0.56) 
0 96 (0 88) 
0 91 (0.76) 
0 97 (0 84) 
0 81(0.35) 
0 93 (0 84) 
0 95(0 51) 
0.96(0 81) 
0.91 (0 66) 
T4 
0 95 (0 88) 
0 90 (0 54) 
0.95 (0 88) 
0 89(0.65) 
0.92(0 81) 
0 74 (0 47) 
0.91 (0.86) 
0 92 (0.55) 
0 95(0 841 
0.90 (0 68) 
Legend: *SB-FGS: Sunnybrook Facial Grading System, HB-FGS House-Brackmann-FGS; 
FDI: Facial Disability Index; ** Spearman's correlation 
It is clear from table 5 that inter-patient differences in sequelae severity show high normative 
stabilities for all sequelae. 
4 Discussion 
The question was whether benefits of Mime therapy are stable over a period of one year. This study 
demonstrates three things, a) No trends were found in the average sequelae scores at the three post-
therapy measurements (0-3-12 months after Mime therapy), except for the pout index and the FDI-
social which showed slight continuous improvement, b) Analysis of individual time courses of 
sequelae for the presence of patterns of change in the penod T1-T4 showed stable patterns in 228 out 
of 386 PSCP's (total 414); the HB-FGS which was analysed separately showed stability in 34 patients 
who showed benefits (total 46). Only a small number of the sequelae deteriorated after therapy 
(26/414 PSCP). c) High normative stability for all sequelae of facial nerve paresis was found over 
time. 
Comparison of Shiau's study14 with our study shows several differences besides the applied 
intervention. Firstly, Shia's use of the term 'long-term effect' is confusing as patients officially 
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stopped therapy after the last rehabilitation session and long-term stability would be more adequate. 
Secondly, Shiau's study is not a RCT and only measures one dependent variable the HB-FGS, a 
relatively insensitive scale. Remarkable is that in spite of this, patients detenorate. It is possible that 
the patients improved during therapy, indicating that follow-up scores deteriorated even further. 26% 
of the patients in Shiau's study deteriorated when comparing initial with follow-up function, compared 
to 13 % (patterns 3.4.b, 3.5.b and 3.6) deterioration after therapy in our study. Thirdly, Shiau's study 
uses only HB scores for comparison. All patients had to respond to Medical Outcomes Study 36-item 
Short-Form Health Survey, but this questionnaire is not further used for comparisons. Besides the HB 
score, we also analyse sequelae with the stiffness scale, the lip-length index and the FDI, giving more 
detailed information not only on asymmetry of the face, but also concerning disabilities and psycho-
social problems. 
Why do benefits of Mime therapy show long-term stability whilst various studies of physiotherapeutic 
interventions do not reveal them (see e.g. van Baar et al.15). We can speculate at this point. The 
learning of motor skills and stability of these gains can be explained by the Three-Stage Model from 
Fitts and Posner.16 In the first stage the patient has to understand the nature of the task, developing 
strategies used to carry out the task, this being a cognitive stage of learning (e.g. abduction of mouth 
comer with variations in speed and amplitude). In the second stage the patient has to refine the skill, 
not only using it in closed skills (e.g. abduction of the affected mouth comer), but also in open skills 
(e.g. smiling).'7 The third stage, or the stability stage, is described as an autonomous stage indicating 
that patients can use these skills in other environments (talking to people and smiling). It seems that in 
Mime therapy after a conscious process of recovery (where high compliance is required), the process 
of recovery is ongoing or continues unconsciously. 
It is conceivable that the environment also plays an important role in stimulating this process and the 
continuation thereof. As a facial nerve paresis has a great impact in the communication and 
interactions with others the influence of the (social) environment will cause actions and reactions by 
the patient. In other words the environment invites reactions from the patient. This may also be one of 
the reasons why the patient compliance is very high; patients are extremely motivated in reducing their 
facial disfigurement. Another explanation could be that patients with facial nerve paresis usually do 
not have pain, so are not curbed in their normal behaviour, making it possible that the "stability 
process" continues unconsciously and does not deteriorate, or that the recovery process is ongoing. 
Other factors contributing to the stability of benefits may be the combination of exercises (important 
in the first stage of treatment) with verbal instructions and an extended homework program for 10 
weeks (important in all stages). This combination is favourable in that benefits become incorporated in 
daily life. 
Another item to consider is the high frequency of "hyper" stability of the HB-FGS. Twelve of the 46 
patients (26%) did not show an improvement during therapy, of which 10 are still unchanged one year 
110 
Stability of benefits of Mime therapy 
after therapy. 34 % of the patients in Shiau's study maintained the same HB level. Both studies show 
that HB scores are not sensitive enough to change. The SB-FGS composite score does not show this 
high frequency of "hyper" stability. Apparently the HB-FGS is not very sensitive in measuring 
improvement during therapy, and this causes doubt as to whether the HB-FGS validly reflects stability 
when present. Therefore we recommend the use of the SB-FGS above the HB-FGS 
In Shiau's study, sex significantly affected the relation between initial and follow-up scores, which 
was not the case in our study. We found no sex differences in the deterioration of sequelae. 
It has been shown that the interaction of Group (waiting list control - Mime therapy group) χ Time 
(time penod T2, T3, T4) was not significant, which indicates that the time course is equivalent in both 
groups. In other words these results contradict the idea that being on the waiting list might have a 
long-term negative effect on the stability of the benefits achieved by Mime therapy. 
Conclusion: 
1. On average, benefits of Mime therapy are stable over three and twelve months for all sequelae 
investigated, except for the pout index and FDI-social which showed continuous improvement 
2. Analysis of the individual sequelae-trajectories showed long-term stability after therapy in 45 % of 
all sequelae of all patients. Other patterns are short or long-term continuous improvements (35 %), no 
achievements of therapy (6 %) or deterioration during or after therapy (14 %). 
3. Mime therapy is an investment that continuously pays dividends. 
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Psychosocial sequelae in patients with facial nerve paresis: does Mime therapy 
have an impact that lasts? 
1. Introduction 
Mime therapy, a modality of physiotherapy, has been promoted in the Netherlands in the past decades as 
an effective way to generate lasting benefits for patients with facial nerve paresis. This study reports on 
the evidence basis for this claim with regards to psychosocial sequelae. Previously we have reported on 
the effectiveness of Mime therapy for improving facial disfigurement ' 3 
1.1 Facial paralysis 
A peripheral facial nerve paralysis is a paralysis of those muscles that are innervated by the seventh 
cranial nerve due to a lesion located in the peripheral part of the nerve.4 Approximately half of the cases of 
peripheral facial nerve paralysis are Bell's palsies; the incidence being 20:100.000 adults per year in 
western countries.5"7 Complete spontaneous recovery of facial function in Bell's palsy is observed in 70 % 
of the cases.8 
Other cases are due to traumatic injury, operative trauma, herpes zoster, diabetes mellitus, tumour growth 
or otitis media, etc. The literature does not provide exact figures for the other aetiologies.10 However, 
complete spontaneous recovery in these cases is described as less than 70 %. Not much is known about 
the prevalence of peripheral facial nerve paralyses. Of the estimated 8 million adults in the Netherlands, 
approximately 1600 patients a year will suffer a Bell's palsy, 30 % (480) of these patients will remain 
with a facial nerve paresis with sequelae varying from mild to very severe. It is generally believed that 
spontaneous recovery of the facial nerve starts within the first weeks and can continue until about nine 
months. When there is no complete recovery after this period of nine months, we refer to the affliction as 
longstanding facial nerve paresis. 
Somatic sequelae of facial nerve paresis are facial disfigurements, leading to inappropriate facial 
expressions and loss of the normal signalling pattern. This in tum leads to difficulties in social interaction 
and role-fulfilment, which generate psychological and physical fatigue and psychological distress.9 
1. 2 Psychosocial sequelae in patients with facial nerve paresis 
Designation of a mental state or behaviour as a sequel of a somatic disorder is a causal attribution. Often 
such attributions are based on frequently observed associations between a disorder and the 'sequel' 
Assigning to a mental state or behaviour the status of 'sequel' of facial nerve paresis gives these sequelae 
a surplus value of inevitability, or even of un-changeability as long as the somatic facial disorder exists. 
Many phenomena have been described in the literature as 'sequelae'of facial nerve paresis, but the 
supposed causal link between facial disorder and the phenomenon of interest has generally not been 
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documented by hard evidence Nevertheless, clinical encounters with patients with facial nerve paresis 
and research have generated a list of psychosocial sequelae. 
1.3 Prevalence of psychosocial sequelae 
The literature reports a variety of psychosocial sequelae attributed to longstanding facial disfigurement 
(facial asymmetry at rest, during movements, and synkinesis): depressed mood and anxieties10"; shame 
and associated withdrawal from social contacts, especially with strangers; lack of disfigurement-adapted 
social skills and distorted contact behaviors12''1; social unusual coping behaviours e.g. avoidance of eye 
contact and low self esteem.M"18 
Most reports of psychosocial sequelae were made before 1997. It is remarkable that in the first edition of 
May's authoritative 'Handbook on the facial nerve' of 1986, two chapters were devoted to emotional 
aspects of facial nerve paresis l9 In the second and revised edition of this handbook (2000) this is not the 
case, no chapter being devoted to emotional aspects.2" Only on page 301 Henkelmann and May state: "yet 
routinely these patients show significant emotional distress, evidence of social isolation, and a high 
degree of motivation to regain their lost facial function". 
Recent studies are few in number. VanSweanngen et al.21 reported that 25 % of their USA patients 
experience depressive symptoms in the mild range and another 25% experience symptoms in the more 
moderate to severe range typical of major depressive disorder. In an earlier study (VanSweanngen et al.9) 
it was found that "the level of psychological distress (i c. depressivity) associated with facial neuromotor 
disorders was equivalent to the severity of psychological distress of outpatients with psychiatric disorders, 
and the incidence of anxiety and depression among outpatients with facial neuromotor disorders was 
considerably higher than the incidence of anxiety and depressive disorders in other outpatient 
populations". 
In contrast, a recent investigation by Boersma et al.22 among 61 Dutch patients with a history of facial 
nerve paralysis showed that they did not differ from the general population in terms of their anxiety, 
depressivity and self-esteem. Moreover, no relation was found for these aspects with duration and 
seventy of the paresis. Nevertheless, 20 % of the respondents reported avoidance of public situations. 
Our own research covering 175 patients, treated with physiotherapy at the University Medical Centre 
Nijmegen over the decade 1986-1996, showed that 32 % of these patients indicated they lacked quality-
of-hfe.21 
This leads to our first research question Ql. how prevalent are psychosocial sequelae in patients with 
longstanding facial nerve paresis, and how plausible is it to consider them as real sequelae? 
1.4 Reducing undesirable psychosocial sequelae 
Psychosocial sequelae are usually attributed to facial disfigurement and dysfunction. Especially 
impairment of smiling is supposed to increase the seventy of depressive symptoms (VanSweanngen et 
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al.21). Data from 29 USA patients showed indeed high correlations between smile impairment and 
depressivity even after partialmg out both global facial impairment and facial disability measured with the 
Facial Disability Index FDI (FDI-Physical).2" 
Unfortunately, there is a lack of evidence based treatments for facial impairments. Mime therapy has 
recently been proven to be an effective intervention in improving facial functioning as measured with 
several indices of facial asymmetry, and in improving disabilities measured with the FDI (Beurskens & 
Heymans1). Under the assumption that psychosocial 'sequelae' are indeed 'real' consequences of facial 
disfigurement and dysfunction, we assume that Mime therapy will also be effective in reducing 
undesirable psychosocial sequelae. 
The need for an effective treatment to reduce specifically psychosocial distress becomes more salient 
when reflecting upon the results of research by VanSwearingen et al. It was found that the physical 
disability associated with (somatic) facial impairment could be substantially predicted by the interaction 
of impairment and psychological distress (depressivity), absorbing the predictive power of distress alone. 
Social disability could be predicted by self-report of anxiety and depressivity alone. VanSwearingen et al. 
hypothesise that depressivity acts as a moderator in the relation between facial impairment and physical 
disability More precisely, facial impairment is assumed to generate depressivity as well as some degree 
of physical and social disability, but physical disability depends less upon impairment when depressivity 
is lower, and there is no direct impact of depressivity on physical disability. Moreover, depressivity acts 
as mediator in the relation between facial impairment and social disability 
This leads to our second research question Q2: is Mime therapy indeed effective in reducing undesirable 
psychosocial sequelae, specifically depressivity? 
The third research question Q3 is concerned with the sustainabihty of the eventual psychosocial benefits 
of Mime therapy over a period of one year. Specific sub-questions are: a) is the level of psychosocial 
functioning achieved directly after therapy, stable after three months and also after twelve months? b) Are 
the relative positions of patients directly after therapy the same as those at three months, and at twelve 
months following termination of Mime therapy? 
In summary, the objectives of this study are: 
1) to provide information regarding the presence of psychosocial sequelae in patients with longstanding 
facial nerve paresis, 2) to demonstrate the effectiveness of Mime therapy in reversing these sequelae for 
the better and 3) to show the stability of eventual achieved benefits 
2. Methods 
2.1 Design of the Nijmegen Mime Therapy Study 
To evaluate the effectiveness of Mime therapy in patients with facial nerve paresis, a randomised 
controlled trial was started in April 1999; the treatment group received Mime therapy for three months 
and the control group forming a waiting list To assess the effectiveness of Mime therapy, a comparison 
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was made between the treatment group and control group at immediate post-test (Tic - T2,), see 
'Introduction chapters 7 - 11' table 1. Follow-up measurements were done to see whether the benefits of 
Mime therapy were stable over a time penod of three months (T2 - T3) and one year (T2 - T4). 
2.2 Participants 
Only patients with longstanding peripheral facial nerve paresis, referred to the physiotherapy outpatient 
departments of the UMC Nijmegen or the "Vrije Universiteit" MC Amsterdam, were considered for 
inclusion. Referrals came from a general practitioner, otolaryngologist, plastic surgeon or neurologist. 
Inclusion criteria were, a) 18 years or older, b) unilateral peripheral facial nerve paresis, c) facial nerve 
paresis existing more than nine months, d) reinnervation visible on the affected side (no contralateral 
cross-innervation), e) absence of dynamic correction (nerve or muscle reconstruction), f) absence of 
congenital facial nerve paresis, and g) sufficient knowledge of the Dutch language. The study was 
approved by the Advisory Committee on Ethics in Human Experimentation at the UMC Nijmegen All 
patients were informed by letter about the research project written consent being obtained prior to 
participation. 
2.3 Treatment 
Mime therapy is a combination of mime and physiotherapy and consists of emotional facial expression 
exercises and functional movements 25 The treatment aims to promote symmetry of the face at rest and 
during movement, and to control synkinesis The treatment group received Mime therapy for three 
months. The control group was a non-treatment group placed on a waiting list, this being chosen as 
control since non-treatment is the usual fate for patients with facial nerve paresis and an alternative 
evidence-supported treatment was lacking. The waiting period started directly after the prc-test and ended 
after three months when the intake for Mime therapy took place. 
2.4 Measurement instruments 
At pre- and post-tests and at both follow-ups patients' facial performance was videotaped and a set of 
questionnaires was completed covering several aspects of psychosocial functioning; these included three 
conceptually distinct areas. The first area 'feeling relaxed in social contacts' was covered by an 8-item 
list. As Mime therapy is built upon the idea of introducing relaxation into emotional expression, this 
variable of relaxation is of theoretical significance. This relaxation questionnaire had been previously 
used in a study of a group form of Mime therapy, where it had consisted of two independent components, 
relaxed feelings in contact with friends and/or family, and relaxed feelings in contact with strangers.26 
The second area covered 'moods and feelings'. Three questionnaires were used, covering four different 
time tracks to be overseen by the patient In the Moods Questionnaire (MQ) the patient indicated the 
extent (scale 1 - 9) to which each of 20 moods had been present in the past week, equal numbers of 
positive and negative moods being included. The Well-being Questionnaire (WBQ) consists of 24 items 
requesting subjective evaluation of indicators of (absence of) quality-of-hfe in the past month.27'28 This 
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questionnaire contains 6 a priori subscales: depressivity, vital exhaustion, generalised anxiety, health-
anxiety, self-control, and positive well-being. 
The experience of depression symptoms in the past three months was assessed with Depriscope.29,30 This 
checklist consists of 31 symptoms associated with depression and asks for the number of days that the 
patient has expenenced each symptom in the past 3 months. Each item is dichotomously scored according 
to whether the number of symptom days was remarkable (i.e. present more frequently than in the 
reference group) or not. The D-Intrusion score (range 0 - 3 1 ) indicates the amount of symptoms which 
have intruded into the patient's mental life, or have been experienced to a remarkable degree in the past 
three months. A D-Intrusion score of 21 or higher indicates that the individual is depression-disordered, 
i.e. at risk for clinical depression. Depriscope also requires the patient to indicate for each symptom 
whether it has been experienced in the past 24 hours; the amount of symptoms for which this is true is 
summarised in the index DNow. 
The third area of psychosocial functioning of patients with facial nerve paresis taps into Behavioural 
Tendencies (BT) to avoid certain situations, and into impressions of being avoided. This BT questionnaire 
was adapted from a German list of psychosocial sequelae of facial nerve paresis, developed by Kiese-
Himmel, Laskawi & Wrede.16 Each of the 23 items was judged by the patient as 'being applicable' or not 
to him/her. See table 1 for sample items from the above mentioned instruments. 
Table 1. Instruments used to assess depressivity, relaxation and avoidance reactions in the Nijmegen 
Mime Therapy Study. 
Instrument 
1. Depressivity 
1.1 Depriscope (31 items) 
Scale II (D Intrusion) 
Scale I (Dnow) 
1.2 Mood scale (20 items) 
1.3 Well-being (24 Hems) 
2. Relaxation (8 items) 
3. Behavioural Tendencies 
Questionnaire (23 items) 
Example 
Indicate how many days you think the condition 
applied to you in the last 99 days (3 months) 
-1 felt depressed 
-1 womed too much about things 
If you have this condition today put an additional 
circle around that number 
To what extend was the mood present the past week 
- happiness - anxiety 
Mark to which extent the statement matches your 
feeling the best over the past month 
Did you feel discouraged or desperate? 
To what extent is the following statement applicable 
-1 feel physically relaxed between strangers 
Answer with yes or no if the situation is due to your 
facial nerve paresis 
-1 avoid acting in public 
Response range 
9 9 - 0 
1 - 0 
9 - 1 
5 - 1 
5 - 1 
1 - 0 
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Moreover, somatic assessments were made of facial disfigurement based on blind scorings of the House-
Brackmann Facial Grading System (HB-FGS)31 and Sunnybrook (SB-FGS)32 from video recordings of 
standardised facial performances. A questionnaire, the Facial Disability Index (FDI)24, consisting of two 
scales FDI-physical and FDI-social, was used assessing two aspects of facial disability. 
2. 5 Analyses 
The first set of analyses is psychometric in nature and concerns the refinement, reliability and validity of 
the measures used in this study. The second set of analyses concerns the short-term effectiveness of Mime 
therapy in improving psychosocial functioning. To this end, multivariate analyses of covanance will be 
done separately for each of the three, conceptually distinct, areas of psychosocial functioning. The final 
set of analyses is directed toward the assessment of the stability of eventual benefits obtained from Mime 
therapy over post-therapy time periods of 3 and 12 months. Levels of psychosocial functioning at 
immediate post-test will be compared to levels at both follow-ups, using MANOVA-based trend analyses. 
Ordinary correlations between successive occasions will be used to indicate stability of inter-patient 
differences for all aspects of psychosocial functioning. 
3. Results 
3.1 Participants and intervention procedure 
50 Patients who met the inclusion cntena were randomly assigned to the Mime therapy group or the 
waiting list control group. At immediate post-test T2 there was one dropout in each group: one patient 
being pregnant, the other patient dropped out due to terminal care of her husband In the study of 
immediate effects, 48 patients were analysed. In the follow-up of these 48 patients there were two 
additional dropouts: one patient was involved in a car accident (ex-waiting list group), the other suffered 
a severe heart attack (ex-Mime therapy group). We assumed that these dropouts did not disturb the 
equivalence of the intervention and control group Data from 46 patients were available at three (T3) and 
twelve months (T4) following treatment. 
For a description of the somatic situation of the patients at pre-test see table 1, chapter 7. Overall facial 
disfigurement is indicated by the scores on HB-FGS and the SB-FGS. 
Patients were individually invited to the hospital for the pre-test. Although patients never met the other 
participants, they were conceptually treated as 'members of pairs', of whom one member was assigned at 
random to the direct treatment condition (Mime therapy), the other member to the waiting list control 
condition. An administrative employee knew of this assignment in advance, but informed the patient on 
same-day start of treatment vs. treatment-start-in-three months only after the patient had completed the 
pre-test assessments The waiting list patients received an appointment card with the date of their 
expected return for therapy and were not contacted by the hospital dunng the waiting penod. 
Mime therapy was given in the outpatient departments of two hospitals. Five trained physiotherapists 
administered Mime therapy, with each patient having his/her 'own' therapist. Mime therapy consisted of 
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auto-massage of face and neck, breathing and relaxation exercises, specific exercises to co-ordinate both 
halves of the face and to decrease synkineses, exercises for eye and lip closure, letter and word exercises, 
and emotional expression exercises." There were ten treatment sessions, with each weekly session 
including sequentially structured exercises lasting approximately 45 minutes. Patients also had to perform 
daily exercises at home. 
3.2 Psychometric analyses of the test battery for psychosocial sequelae of facial nerve paresis 
The general strategy is firstly to investigate per area the structure of the set of scales at Tl (because we 
expect variation to be largest pre-intervention) and interpret the Tl structure in the light of knowledge 
from previous research, and secondly to investigate at T2, T3 and T4 whether a similar structure as at Tl 
is present. This structural stability over time is especially desirable for answering the research question on 
the stability level of benefits achieved by Mime therapy. At all time points, Cronbach's coefficient alpha 
will be reported as an estimator of scale reliability; see table 2 
Table 2. Reliability of scales (Cronbach's coefficient alpha) at all time points. 
Area A 'Relaxation' 
Area Β 'Moods & Feelings' 
or 'Depressivity' 
bl. Dnow (Depnscope) 
b2. Down (Moods Q) 
b3. Optim (Moods Q) 
b4 Depressivity (WB) 
b5 Vital exhaustion (WB) 
b6. General anxiety (WB) 
b7. Health-anxiety (WB) 
b8 Positive wel 1-b (WB) 
b9. Self-control (WB) 
blO. D-Intrusion (Depnscope) 
Area C 'Avoidance tendencies' 
source: BTQ 
cl.Detrel* 
c2 Socsup 
c3 ACFP 
TO 
.90 
70 
.86 
.68 
87 
.71 
.72 
.65 
.47 
.75 
.96 
.52 
68 
.85 
Tl 
.84 
.74 
.90 
.65 
.84 
.81 
78 
.84 
.37 
73 
.94 
.61 
.54 
84 
ALPHA 
T2 
.82 
80 
91 
81 
.92 
.81 
.84 
.79 
.73 
.73 
.95 
86 
.51 
.71 
T3 
.87 
.86 
.91 
.84 
.89 
84 
.83 
.79 
76 
86 
.95 
.75 
83 
81 
T4 
.90 
86 
89 
.81 
.85 
.87 
.60 
.82 
.63 
.54 
.94 
79 
.59 
.82 
Legend: * Detrel Deterioration of relations, Socsup: receiving social support; ACFP Avoiding Confrontation 
with own Facial nerve Paresis. 
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3.2.1 Relaxation Questionnaire 
Pnncipal component analysis of the Relaxation Questionnaire (RQ), and inspection of the scree-plot, at 
Tl (immediately before start of Mime therapy) showed to contain one component; 'relaxed feelings in 
contact with fhends/family/strangers' This component was also found in the data at T2, T3 and T4. 
Alpha-coefficients at each time point were high (between .82 and 90). 
3.2.2 The Moods Questionnaire 
Principal component analysis of the MQ at Tl showed the questionnaire to contain two components, an 
optimistic component labelled 'Optim' (items 1, 8, 10, 15, 17, 18, 20; the items 15 and 18 arc rcvcrsed-
scored) and a component labelled 'Down' assessing depressed moods (items 2, 3, 4, 5, 6, 7, 12, 13, 16, 
19). Three items were left out, numbers 9, 11 and 14, respectively 'touched', 'melancholy' and 'insecure', 
because they could not be classified as clearly and/or consistently belonging to one of the components. A 
similar structure of the MQ was observed at T2, T3 and T4. These two components explained 
respectively 50 %, 56 %, 58 % and 55 % of the variance at Tl, T2, T3 and T4. Alpha-coefficients at each 
time point were high for both scales, except for the scale 'Optim' at Tl where a moderate alpha of 65 
was found 
3.2.3 The Well-being questionnaire 
The WBQ27 has 6 subscales, based on prior research: general anxiety (items 2, 5, 12, 13), depressivity 
(items 4, 8, 11, 19, 24), positive well-being (items 1, 7, 18), self-control (items 3, 6, 10, 14, 21), vital 
exhaustion (items 9, 15, 22, 16) and health-anxiety (items 17, 20, 23). Alpha-coefficients at each time 
point were moderate to high, with a notable exception for the scale positive well-being, which showed 
low alpha's at TO and at Tl. An alternative way to estimate reliability is through the test-retest 
correlation For the untreated control group the (TO, Tl) correlation is .53 (p < .01), and the (Tl, T2) 
correlation for the whole sample is .65 (p < 01) We take this as an indication that the positive well-being 
scale has sufficient reliability, despite its low alpha's at TO and Tl. We see no reason to exclude the 
positive well-being scale from the set of measures of the target variables. 
3.2.4 Depriscope 
Just as in previous research, the pnncipal components analysis of the 31 depression symptoms at Tl 
revealed a strong first unrotated factor on which all symptoms had positive and high loadings. This was 
the case both when raw 'number of experience days' per item were the data, as well as when each item 
was dichotomously scored for 'being experienced to a remarkable degree' or not. The index D-Intrusion 
was formed per patient as the sum of all 31 dichotomous scored items, and indicates the amount of 
depression symptoms experienced to a remarkable degree within the past 3 months A similar analysis of 
the dichotomous 'present/absent' scores in the past 24 hours for all 31 items also showed one general 
factor (next to several other smaller ones); the index DNow was calculated per patient as the sum of these 
31 'present/absent in past the 24 hrs' scores. 
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Analogous analyses at T2, T3 and T4 gave similar results for D-Intrusion and DNow. For the D-Intrusion 
items, the first unrotated factor explained more than half of the explainable variance at all time points Tl 
- T4, and all symptoms had positive and high loadings. Alpha coefficients for D-Intrusion are high 
(between .94 and .96) at all time points (see table 2). 
Depriscope also provides the possibility to assess someone as 'depression-disordered' on the basis of the 
D-Intrusion score: to be a 'case' the D-Intrusion score has to be higher than 20 The value of this cut-off 
point is based upon an aspect of the internal structure of Depriscope, which can be checked for its 
presence in the sample of this study. When a regression-plot is made of the total number of days in which 
depression symptoms have been experienced (NDepDays) against the number of symptoms experienced 
to a remarkable degree (=D-Intrus), a gradual, small increase of NDepDays can be observed for every 
increase in the number of symptoms (D-lntrus), up to about 20 symptoms. From 21 symptoms onward 
more symptoms experienced lead to a disproportionate, exponential increase in the number of experience 
days. Such a regression plot is shown for Tl data in figure 1 below. We take this as evidence that 
although D-Intrus measures depressivity, a D-lntrus score higher than 20 signals that the individual is in a 
different state of mind, namely 'being flooded by depression symptoms' or 'depression-disordered'. 
Figure 1. 
Number of depri-symptom days 
in function of amount of symptoms 
Ώ
 Observed 
π Growth model 
0 
3.2.5 Behavioural Tendencies Questionnaire 
The BTQ items have their origin m interviews with German patients. Nothing is known from previous 
research regarding the structure of this set of complaints. Comparison of the principal components 
solutions between time points did not generate an interprétable and continuous structure We suspected 
that this could be due to the correlated (oblique) nature of the underlying structure at some time points. 
Therefore we applied hierarchical cluster analysis (Ward method) to the set of 23 BTQ items. Three 
at p re - t e s t N M T S (N = 50) 
D-Intrusion ( n o t symptoms) at prc-icst 
Ht of growth model Η · · 2 - 0 70 
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interprétable and over time replicable clusters were found: a) "deterioration of relations" (Detrel) (items 
1, 2, 3, 7, 22), b) "receiving social support" (Socsup) (items 4, 5, 6) and c) "avoiding confrontation with 
own facial nerve paresis in contacts with others" (ACFP) (items 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 
19,20,21,23). 
Alpha coefficients are moderate to high at all time points for the components, ranging from .52 to .86 for 
Detrel, from .51 to .83 for Socsup and from .71 to .85 for ACFP. 
3.2.6 Convergent validity within each area 
Area A: Relaxation 
The test battery or the background variables do not contain variables with which convergence on a priori 
grounds can be expected. 
Area B: Depressive Moods & Feelings 
Close inspection of the WBQ, the MQ and Depriscope reveals two things. Firstly, the instruments contain 
4 scales which all measure depressivity by retrospective reporting over 4 different, but overlapping time 
tracks. The DNow-score indicates the presence of depressive symptoms in the past 24 hours; the DOWN-
scale from WBQ indicates the intensity of depression, feelings & moods during the past week; the 
Depressive Well-being-scale from WBQ covers depressive states of mind having occurred in the past 
month; and the Depriscope indicator D-Intrus refers to the amount of depressive symptoms which have 
intruded into the individual's mental life in the past 3 months If all these 4 variables measure aspects of 
the same depressive state of mind, one might expect these variables to show significant & substantial 
intercorrelations. This is indeed the case at all time points Tl - T4, as shown in tables 3 a-c 
A second outcome of the close inspection of WBQ, MQ and Depriscope is that the remaining 6 scales 
also assess content that is supposed to converge with measures of depressivity. The two anxiety-scales 
(General Anxiety and Health Anxiety) should show convergence because of the frequently demonstrated 
co-morbidity of anxiety and depressivity. The Optimistic mood scale from MQ and the Positive Well-
being scale from WBQ should converge empirically with depressivity measures because their item 
contents assert the antidote to depressivity. The WBQ scale VitalExhaustion assesses a well-known 
symptom of depression, persistent fatigue, and belongs therefore to the depressivity complex The WBQ 
scale Self-in-control assesses whether the individual has not (yet) the idea that he/she is helpless against 
the stream of events; such helplessness is according to Sehgman a key ingredient leading to 
depressivity.34 Measures of depressivity are therefore expected to highly correlate (negatively) with the 
Self-in-control scale. When overseeing these expected convergences between 10 scales, one might even 
find such a high degree of overlap suggesting that they are all measuring aspects of the same underlying 
construct; 'depressivity'. 
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Table 3 a-e. Intercorrelations of 4 measures of depressivity at 5 time points. All correlations are 
significant (p < .01, one-sided test). 
3.a. At TO (N = 25) 
DownTO 
DepWbTO 
DInlrusTO 
DnowTO 
.55 
.60 
.70 
DownTO 
.71 
68 
DepWbTO 
.61 
3.b. AtTl (N = 49) 
DownTl 
DepWbTl 
DlntrusTl 
DnowTl 
.47 
.63 
47 
DownTl 
.78 
.77 
DepWbTl 
.70 
3.C. At T2 (N = 47) 
DownT2 
DepWbT2 
DIntnisT2 
DnowT2 
.53 
.51 
.50 
DownT2 
.74 
.69 
DepWbT2 
.79 
3.d. At T3 (N = 46) 
DownT3 
DepWbT3 
DIntrusT3 
DnowT3 
.67 
.63 
.57 
DownT3 
.78 
72 
DepWbT3 
.79 
3.e. AtT4(N=46) 
DownT4 
DepWbT4 
DIntnisT4 
DNowT4 
.70 
73 
63 
DownT4 
.80 
.72 
DepWbT4 
.79 
Principal component analyses on the intercorrelations of the 10 scales in area 2 showed indeed that at all 
4 time points only 1 component with an eigenvalue > 1.0 could be extracted, on which all scales had high 
loadings with the appropriate signs. This component was identified as 'depressivity'. See table 4 for the 
pattern of factor loadings at T1-T4. 
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Table 4. Loadings of 10 scales of area Β on one 'depressivity' dimension for 5 time points. Principal 
components analysis extracted at each time point only 1 factor with eigenvalue > 1.0. 
Scale/Source 
Down / Mood Questionnaire 
Optim / MQ 
Health anxiety / Well-Being Q 
Vital exhaustion / WBQ 
Self-control / WBQ 
Positive well-being / WBQ 
Depressivity / WBQ 
General anxiety / WBQ 
D-Intrusion / Depriscope 
D-Now / Depriscope 
Ν of subjects in 
Principal component analysis 
% variance explained 
TO 
.86 
-.81 
76 
.67 
-86 
-63 
89 
82 
77 
.72 
25 
62% 
Tl 
.86 
-.74 
.80 
.64 
-.79 
-.74 
.92 
87 
83 
.65 
49 
6 2 % 
T2 
.83 
-69 
.90 
.65 
-.86 
-.86 
.94 
.86 
.81 
.65 
47 
66% 
T3 
90 
-.77 
.77 
67 
-92 
-84 
91 
.86 
85 
71 
46 
68% 
T4 
87 
-.77 
90 
81 
-85 
-.77 
.95 
.76 
84 
79 
46 
70 % 
Area C. Behavioural tendencies 
The clusters 'social support received' and 'deterioration of relations' are expected to correlate negatively. 
At all 5 time points a significant negative correlation was found, ranging between -.43 and - 57 
3.3 Prevalence of psychosocial sequelae 
Assessments at pre-test provide an overview of the prevalence of psychosocial sequelae in patients with 
facial nerve paresis referred for physiotherapy. Inspection of the mean scores of the variables in areas A 
& Β makes clear that not every patient is 'relaxed with friends/family/strangers'. Depressivity is present 
in moderate to serious degrees: forty percent of the patients are 'depression-disordered' at pro-test on the 
basis of the D-Intrusions score. As can be seen from table 5, psychosocial sequelae in areas A and Β are 
in our sample empirically unrelated to sex, age, duration of the paresis, and to measures of facial 
disfigurement (HB, SB-total). It is notable that, in this sample, supposed cause (facial disfigurement) and 
supposed sequelae are unrelated. For area C, deterioration in relations was not frequently observed, and 
was unrelated to sex, age, duration of facial nerve paresis, and degree of facial disfigurement. The same is 
true for social support received, except that it is more frequently reported by women then by men. The 
amount of behavioural strategies to avoid being confronted with own facial nerve paresis is clearly related 
to indices of facial disfigurement (HB and SB) and to the degree of handicaps (FDI) reported. 
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Table 5. Prevalence of psychosocial sequelae from 3 areas at pre-test (Pre-test = TO for control group, Tl 
for treatment group), their relation with sex, age, duration of facial nerve paresis, and facial disfigurement 
[House-Brackmann (HB) and Sunnybrook (SB) total score], and indicators of physical disability and 
social handicap (FDI) at pre-test. Ν = 50. 
Psycho-social sequel at pre-test 
Area A 
Relaxation 
8 items, range 8-40 
Area Β 
D-Now (Depnscope) 
31 items, range 0 - 3 1 
Down (MQ) 
10 items, range 10-90 
Optimism (MQ) 
7 items, range 7 -63 
Depressive (WBQ) 
5 items, range 5-25 
Vital exhaustion (WBQ) 
4 items, range 4 - 2 0 
General anxiety (WBQ) 
4 items, range 4 - 2 0 
Health anxiety (WBQ) 
3 items, range 3-15 
Positive well-being (WBQ) 
3 items, range 3-15 
Self-control (WBQ) 
5 items, range 5-25 
D-Intrusion (Depnscope) 
31 items, range 0 - 3 1 
[% depression-disordered, 
i.e. DIntrus >20 1 
AreaC 
Detenoration relations (BT) 
5 items, range 0 - 5 
Social support received (BT) 
3 items, range 0 - 3 
Avoid confront fac paresis (BT) 
15 items, range 0 - 15 
Mean 
SD 
27.8 
7.4 
5.3 
53 
34.6 
15.9 
41.0 
8.0 
10.8 
4.3 
10.3 
2.8 
9.2 
3.0 
8.5 
2.8 
113 
1.9 
195 
3.3 
17 1 
9.2 
40% 
0 66 
1.12 
2.38 
0.88 
4.50 
3.71 
Sex 
.15 
.04 
-.12 
.23 
-.08 
.04 
-06 
-02 
-.08 
.13 
-.06 
-.26 
.28* 
-.00 
Age 
-.25 
.14 
-01 
-.10 
.02 
-.09 
.01 
.10 
.19 
.04 
-.03 
-.15 
-.05 
.23 
Duration 
of paresis 
01 
-.03 
.00 
.07 
-.03 
.07 
-04 
-04 
.05 
.08 
.11 
-.07 
-.06 
-.07 
HB-
score 
-.22 
.04 
.15 
-.14 
.17 
-.08 
.22 
.22 
-.07 
-.26 
-02 
.03 
.03 
.32* 
SB-
total 
.23 
-.06 
-.14 
.16 
-.23 
.05 
-.18 
-.24 
14 
23 
-00 
-.06 
.11 
-.32* 
FDI-
Physical 
.45* 
-.23 
.02 
.17 
-.07 
-.06 
-.21 
-.34* 
-.05 
14 
07 
16 
-03 
-.55* 
FDI-
Social 
.62* 
-.33* 
-.44* 
.60* 
-.53* 
-.51* 
-.45* 
-.50* 
.28* 
.42* 
-.43* 
-.16 
.16 
-.65* 
* = p< .05 (two-sided) 
Table 6 shows the prevalence of each item from the Kiese-Himmel list (BTQ) at pre-test. A comparison is 
made with the prevalence of the sequelae present in the study of Kiese-Himmel et al. For this comparison 
both groups of the study of Kiese-Himmel (idiopathic and post-operative facial nerve paresis, resp. Ν = 
20, Ν = 14) are included together. In general no large differences are present. 
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Table 6. Prevalence of problems reported in BTQ in percentage of patients (N = 50) at pre-test, and 
comparison wilh the prevalence in participants of the study of Kiese-Himmel et al. (Ν = 34). Ci = number 
of cluster to which item belongs. 
Behavioural problem 
CI. The relation with my partner detenorated 
CI The relation with my family deteriorated 
CI The relation with my friends deteriorated 
C1.1 "talk" more with my hands 
CI. 1 feel left alone with my problems 
C2.1 [do not] receive social support from friends 
C2 I [do not] receive social support from my partner 
C2 I [do not]receive social support from family 
C3 I avoid doing anything before an audience 
C3. 1 fear new contacts 
C3 I feel inferior to my discussion partner 
C3.1 dislike being addressed about my paresis 
C3. 1 have the impression of being stared at 
C3.1 feel perceived as helpless 
C3 I feel my mental capacities to be underestimated 
C3.1 avoid starting a conversation 
C3 I slay in the background during conversations 
C3. 1 feel my facial expressions are misunderstood 
C3 I avoid looking at my discussion partner 
C3 I smile less, so my paresis is not apparent 
C3. 1 try to hide my paresis (with my hand) 
C3.1 feel ashamed in public 
C3.1 avoid contacting others through eye contact 
This study % 
16 
10 
18 
12 
12 
20 
20 
22 
22 
28 
20 
36 
46 
14 
52 
20 
40 
36 
12 
46 
40 
26 
14 
Kiese-Himmel % 
3 
6 
26 
9 
14 
30 
13 
22 
26 
29 
35 
29 
38 
14 
20 
38 
61 
29 
23 
49 
35 
20 
35 
3.4. Effectiveness of Mime therapy 
3.4.1 Short-term effectiveness of Mime therapy in improving psychosocial functioning 
The post-randomisation equivalence of treatment and control group at pre-test was checked with two-
tailed t-tests for the continuous variables, and chi-square tests for the categorical variables This 
equivalence is needed in order to infer therapy efficacy from post-test differences. Background 
characteristics of the patient groups are given in chapter 7 table 1, and information on pre-test target 
variables is given in table 7. None of these variables showed significant between-group differences. 
Effectiveness analysis started with a check as to whether the uncorrected post-test means of the treatment 
group differed in the expected direction from those in the control group. Post-test scores on all target 
variables were then subjected to multivariate analyses of covariance (MANCOVA), followed up by 
univariate F tests to analyse the effects of Mime therapy. 
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Table 7. Mean scores of indicators of psychosocial functioning for waiting list control (WL) (N = 24) and 
Mime therapy (MT) group (N = 24) respectively at pre- and post-test in three areas. Note that pre-test 
means are observed means [with observed standard deviation (SD)], and post-test means (SeM = standard 
error of mean) are corrected for all corresponding pre-test variables in their area. None of the pre-test 
differences is significant (two-sided t-test). Post-test based effect size (Hedges'g) takes into account pre­
test scores. 
Area A 'Relaxation' 
Pre-test Mean (SD) 
WL 
28.8 (8.2) 
Area Β 'Moods & Feelings' 
or 'Depressivity' 
bl. Dnow (D-scope) 
b2. Down (Moods Q) 
b3. Optim (Moods Q) 
b4. Depressivity (WB) 
b5. Vital exhaust (WB) 
b6. Gen. Anxiety (WB) 
b7. Health anxiety (WB) 
b8. Positive well-b (WB) 
b9. Self-control (WB) 
blO. D-Intrusion 
(Depnscope) 
5.5 (5.0) 
32.4(14.3) 
41.3(8 3) 
10.8(4.5) 
104(3.1) 
9.1(3 2) 
8.7 (2.8) 
10.8(4.5) 
19.8(3.4) 
15 6(9.9) 
Area C 'Avoidance tendencies' 
source- BTQ 
cl. Det. relationships 
c2. Social support 
c3. ACFP 
0.48 (.87) 
2 4 (.92) 
4 2(3.7) 
MT 
26 8 (6 6) 
5 1 (5 7) 
36 8(17.6) 
40.7 (7.8) 
10.9(4 3) 
10.2(2.6) 
9.3 (3.0) 
8 3 (2 8) 
10.9(4.3) 
19.3(3.3) 
18.5(8 4) 
0.84(1.3) 
2.3(85) 
4.8(3 7) 
Post-test Mean 
(corrected for 
WL 
24 7 ( 64) 
5.8 (.48) 
37.4(1.8) 
38.4(1.1) 
11.7 (.50) 
114(.38) 
9.7 (.41) 
8.7 (.42) 
10 5(22) 
19 3 (.42) 
19.6(1.0) 
0.8 (.13) 
2.3(10) 
6.1 (4 6) 
(SeM) 
area-specific prc-tests) 
MT 
32.8 (.64) 
2.4 (.48) 
25.6(1.8) 
48.4(1.1) 
8.9 (.49) 
8.9(38) 
7.7 (.41) 
7.0 (.42) 
12.0 (.22) 
21.6(42) 
14.3(1.0) 
0.3 (.13) 
2.9(11) 
1.3 (.46) 
sign.? Effect-size g 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
2.6 
1 50 
1 37 
1.96 
1.16 
1.41 
1.04 
0 87 
1.44 
0 99 
1 10 
0.88 
1.10 
2 10 
The mean values of the target variables (adjusted for pre-test scores in their area) can be found in table 7, 
on the right hand side. For two of the sequelae we did not have an expectation concerning the direction of 
the expected difference between control and treatment group ("deterioration of relations", "social 
support"); for all other variables, one sided statistical tests being appropriate for them. 
Inspection of post-test means of the target variables showed that the target variable difference between the 
treatment and control group was in the expected direction (Mime therapy is associated with "better" 
scores). 
All variables representing one area were entered in a single MANCOVA. For all three areas, MANCOVA 
showed the multivariate statistic Wilks' Lambda to be significant (p < 0 05). The within area univariate F 
tests separately calculated for each target variable were also significant for all variables. The literature on 
depressivity frequently reports sex differences in depressivity. We used sex as a separate, additional 
factor to treatment in our MANOVA design. When analysing the 10 depressivity scales in area B, no 
main effect of sex was found and also no sex by treatment interactions for any of the groups of the 10 
variables in area Β (Wilks' Lambda not significant) 
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For all areas, Mime therapy was effective in the expected direction on all target variables with effect sizes 
in Area A of 2.6, in Area Β between 0.87 and 1.96 and in area C between 0.88 and 2.1. All effect sizes 
were large, Hedges's g > 0.8 15 See table 7 for an overview of the results obtained. The variables for 
which we did exploratory analyses, "deterioration of relations" and "social support", were both improved 
by Mime therapy. 
In conclusion' standard Mime therapy is shown to be effective in substantially reducing psychosocial 
sequelae of patients with longstanding facial nerve paresis. 
3.4.2 Stability of group outcome levels on relaxation, depressivity and avoidance tendencies 
Two types of stability were analysed: stability of outcome level (A), and stability of inter-patient 
differences in outcomes (B). 
A. Stability of outcome level 
Stability of outcome level (A) was analysed (Al) as absence of changes over time in the average scores of 
the three post therapy measurements, and secondly (A2) by inspection of the change profiles of all 
individual patients for some sequelae. 
A 1 Absence of post-therapy trends in group averages 
Group-level analysis of absence of changes over time is performed by applying repeated measures 
analysis of variance [AN(C)OVA] on T2, T3 and T4 scores with the respective immediate prc-thcrapy 
(Tl) score as covanate, in combination with testing for absence of trends. Presence of mean level stability 
will be inferred from the absence of significant (p < 0.05) trends (linear or quadratic) in the three post-
therapy measurements. Significant trends will be inspected for remission or continued improvement To 
test whether the differential pre-therapy history (waiting list versus immediate therapy) of our RCT 
participants influences the course of post-therapy outcomes, the "treatment" condition was added as a 
factor in the resulting time (3) by treatment (2) ANOVA design. 
Mean level stability was found in the relaxation variable of Area A. In Area Β stability was found for all 
ten variables, with two exceptions. The variable 'self-control' showed a significant linear and a 
significant quadratic trend indicating improvement; the variable 'Down' showed a significant linear trend 
also indicating improvement. In Area C no significant trends were found for any of the three variables 
A.2 Change profiles of individual patients 
All individual time courses of selected psychosocial sequelae of all patients with facial nerve paresis were 
categorised for the presence of patterns of change in the period T1-T4. For each area a representative 
variable was chosen for analysis: Area A, relaxation was covered by the variable relaxation of this area, 
Area B, depressivity was covered by the variable D-Intrusion, as this variable covers most of time span 
between the three successive measurements T2-T3-T4. Area C is represented by ACFP (avoidance of 
confrontation with own facial nerve paresis). For a classification of change patterns see table 8. Patterns 
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that are evident of long-term (12 months) stability after therapy fall within the range (T2 ± 2.SE, SE = 
Standard Error of the mean). Put differently, when the condition (T2 - 2.SE) < T3,T4 < (T2 + 2.SE) is 
met, the change pattern T2 —> T3 -> T4 is classified as long-term stable. See table 8 for an overview of all 
change patterns. 
Table 8. Overview of change patterns from pre-therapy to one year after Mime therapy (Tl to T4) for 
relaxation (Area A) with strangers and friends, depressivity/D-intrusion (Area B), and avoidance of 
confrontation with own facial paralysis (Area C), Ν = 46. 
Pattern 
1. Deterioration during therapy, at T2 (T1-T2), T2 < (Tl - 2.SE) 
2 No benefits of therapy (T1-T2) 
2.1 No benefits, T1=T2, changes thereafter at T3 and/or T4 
2.2 "Hyper" stability (T1 =T2=T3=T4), no changes during therapy and 
thereafter, differences at T2, T3 or T4 < (Tl ± 2.SE) 
3 Improvements during therapy (T1-T2) 
3.1 Improvement continues, T4 superior to T3 [T4 > (T3 + 2.SE)], T3 
superior to T2 [T3 > (T2 + 2.SE)] 
3.2 Improvement continues at T3, achieved level at T3 still present at T4, T3 
superior to T2 [> (T2 + 2.SE)], T3 = T4 [T4 < (T3 ± 2.SE)] 
3.3 Achieved level at T2 still present at T3 and T4, T2 = T3 = T4 [< (T2 ± 
2.SE)] 
3.4 Achieved level at T2 still present at T3 and changes at T4 
a. T2 = T3 [T3 < (T2 ± 2.SE)], improvement at T4 [T4 > (T2 + 2.SE)] 
b. T2 = T3 [T3 < (T2 ± 2.SE)], deterioration at T4 [T4 < (T2 + 2 SE)] 
3.5 Achieved level at T2 still present at T4 and changes at T3 
a. T2 = T4 [T4 < (T2 ± 2.SE)], improvement at T3 [T3 > (T2 + 2 SE)] 
b. T2 = T4 [T4 < (T2 ± 2.SE)], deterioration at T3 [T3 < (T2 + 2.SE)] 
3.6 Deterioration after therapy, deterioration at T3 and T4 [T3, T4 < (T2 + 
2.SE)] 
Area 
A BIO C3 
0 1 0 
6 13 0 
1 2 3 
3 3 1 
5 7 3 
25 10 12 
1 2 8 
3 1 10 
0 2 0 
0 3 6 
2 2 3 
Categories 1, 2.1 and 2.2 in table 8 indicate no benefits of therapy and are therefore not relevant for 
answering our question regarding stability of benefits. In area A this is the case in 7 patients, in Area Β in 
16 patients and in area C in 3 out of the total number of 46 patients. 
Of the remaining categories (improvements during therapy), pattern 3.6 shows repeated deterioration after 
therapy, both at 3 and 12 months, in Area A this occurs in 2 patients, in Area Β in 2 patients, and in Area 
C in 3 patients. Absence of 12 months stability is indicated by pattern 3.4b; in Area A 3 patients, in Area 
Β 1 patient and in Area C 10 patients show this pattern. A three months deterioration-dip (pattern 3.5b) is 
shown in Area A in none of the patients, in Area Β in 3 patients and in Area C in 6 patients. All other 
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categories show either perfect stability or even improvements; for Area A this is seen in 34 patients, for 
Area Β in 24 patients, and for Area C in 24 patients. 
A.3 Analysis of stability of inter-patient differences 
Correlations between the presence of sequelae at the immediate post-therapy (T2), at three months (T3) 
and at twelve months (T4) are shown in table 9. With the exception of general anxiety at T4 and positive 
wellbeing at T4, the relative position of patients three and twelve months after therapy is almost the same 
as at T2 for all psychosocial sequelae. 
Table 9. Stabilities of relative positions of patients concerning three areas of psychosocial sequelae of 
facial nerve paresis. Nijmegen Mime Therapy Study; Ν between 45 and 48 due to missing scores on some 
variables. Cells contain correlations between position at T2 (immediate post-therapy) and three months 
(T3), respectively 12 months later (T4). 
Area variable 
Area A: Relaxation 
Area B: Depressivity 
bl. Dnow (amount of depn-symptoms in past 24 hrs) 
b2 Down (in past week) 
b3 Optim(istic) (in past week) 
b4 Depressivity (WBQ) (in past month) 
b5. Vital exhaustion (WBQ) 
b6. General Anxiety (WBQ) 
b7. Health anxiety (WBQ) 
b8. Positive well-being (WBQ) 
b9. Self-control (WBQ) 
blO. D-Intrusion (amount of depri-symptoms in past 3 months) 
Area C: Avoidance tendencies 
c2. Deterioration of relations 
c3. Social support received 
cl. ACFP (Avoidance of confrontation with own facial nerve paresis) 
T3 
94 
.91 
.79 
80 
.85 
83 
70 
.79 
79 
.83 
.89 
.89 
73 
.95 
T4 
.90 
.85 
.81 
76 
.78 
78 
.47 
78 
.57 
.64 
.84 
.83 
.87 
88 
4. Discussion and conclusion 
This study had three objectives: to describe the prevalence of psychosocial sequelae in a sample of Dutch 
patients with longstanding facial nerve paresis, to determine the effectiveness of Mime therapy in 
reducing these psychosocial sequelae, and to assess the stability of benefits achieved. We will discuss the 
results in this order. 
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Prevalence of psychosocial sequelae before treatment 
Feeling relaxed in contacts with family or friends is not a problem, but many patients with sequelae of 
longstanding facial nerve paresis report feeling tension in contacts with strangers Absence of relaxation 
is clearly related to the level of disability, reported by patients. 
Differences between facial nerve paresis patients in measures of psychosocial distress and well-being 
seem best described by depressivity. The level of depressivity in this sample is high, as can be seen from 
the depression symptoms experienced (5.3 on average) in the past 24 hours, 40% of patients being in the 
depression-disordered range. This is in line with all clinical reports in the literature, but differs from the 
report on patients with facial nerve paralysis from Groningen where normal levels were reported 
(Boersma22). Depressivity is clearly related to FDI measures of social disability, but not to physical 
disability. Comparing average total performance on the well-being scale with a group of Dutch rheumatic 
patients and a Dutch group of pain patients, our patients with longstanding facial nerve paresis seem to 
have similar scores.36,17 
Most patients report a good social support, and rarely report a deterioration in personal relations. Both 
variables are unrelated to reported physical or social disability. 
A substantial number of patients report behaviours and situation interpretations related to avoidance of 
being confronted in social contacts with their own facial nerve paresis. In this respect we find similar 
results as Kiese-Himmel et al.16 for German patients. Remarkable in our sample is the 52 percent that 
reports 'feeling that my mental capacities are underestimated'. 
Puzzling is the complete absence of any correlation between measures of objective facial disfigurement 
(HB, SB) and relaxation, or depressivity. The 'sequel' label attached to these variables led us to expect 
such correlations. This result for depressivity is not in line with the VanSweanngen hypothesis Only the 
ACFP variable (avoidance of confrontation with own facial nerve paresis) showed the expected 
correlations with facial disfigurement, and also with disabilities. 
Effectiveness of Mime therapy and stability of benefits achieved 
This RCT shows clearly that Mime therapy was effective in reducing undesirable psychosocial sequelae 
in patients with longstanding facial nerve paresis. Moreover, the effect sizes were large to very large. 
These effects are of clinical significance, especially as it could be shown that for most patients the 
benefits achieved could be sustained over a period of 12 months. The literature reports only three other 
RCT studies, none showing effects of the interventions used It seems that Mime therapy, until now, is 
unique in producing large, clinically relevant and sustainable effects in improving the conditions of 
patients with facial nerve paresis, both with regards to facial disfigurement (reported elsewhere) and 
psychosocial sequelae. 
The effectiveness of Mime therapy in reducing depressivity is especially remarkable. For the ten indicator 
variables of depressivity, effect sizes were found varying between 0 87 and 1.96; average effect size is 
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1.28. A recent meta-analytic review of 69 programs for reduction/prevention of depressivity reports for 
intervention programs with a duration between 1,5 and 3 months (33 programs) an average effect size of 
0.21.38 Mime therapy scores in comparison so well, that one might be tempted to use an adaptation of 
Mime therapy in facially non-disordered individuals for treating depressivity. 
References 
1. Beurskens CHG, Heymans PG. Effectiveness of Mime therapy: improvement of facial disfigurement 
in patients with facial nerve paresis. Submitted 2003. 
2. Beurskens CHG, Heymans PG. Positive effects of Mime therapy on sequelae of facial nerve paresis: 
tiffhess, lip mobility and social & physical aspects of facial disability. In press. Otol Neurotol 
3. Beurskens CHG, Heymans PG, Oostendorp RAB. Stability of benefits of Mime therapy in sequelae 
of facial nerve paresis over a one year period. Submitted 2003. 
4. Pease RW, editor Memam-Webster Medical Desk Dictionary. Springfield, Massachusetts: Merriam-
Webster Inc. Publishers; 1993. p. 233. 
5. Adour KK, Byl FM, Hilsinger RL, Kahn ZM, Sheldon MI. The true nature of Bell's palsy: analysis of 
1000 consecutive patients. Laryngoscope 1978;88.787-801. 
6 Peitersen E. The natural history of Bell's palsy. Am J Otol 1982;4:107-11. 
7. Devnese PP, Schumacher T, Scheide A, Jongh RH de, Houtkooper JM. Incidence, prognosis and 
recovery of Bell's palsy. A survey of about 1000 patients (1974-1983). Clin Otolaryngol 1990;15:15-
27. 
8 Peitersen E. Natural history of Bell's palsy. In: Stennert ER, editor. The Facial Nerve Proceedings of 
the Vllth International Symposium on the Facial Nerve; 1992 June 9-14, Cologne, Germany. Berlin, 
Heidelberg, New York: Springer-Verlag, 1994. p. 547. 
9. VanSwearingen JM, Cohn JF, Tumbull J, Mrzai T, Johnson P. Psychological distress· linking 
impairment with disability in facial neuromotor disorders. Otolaryngol Head Neck Surg 
1998; 118.790-6. 
10. Hirschenfang S, Goldberg MJ, Benton JG. Psychological aspects of patients with facial paralysis. Dis 
Nerv Syst 1969;30·257-61. 
11. Twerski AJ, Twerski Β. The emotional impact of facial paralysis. In: May M, editor. The facial 
Nerve. New York: Thieme Inc.; 1986 p. 788-94. 
12. Rumsey N, Bull R. The effects of facial disfigurement on social interaction. Human learning 
1982;5:203-8. 
13. Robinson E, Rumsey N, Partridge I. An evaluation of social interaction skills training for facial 
disfigured people. Brit J Plast Chir 1996;49:281-9. 
14. Hoos L, Devnese PP. The management of psychosocial problems of patients with facial paralysis. In: 
Portmann M, editor. The Facial Nerve. New York: Masson Publishing; 1985. ρ 337-40. 
133 
Chapter IO 
15. Macgregor FC. Facial disfigurement: problems and management of social interaction and 
implications for mental health. Aest Plast Surg 1990; 14-249-57. 
16. Kiese-Himmel C, Laskwawi R, Wrede S. Psychosoziale Probleme und Krankheitsverarbeitung von 
Patienten mit Defektheilung nach Fazialisparese. HNO 1993;41:261-7 
17. Diels HJ. New concepts in nonsurgical facial nerve rehabilitation Adv Otolaryngol Head Neck Surg 
1995,9:289-315. 
18. Neely JG, Neufeld PS. Defining functional limitation, disability, and social limitations in patients 
with facial paresis: initial pilot questionnaire. Am J Otol 1996;17:340-2. 
19. May M, editor. The Facial Nerve New York, Thieme; 1986. 
20. May M, Schaitkin BM, editors. The Facial Nerve. Second edition. New York, Stuttgart: Thieme; 
2000. p. 64. 
21. VanSwearingen JM, Cohn JF, Bajaj-Luthra A. Specific impairment of smiling increases the severity 
of depressive symptoms in patients with facial neuromuscular disorders. Aest Plast Surg 
1999;23:416-23. 
22. Boersma R. Psychosociale gevolgen van facialis paralyse. Rijksuniversiteit Groningen: Uitgave 
Faculteit der Medische Wetenschappen; 2001. 
23. Beurskens CHG, Heymans PG. Descriptive outcomes of patients with facial nerve paresis referred for 
physiotherapy. Submitted. 2003 
24. VanSwearingen JM, Brach JS. The Facial Disability Index: reliability and validity of a disability 
assessment instrument for disorders of the facial neuromuscular system. Phys Ther 1996,76:1288-98. 
25. Devriese PP, Bronk J. Non-surgical rehabilitation of Facial Expression. In: Fisch U, editor. Facial 
Nerve Surgery. Amstelveen, The Netherlands. Kugler Medical publications; 1977. p. 290-4. 
26. Heymans PG, Psychological aspects of facial paralysis. Paper presented at the Symposium 
'Optimising partial recovery following facial nerve paralysis' at the XVI World Congress of 
OtoRhinoLaryngology Head and Neck Surgery held at Sydney, T"1 March, 1997. 
27. Dupuy HJ. The general well-being schedule. In McDowell I, Newell C, editors. Measuring health: a 
guide to rating scales and questionnaires. New York: University Press; 1996. 
28. Van Dam V. De WB-vragenlijst. Een instrument voor welbevinden? Scriptie. Hogeschool van 
Arnhem en Nijmgegen. 1998. 
29. Heymans PG. Depression among Vidnoie's adolescents. Report on the Vidnoie project. Utrecht: 
Dept Developmental Psychology; 1996. 
30. Heymans PG. Measuring depression - intrusion with Depriscope in the Rukad project: scoring rule 
and procedures. Utrecht Dept. Developmental Psychology: Report nr 5 Rukad project; 2001. 
31. House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg 
1995;113:146-47. 
32. Ross BG, Fradet G, Nedzelski JM. Development of a sensitive clinical facial grading system. 
Otolaryngol Head Neck Surg 1996;114:380-6. 
134 
Psychosocial sequelae in patients with facial nerve paresis 
33. Devriese PP, Beurskens C, Heiningen van I. Rehabilitation of Facial Expression by Mime. 
Amsterdam: Huisdrukkerij A.Z.U.A.; 1998. 
34. Sehgman M. Helplessness: On depression, development and death. San Francisco: Freeman; 1975. 
35. Hedges LV & Olkin I. Statistical methods for meta-analysis. New York: Academic Press; 1985. 
36. Reek van der L, Oever van der W, Molen van der P. De welbevindenvragenlijst. Hogeschool 
Rotterdam: Scriptie; 1999. 
37. Behage E. Van den Heuvel R, Klein L, Van de Port. De Welbevindenvragenlijst, een betrouwbaar 
meetinstrument? Fontys Hogescholen Eindhoven: Onderzoeksverslag; 2000. 
38. Jané-Llopis E. What makes the ounce of prevention effective? [Dissertation] Nijmegen KUN; 2003. 
p. 136-7. 

Chapter 11 
Improving emotional readability in patients with facial nerve paresis 
Carien H.G. Beurskcns' , Peter G. Hey mans2 
1. Department of Physiotherapy, University Medical Centre Nijmegen 
2. Department of Developmental Psychology, Utrecht University 
Submitted 
137 
Chapter 11 
Improving emotional readability in patients with facial nerve paresis 
Introduction 
Facial cues are an important support for the interpretation of the meaning of a verbal message. Sometimes the 
message only consists of a facial pattern. A multitude of facial muscles is involved in generating facial action 
patterns which convey emotional expressions (Ekman, 1978)1. The facial nerve (N VII) with five pairs of 
branches, controls the basic tension and contraction of the facial muscles. These muscles are responsible for 
the facial movement, and are the basis for displays of emotions, readability and empathy. Normally, both 
halves of the face are symmetric, both when the face is at rest and during movement. Non-deliberate 
asymmetry is perceived as uncanny. 
The facial nerve can be damaged, mostly on one side. A penpheral facial nerve paralysis is a paralysis of 
the muscles innervated by the seventh cranial nerve due to a lesion located in the peripheral part of the 
nerve2. Here we restrict ourselves to one-sided damage to the penpheral part of the facial nerve, as it 
produces marked asymmetry in the still and moving face. Central lesions such as those caused by stroke also 
lead to asymmetry, but this is seen as only a minor problem in companson to the massive motor and speech 
problems. 
Approximately half of the cases of peripheral facial nerve paralysis are Bell's palsies; the incidence being 
20:100.000 adults per year in western countries3"5. Other cases have a variety of aetiologies, mostly 
traumatic injury, operative trauma, herpes zoster, diabetes mellitus, tumour growth or otitis media. 
A unilateral facial nerve paresis is mainly characterised by facial asymmetry, but is also associated with a 
number of other problems such as stiffness, problems with drinking, eating and speech, lacrimation problems, 
psychosocial distress and a reduced quality of life. Patients also report that they are reluctant to return to work 
or go to public places or events, because they feel 'misunderstood' or 'not themselves', or 'feel not treated as 
the person they used to be'. 
Interpersonal communication may be impaired due to the fact that the facially malfunctioning individual 
produces facial cues which are misinterpreted according to the basis of usual display rules67. The Nijmegen 
Mime Therapy Study (NMTS), reported that 52 % of the included patients with facial nerve paresis 
experience their mental capacities as being underestimated.8 Furthermore 36 % of patients feel their facial 
expressions are misunderstood and 46 % of patients smile less, to camouflage their paresis. This 
illustrates that a facial nerve paresis is not only a problem for the individual patient, but also for the social 
environment, leading to miscommunication. 
We hypothesise that these miscommumcations depend upon the emotional readability of the face of an 
individual. Moreover, we think that there are relatively stable differences between individuals in 
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emotional readability, and that these differences are co-determined by the degree of facial disfigurement. 
In earlier studies we have shown that Mime therapy is effective in improving facial disfigurement 
Therefore we expect that Mime therapy is also effective in improving facial emotional readability in 
patients longstanding facial nerve paresis 
In the NMTS an instrument was developed, the FERS (Facial Emotional Readability Stones) which aims to 
describe the inter-individual differences in emotional readability and is assumed to be sufficiently sensitive in 
perceiving eventual changes in emotional readability. A standardised task was designed to facilitate the 
production of 'natural' facial emotional displays by patients, and their categorisation into six basic emotions 
(sadness, fear, anger, happiness, disgust and surprise9) by observers. This task emulates the natural situation 
of emotional displays as far as possible, both for the patient and observer. 
Below two studies are reported; firstly a clinimetnc study including the construction of the instrument, its 
reliability and its outcomes in two groups, a "patient" and a "non-patient" group and secondly, the results of 
Mime therapy to improve emotional readability. 
The above mentioned considerations lead to the following four hypotheses to be tested: 
1. It is more difficult to correctly read emotions from the faces of patients with facial nerve paresis than 
from non-impaired faces. 
2. Emotional readability of the face of an individual patient with facial nerve paresis is negatively correlated 
with the extent of facial disfigurement. 
3 Mime therapy is effective in improving emotional readability of the faces of patients with facial nerve 
paresis. 
4. The benefits of Mime therapy in improved emotional readability are stable. 
In two empirical studies these four hypotheses will be tested. Study 1 compares "normal" face with faces 
of patients with facial nerve paresis. Study 2 is a randomised controlled trial (RCT) combined with 
follow-ups where improvements in emotional readability are aimed at and the sustainability of benefits is 
investigated. Both studies make use of an instrument that was especially designed for the NMTS' the 
FERS test. 
Study 1. Comparison of emotional readability effaces with and without facial nerve paresis 
Methods 
Design 
A static-group comparison was made between a group of patients with a facial nerve paresis and a group of 
non-patients with regard to the ease of recognition of emotion by observers from moving facial displays. 
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Participants: subjects and observers 
Five patients with facial nerve paresis [adults (not included in the NMTS) with a duration of facial nerve 
paresis between two weeks and six months] receiving physiotherapy at the outpatient department of the 
university hospital, and 12 individuals with undamaged, 'normal' faces were given the FERS, desenbed 
below. Administrative hospital staff volunteered as subjects with "normal" faces. 
Subjects' facial performance was videotaped, and shown to independent observers, who had the task of 
categorising the facial displays into six emotional categories. 
Materials and procedure 
A core story was constructed based upon a series of connected events which most people easily 
recognise; during this story events with emotional significance occur. Six basic emotions (sadness, fear, 
anger, happiness, disgust and surprise) each occur twice, dispersed throughout the story. The task of the 
subject is I) to listen to the story as it is narrated, 2) to empathise with the main character in each of the 
events and 3) to facially express the verbally narrated emotion connected to each event. The task of the 
observer is described under 'scoring', below. For research purposes, six versions of the basic story were 
created differing with regard to the sequence of the emotionally significant events. Each subject heard 
only one version of the story. 
Procedure for ehcitation and recording facial emotional displays 
A standard method for positioning the patient, lighting, and distance of the camera from the subject was 
used and a stationary video camera recorded the subject's face. The patient was seated comfortably on a chair 
against a blank wall facing the video camera at 2.5 meter distance and listened to the narrated story by means 
of a head phone. Patients heard a bleep each time (12 times) an event connected emotion had to be displayed. 
The whole procedure, including instruction and responding to the narration, took approximately 6 minutes. 
Scoring of facial displays 
The sound-muted video recordings of each subject's performance were shown to observers who marked on a 
scoring sheet each of the 12 (2 χ 6 emotions) facial expressions as a display of one of the six basic emotions. 
Markers on the video (a bleep preceded each displayed emotion) indicated to the observer that an emotionally 
significant event had been narrated The speed of the videotape was real time, i.e. the same speed as used in 
recording; repetition of parts of the tapes was not permitted. 
Results 
Videotapes of facial displays werejudged by observers. Patients (5) were judged by 10 observers, 
"normals" ( 12) being judged by 2 observers, having regular professional experience with facially 
impaired individuals; most of the observers were physiotherapists. Only two observers judged the 
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normals"; the very high recognition rate of the facial displays did not make it necessary to employ more 
observers. 
For each subject a confusion-matnx was calculated. This 6x6 matrix consists of six rows indicating the 
emotions intended by the subject, and six columns indicating the six emotions perceived by the observer. 
Within each group (patients and non-patients) the individual confusion matnces were pooled to form a group-
level confusion matrix. Table 1 shows both of these confusion matnces The cell (x,y) in each matrix 
indicates the frequency with which intended emotion χ was recognised by the observer as emotion y. Good 
performance in the FERS task is indicated by relatively high values on the main diagonal of this matnx. 
The diagonal values show the rate of recognition for each emotion by independent observers; the off-
diagonal values indicate the confusion-rates. For example, it was found that the emotional expression of 
'fear' by patients was frequently interpreted as "anger" (22 %) or "sadness" (24 %) (an observer 
confusion), but not in "non-patients", respectively 0 % and 2 %. 
Table 1. Confusion matnces between 6 emotions for "normal" individuals (upper matrix) and 
patients with facial nerve paresis (lower matnx) Cells indicate the frequency with which a facially 
intended row-emotion is perceived by observers (N=2 / N=10) as the column-emotion. 
"Normals" (N= 12) 
1 An sadness 
2 Bn fear 
3 Cn anger 
4 Dn disgust 
5 En surprise 
6 Fn happiness 
Column total 
Patients (N=5) 
7 Ap sadness 
8 Bp fear 
9 Cp anger 
lODpdisgusi 
11 Ep surpnse 
12 Fp happiness 
Column total 
Perceived emotion by observers 
Sadness fear 
1 
a 
37 
1 
0 
2 
0 
0 
40 
28 
24 
16 
19 
5 
4 
96 
2 
b 
8 
43 
2 
7 
5 
0 
65 
32 
25 
10 
9 
15 
8 
99 
anger 
3 
c 
1 
0 
42 
1 
0 
0 
44 
17 
22 
44 
9 
4 
5 
101 
disgust 
4 
d 
2 
1 
4 
38 
0 
0 
45 
13 
8 
18 
32 
14 
8 
93 
surpnse happiness 
5 
e 
0 
3 
0 
0 
43 
0 
46 
6 
17 
8 
9 
58 
20 
118 
6 
f 
0 
0 
0 
0 
0 
48 
48 
4 
4 
4 
22 
4 
55 
93 
row total 
48 
48 
48 
48 
48 
48 
288 
100 
100 
100 
100 
100 
100 
600 
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For each emotion a bias-corrected readability index (ER^) similar to Wagner's H(u) is calculated . This 
index permits comparison between emotions, and between groups. Correction is necessary as observers show 
preferential use of certain emotions above others e.g. fear in the upper matrix is perceived more frequently 
than sadness or surprise. See table 2 for the bias-corrected emotional readability index in the group of normal 
individuals and the group of patients. 
Table 2. Emotion readability index (Efyc) (bias-corrected) in individuals with normal 
facial displays (N = 288 emotions) and patients with facial nerve paresis (N = 600 emotions). 
Emotions 
Sadness 
Fear 
Anger 
Disgust 
Surprise 
Happiness 
"Normal" individuals 
0.71 
0 59 
0 83 
0 67 
0.84 
1.00 
Patients 
0.08 
0.06 
0.19 
0.11 
0.28 
0.32 
Table 2 shows clearly that patients produce emotional displays of a much lower quality than 'normal' 
individuals [the average ER(C) ("normals") = 0.77, the average ER^, (patients) = 0.176] and that some 
emotions are more easily readable e.g happiness versus fear. 
Reliability of the FERS 
The consistency of categorisation behaviour of the observers was estimated using Cohen's kappa Videos 
of 26 patients with facial nerve paresis displaying emotions were independently scored by two 
physiotherapists (CB and JB). The videos of individuals were presented to each rater in a randomised 
order. This scoring was repeated after a wash-out period of two weeks. For all 26 patients, all emotional 
displays were scored, 312 in total (26 patients χ 6 emotions χ 2 replications). Intrarater reliability for each 
of the raters (test-retest reliability per rater) was calculated from an initial scoring and from a second 
scoring two weeks later. The inter-rater reliability was 0.83 (kappa) for the first scoring and 0.82 for the 
second scoring two weeks later. The intra-rater reliability was 0.88 (kappa) for rater CB and 0 79 for rater JB. 
Conclusion of study 1 
A standardised procedure was set up to assess the readability of six emotions from the facial displays of 
facially impaired patients. The task produced facial display performances from subjects that observers 
could categorise with intra- and interrater agreement The FERS procedure discriminated quite clearly 
between the facial performances of a group of patients and those of a group of normal individuals. 
Moreover, these differences in ER )^ are emotion-specific. 
The sensitivity of FERS to change will be investigated in study 2. 
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Study 2. Emotional readability improvement in the NMTS 
Methods 
Design of the Nijmegen Mime Therapy Study 
To evaluate the effectiveness of Mime therapy in patients with sequelae of longstanding facial nerve 
paresis, a randomised controlled trial was started in April 1999; the treatment group received Mime 
therapy for three months and the control group formed a waiting list. To assess the effectiveness of Mime 
therapy, a comparison was made between the treatment and control group at immediate post-test (Tlc -
T2,). Follow-up measurements were performed to ascertain whether the benefits of Mime therapy were 
stable over a time period of three months (T2 - T3) and one year (T2 - T4). The design is schematically 
represented in table 1 of the 'Introduction to chapters 7 - 11' 
Participants 
Patients with longstanding peripheral facial nerve paresis, referred to the physiotherapy outpatient 
departments of the UMC Nijmegen or the "Vrije Universiteit" MC Amsterdam, were considered. 
Referrals were made by a general practitioner, otolaryngologist, plastic surgeon or neurologist. Inclusion 
criteria were: a) 18 years or older, b) unilateral peripheral facial nerve paresis, c) facial nerve paresis 
existing more than nine months, d) reinnervation visible on the affected side (no contralateral cross-
innervation), e) absence of dynamic correction (nerve or muscle reconstruction), f) absence of congenital 
facial nerve paresis, and g) sufficient knowledge of the Dutch language. The study was approved by the 
Advisory Committee on Ethics in Human Experimentation at the UMC Nijmegen. All patients were 
informed by letter about the research project and written consent was obtained pnor to participation. 
Treatment 
Mime therapy is a combination of mime and physiotherapy and consists of facial emotional expression 
exercises and functional movements". The aims of the treatment are to promote symmetry of the face at 
rest and during movement, and to control synkinesis. The treatment group received Mime therapy for 
three months. The control group was a non-treatment group placed on a waiting list, this being chosen as 
control since non-treatment is the usual fate for patients with facial nerve paresis and an evidence 
supported treatment is lacking. The waiting period began directly after the pre-test and ended after three 
months when the intake for Mime therapy took place12 
Measurement instruments 
Emotional readability was assessed with the FERS. For a description of the FERS instrument see study 1 
above. Two indices are constructed from FERS: a) the amount of correctly recognised facial displays 
(CRFD) and b) emotion specific readability (ER^)) estimated on group level. Index a, amount of CRFD 
143 
Chapter 11 
has a specific value for each individual in the study; index b (ER^), has a specific value for each of the 
six emotions as displayed by each group of subjects. 
Facial disfigurement was assessed with the Sunnybrook Facial Grading System (SB-FGS) and the House-
Brackmann (HB) FGS. Both scales have high reliability, SB-FGS being a more refined scale giving 
separate information about the face at rest, in movement and degree of synkinesis. 
Analyses 
The first set of analyses is a descriptive analysis of pre and post-test. The ER ,^ will be reported for six 
basic emotions in the treatment and control group. The means and standard deviations of the amount of 
CRFD will be reported and its correlations with the SB-FGS and the HB-FGS, both measuring the degree 
of facial disfigurement. 
The second set of analyses concerns the short-term effectiveness of Mime therapy in improving emotional 
readability using t-tcsts and ANOVA-based analyses. The third set of analyses is directed toward the 
assessment of the stability of eventual benefits obtained from Mime therapy over time penods of three 
and twelve months post-therapy. Levels of emotional readability at immediate post-test will be compared 
to levels at both follow-ups using MANOVA-based trend analyses. Pearson correlations between 
successive occasions will be calculated to indicate stability of inter-patient differences in amount of 
CRFD. 
Results 
Participants and intervention procedure 
50 patients who met the inclusion criteria were randomly assigned to the Mime therapy group or the 
waiting list control group. At immediate post-test 12 there was one dropout in each group: one patient 
being pregnant, the other patient dropping out due to caring for her terminally ill husband. In the study of 
immediate effects, 48 patients were analysed During the follow-up of these 48 patients there were two 
additional dropouts; one patient was involved in a car accident (ex-waiting list group), the other suffered a 
severe heart attack (ex-Mime therapy group). It is assumed is that these dropouts did not disturb the 
equivalence of the intervention and control group. Data were available from 46 patients at three (T3) and 
twelve months (T4) following treatment. 
For the somatic situation of the patients at pre-test see chapter 7, table 1. Overall facial disfigurement is 
indicated by the scores on the HB-FGS and the SB-FGS. 
Patients were individually invited to the hospital for the prc-tcst. Although patients never met the other 
participants, they were conceptually treated as 'pairs' of which one member was assigned at random to 
the direct treatment condition (Mime therapy), the other member being assigned to the waiting list control 
condition. The administration knew this assignment in advance, but informed the patient on 'same-day 
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start of treatment' vs. 'treatment-start-in-three months'. The waiting list patients received an appointment 
card with the date of their expected return for therapy; they were not contacted by the hospital during the 
waiting period 
Mime therapy was given in the outpatient department of the hospital, five trained physiotherapists 
administering Mime therapy, with each patient having his/her 'own' therapist. Mime therapy consists of 
auto-massage of face and neck, breathing and relaxation exercises, specific exercises to co-ordinate both 
halves of the face and to decrease synkineses, exercises for eye and lip closure, letter and word 
articulation exercises, and emotional expression exercises. 
There were ten treatment sessions, with each weekly session including sequentially structured exercises 
lasting approximately 45 minutes Patients also had to perform daily exercises at home 
Descriptive analysis 
Table 3 shows the bias-corrected readability indices for 6 basic emotions (ER(C|) for both groups at pre 
and post-test, indicating improvement only in the Mime therapy group at post-test. All emotional displays 
improve substantially, with exception of "surprise". 
Table 3' Bias-corrected readability indices* for six basic emotions (ER^,) in treatment and control group. 
Indices are based on pooled confusion data from patients with facial nerve paresis (in each group Ν = 25 
at pre-test and Ν = 24 at post-test). 
Emotion 
1. Sadness 
2. Fear 
3. Anger 
4. Disgust 
5 Surprise 
6 Happiness 
Pre-tesl 
Waiting list group 
0 44 
0 26 
0 32 
0 56 
0.47 
0.75 
Pre-test 
Mime therapy group 
0 47 
0.27 
0.32 
0.63 
0.48 
0.77 
Post-test 
Waiting list group 
041 
0 29 
0 29 
0.53 
0.50 
061 
Posl-tesl 
Mime therapy group 
0 90 
0 70 
0 77 
0 87 
0 59 
0 90 
* Readability index is calculated according to H(u) proposed by Wagner (1993) 
Correlations of the amount of correctly recognised facial displays (CRFD) with the degree of facial 
disfigurement measured by the subscales (rest, movement, synkinesis) and total scale of the Sunnybrook 
and the House-Brackmann scores at pre and post-test are given in table 4. 
The absence of significant negative correlations with the extent of facial disfigurement is not in line with 
our hypothesis number 2. 
Such expected significant correlations are however found at all three post-treatment occasions but, only 
for the SB-FGS Significant correlations (p < 0.05, one-sided) between amount of CRFD and SB total are: 
.27, .30, .29 at T2, T3, T4, respectively. 
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Table 4. Means, standard deviations, and correlations of the amount of CRPD with the subscales (rest, 
movement, synkinesis) and total scale of the Sunnybrook (SB) and the House-Brackmann (HB) score at 
pre-test, Ν = 50. None of the correlations is significant (p < 0.05, one-sided). 
Mean 
SD 
Correlation 
with CRFD 
SB rest 
Pre 
11.6 
4.2 
-22 
SB move 
Pre 
55.6 
16.1 
22 
SB synk 
Pre 
8.0 
3.0 
0.09 
SB total 
Pre 
35 5 
18.5 
0.21 
HB 
Pre 
39 
0.8 
-.14 
ACRFD 
Pre 
8.3 
2.1 
Short-term effectiveness of Mime therapy in improving emotional readability 
Effect analyses were performed separately for the two outcome variables: a) the amount of correctly 
recognised facial displays (CRPD) per patient and b) emotion-specific emotional readability scores (ER<C)) 
per group. Regarding dependent variable (a) the individuals were treated as statistical replications; 
regarding dependent variable (b) the emotions were treated as replications. 
To check the equivalence of the two groups for the amount of correctly recognised facial displays at pre­
test, two sided t-tests were performed. The groups did not differ significantly (p < 0.05) at pre-test, see 
table 5. In our opinion, group equivalence is not attenuated by the loss of one patient from each group as 
the reasons for dropout are unrelated to the trial. 
A check was then made as to whether the post-data did not contradict the direction hypothesised. On both 
dependent variables the experimental group scored better than the control group at post-test. 
The scores of the treatment group at post-test were then statistically compared with those of the control 
group (ANOVA, t test). The treatment group scored significantly better for the amount of CRFD 
compared to the control group [F test = 20.9, ρ < 0.05; effect size g = 1.3 (Hedges and Olkin'4)]. For the 
ER^, the treatment group also scored significantly higher with regard to emotional readability (t = 4.7, ρ < 
0.05), efTect size g = 2.7. 
These results show that Mime therapy is effective in improving emotional readability. This is consistent 
with our hypothesis number 3 
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Table 5. Emotional recognition at pre- and post-test in the waiting list and Mime therapy group for two 
dependent variables: 1) the amount of correctly recognised facial displays (CRFD) 2) emotion-specific 
bias-corrected readability (ER<c))(in each group Ν = 25 at pre-test and 24 at post-test). 
CRFD 
(range: 0-12) 
ER<o 
(range: 0.00-1.00) 
Pre-test waiting 
list group 
Mean (SD) 
8 1(2 1) 
0.47(0.18) 
Pre-test Mime 
therapy group 
Mean (SD) 
8.5(2.1) 
0.49(0.19) 
Post-test waiting 
list group 
Mean (SD) 
7.9(2.2) 
0.44(0.13) 
Post-test Mime 
therapy group 
Mean (SD) 
10.6(1.8) 
0 79(0.13) 
Long-term stability of improvements in emotional readability 
Two types of stability were analysed: stability of outcome level (A), and stability of inter-patient 
differences in outcomes (B). These analyses were made for only one index of emotional readability: the 
amount of CFRD. The reason is that these analyses presume scores at individual levels. 
A. Stability of outcome level 
Stability of outcome level (A) was firstly analysed (Al) as absence of changes over time in the average 
scores of the three post therapy measurements, and secondly (A2) by inspection of the change profiles of 
all individual patients for some sequelae. This analysis was only performed for the amount of correctly 
recognised emotions. 
A. 1 Absence of post-therapy trends in group averages 
Group-level analysis of absence of changes over time was performed by applying repeated measures 
analysis of variance (ANCOVA) on T2, T3 and T4 scores with the respective immediate pre-therapy (Tl) 
score as covariate, in combination with testing for absence of trends. Presence of mean level stability was 
inferred from the absence of significant (p < 0.05) trends (linear or quadratic) in the three post-therapy 
measurements. Significant trends were inspected for remission or continued improvement. To test 
whether the differential pre-therapy history (waiting list versus immediate therapy) of our RCT 
participants influenced the course of post-therapy outcomes, the "treatment" condition was added as a 
factor in the resulting time (3) by treatment (2) ANOVA design. 
Significant differences were found between time points (Wilks' Lambda = 0.85, ρ = 0.03) for the amount 
of correctly recognised facial displays, which was due to a linear trend (F = 6.8, ρ = 0.01; adjusted means 
are T2 = 10 6, T3 = 10.6, T4 = 10.8). The benefits of Mime therapy in improving readability of facial 
emotional displays do, on average, not deteriorate but even improve a little bit. 
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Α.2 Change profiles of individual patients 
All individual time courses of the CRFD of all patients with facial nerve paresis were categorised for the 
presence of patterns of change in the period T1-T4. For a classification of change patterns see table 6. 
Patterns that were considered to evidence long-term (12 months) stability after therapy fall within the 
range (T2 ± 2.SE, SE = Standard Error of the mean). Put differently, when the condition (T2 - 2 SE) < 
T3,T4 < (T2 + 2.SE) is met, the change pattern 12 -> T3 -> T4 is classified as long-term stability. See 
table 6 for an overview of all change patterns. 
Table 6. Change patterns from pre-therapy to one year after Mime therapy (Tl to T4) for amount of 
correctly recognised facial emotional displays. Ν = 46 patients with facial nerve paresis from NMTS. 
Pattern 
1. Deterioration during therapy, at T2 (T1-T2), T2 < (Tl - 2 SE) 
2. No benefits of therapy (T1-T2) 
2.1 No benefits, T1=T2, changes thereafter at T3 and/or T4 
2.2 "Hyper" stability (T1=T2=T3=T4), no changes during therapy and (hereafter, 
differences at T2, T3 or T4 < (Tl ± 2.SE) 
3 Improvements during therapy (T1-T2) 
3.1 Improvement continues, T4 superior to T3 [T4 > (T3 + 2.SE)], T3 superior to 
T2 [T3 > (T2 + 2.SE)] 
3.2 Improvement continues at T3, achieved level at T3 still present at T4, T3 
supenor to T2 [> (T2 + 2 SE)], T3 = T4 [T4 < (T3 ± 2 SE)] 
3.3 Achieved level at T2 still present at T3 and T4, T2 = T3 = T4 [< (T2 ± 2.SE)] 
3.4 Achieved level at T2 still present at T3 and changes at T4 
a. T2 = T3 [T3 < (T2 ± 2.SE)], improvement at T4 [T4 > (T2 + 2.SE)] 
b. T2 = T3 [T3 < (T2 ± 2.SE)], deterioration at T4 [T4 < (T2 + 2.SE)] 
3.5 Achieved level at T2 still present at T4 and changes at T3 
a T2 = T4 [T4 < (T2 ± 2 SE)], improvement al T3 [T3 > (T2 + 2 SE)] 
b. T2 = Τ4 [Τ4 < (Τ2 ± 2 SE)], deterioration at Τ3 [Τ3 < (Τ2 + 2.SE)] 
3 6 Deterioration after therapy, deterioration at T3 and T4 [T3, T4 < (T2 + 2 SE)] 
Number of patients 
0 
0 
4 
4 
3 
2 
17 
3 
3 
3 
3 
4 
Categories 1,2 1 and 2.2 as shown in table 8 indicate no benefits of therapy and are therefore not relevant 
for answering our question regarding stability of benefits. This is the case in 8 of the total number of 46 
patients. 
Of the remaining categories (improvements during therapy), pattern 3.6 shows repeated deterioration after 
therapy, both at 3 and 12 months, occurring in 4 patients. Pattern 3.4b shows that 12 months stability is 
absent in 3 patients. A three months deterioration-dip (pattern 3.5b) is shown in 3 patients All other 
categories show either perfect stability or even improvements, seen in 28 patients. 
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Β Analysis of stability of inter-patient differences 
Pearson correlations between tune points T2, T3 and T4 are calculated for the amount of correctly 
recognised emotions (CFRD) These correlations are all significant and high. 0 90 (T2-T3) and 0.83 (T2-
T4)(p<0 01). 
Concluding observations 
This study had four hypotheses. The first hypothesis, that the quality of facial emotional displays in 
patients with longstanding facial nerve paresis is low, is supported by the results of study 1. 
The newly developed FERS procedure turned out to be a reliably scorable and discriminative tool. 
Hypothesis 2, that there is a negative relation between facial disfigurement and emotional facial 
readability, was not supported by our NMTS patients at pre-test After therapy however their emotional 
facial readability was more in line with their (changed) degree of facial disfigurement; further analysis is 
needed to reveal eventual causal connections. Mime therapy turned out to be an effective treatment in 
improving emotional facial readability as expected in hypothesis 3. Effect sizes are substantial Of clinical 
relevance is information about the sustainability of the achieved benefits The amount of correctly 
recognised facial emotional displays does, on average, not deteriorate, but even improve a little bit after 
three and twelve months, also on an individual level Stability, or even continuing improvements were 
found in 28 out of 38 relevant cases. 
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General discussion 
Our central hypothesis was that facial asymmetry improves as a consequence of Mime therapy in patients 
with longstanding peripheral facial nerve paresis and that this results in improvements in secondary 
sequelae: facial stiffness, dysfunction in eating, drinking, speaking, rinsing and lacnmation, non-
wellbeing, psychosocial problems, and lack of emotional readability. 
The data presented, massively support the first implied hypothesis that Mime therapy is effective in 
patients with facial nerve paresis. Nearly all outcome variables were significantly and substantially 
improved at the post-test when the Mime therapy group was compared to the waiting list group. 
Mime therapy induces substantial improvements of outcome variables on all three levels of the 
International Classification of Functioning, Disability and Health (WHO). 
Functioning level: 
- facial disfigurement: 
- asymmetry at rest (except resting asymmetry of the eye), 
- asymmetry during voluntary movements; 
- synkinesis; 
- stiffness; 
- lip (im)mobility; 
- low emotional readability. 
Disability level: 
- problems with eating, drinking, nnsing; 
- problems with speaking; 
- problems with lacrimation. 
Health level: 
- tension in social contact; 
- depressivity, 
- avoidance of confrontation with own facial nerve paresis in social contact 
The data also give clear support to the second implied hypothesis that these benefits of Mime therapy are 
stable. Both after three and twelve months post-therapy, such stability could be demonstrated for the 
majority of sequelae in most patients. 
The third implied hypothesis states that improvements in secondary sequelae are dependent upon 
improvements in facial asymmetry. We have not yet analysed all data in this respect as these analyses go 
beyond the time frame for this dissertation. Some form of path analysis will be applied to test this third 
hypothesis. 
Critical reflections on the research presented will be given below. 
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Strength of the design 
Positive effects of Mime therapy were inferred from the existence of post-test differences between two 
random-assigned groups. Patients of the treatment group directly entered (after the pre-test) a ten-week 
treatment program. Patients in the control group were (after the pre-lest) told that the start of their 
treatment was scheduled three months later. The random assignment procedure ensured that the groups 
were equivalent directly after the assignment. The differences between the two groups at post-test can 
only be attributed to differences arising after the assignment. Obviously, receiving Mime therapy (or not) 
is one of the relevant differences, but are there other relevant factors? 
Resentment felt by patients assigned to the waiting list could be one, however, patients never made 
negative remarks in this respect, possibly because waiting lists are ubiquitous phenomena in the Dutch 
health care system. If such resentment had been formed in the waiting list group, ils consequences might 
also have been visible in the three post therapy measurements. In analysing these data for trends, wc have 
not found differential trends for patients from the waiting list and Mime therapy groups, for any of the 
sequelae. The absence of such differential trends, also for the psychosocial variables, makes it implausible 
that eventual resentment from being assigned to the waiting list has carry-over to later time points. 
One might speculate about the utility of having a third randomised group in this trial, a control group 
receiving no treatment at all, but with measurements at T1-T4. In that case we could have investigated the 
stabilities of the effects of Mime therapy (and their sizes) instead of the stabilities of benefits, which have 
been now demonstrated. 
Intervals between measurements were based upon a three month grid; the duration of the treatment. 
Shorter measurement intervals, including measurement occasions while the treatment is in progress, 
would have generated data on the recovery process and on which parts of Mime therapy mostly contribute 
to the final effect. Process studies did not have high priority at the time design decisions about NMTS 
were made 
Blinding 
Blinding of patients, therapists and observers is considered an important characteristic of good medical 
research.1"' However, in physiotherapy research it is often not possible to blind patients and therapists for 
a specific intervention. 
In our study patients were not blinded as to whether they were on the waiting list or not as treatment is a 
real condition; however, as waiting lists in the Dutch health care system are ubiquitous, patients 
considered this as 'normal'. We have no indication that patients in the waiting list group felt 
'disadvantaged', or that patients in the treatment group felt 'elected'. 
Therapists were not blinded for the group condition, as they had to carry out the treatment. We assume 
that the therapist's knowledge about the patient's condition did not differentially influence the symmetry 
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measurements at post-test. In general, therapists did not have access to the pre-test data of patients when 
collecting data at post-test. Blinded to the condition, efforts were made to score and analyse the 
information obtained (waiting list versus treatment group). The main outcome variables were scored by 
observers from video recordings, blinded to condition and time of measurement. 
Generalisation 
Our patients are a sample drawn from the continuous stream of patients requiring specialised 
physiotherapy in academic hospitals We consider the time period when the eligibility window was open 
as a random sample out of this time stream. Background data of patients included in the RCT do not 
differ from the background data of patients included in the archive study covering the decade 1987-1997. 
We believe that the conclusions drawn regarding Mime therapy apply to most Dutch patients with facial 
nerve paresis 
Duration of the paresis and commencement of Mime therapy 
Patients in our study were included when the duration of the paresis was at least nine months. However, 
duration of paresis did not affect the effectiveness of Mime therapy in improving facial disfigurement 
(chapter 7). 
There are various ideas in the literature concerning the length of 'longstanding' or chronic paresis Some 
authors state 6 months are being longstanding, others speak of 9, 12 months or even more.""6 The 
advantage of starting at a later stage is the "stability" of the situation of the paresis Disadvantages are that 
the patient has to wait a long time before beginning therapy; starting at an earlier stage during the 
reinnervation process may be helpful into supporting spontaneous recovery. In general, clinical reports on 
early treating patients are positive 
Mechanisms responsible for the effectiveness of Mime therapy 
The RCT design allowed us to conclude that Mime therapy is effective. One should however be aware 
that Mime therapy is a complex compound covering events occurring over ten weeks both in the clinic 
and at home. In an institutionalised setting, a therapist interacts with a patient whose complaints centre on 
a body part (the face) which is loaded with cultural values. In this compound many processes can 
simultaneously contribute to the final outcome of Mime therapy. 
There is yet no uniform theoretical basis of Mime therapy. How can it be that Mime Therapy is effective? 
Working mechanisms are still unknown. Could it be due to plasticity of the brain, existence of new 
pathways, improved muscle function due to a better circulation or relaxation, or motivation of the 
patient''7 B 
In the last two decades there has been a growing interest in theones of motor control and the 
implementations in clinical practice'. 
Such a theory can provide a conceptual framework not only in clinical practice, but also in research to 
understand how and why a certain modality of physiotherapy could be effective. Three motor theory 
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approaches will be briefly touched upon. Schmidt's schema theory10, Fitts and Posner's" stages of 
releaming of motor skills, and experimental work involving the neuro-physiological basis of releaming 
When applying the schema theory of Schmidt to evaluate the effectiveness of Mime therapy, one is able 
to analyse the different process levels necessary for releaming and functional recovery Schmidt proposed 
that several conditions of a generalised motor program, necessary to perform daily life movements, are 
stored in memory. In our patient group the facial nerve paresis is acquired and not congenital, therefore 
this generalised motor program is still available and probably recallable. Schmidt states that the following 
four elements are stored in memory: 
1. The initial movement condition (e g position of the lips) 
2. Parameters necessary for movement planning and available in the generalised motor program 
(e.g. timing, speed, distance and direction of the movement) 
3. The outcome of the movement (c g a smile). 
4. The sensory consequences of the movement, i.e. how it should feel (e.g. smiling and feeling 
happy). 
This motor information is stored in abstracted form according to Schmidt's schema theory a recall 
(motor) schema (1,2, and 3) and a recognition (sensory) schema (4) As a consequence of the paresis, the 
patient is faced with different sensory consequences as could be expected in the original schema In Mime 
therapy, the physiotherapist stimulates the patient to use the original motor program, present in memory, 
to re-discover the movement At the same time the physiotherapist gives sensory feedback to 
simultaneously recover the sensory schema. It is necessary that this external feedback (knowledge of 
result and performance) becomes intrinsic. 
Recovery of functional movements following a facial nerve paresis implies searching the memory to 
reactivate and re-train the original motor program, integrating these changes into the motor cortex. 
When a patient with a facial nerve paresis is (rc)lcaming a new task step by step, for example raising the 
eyebrows, according to the recall schema optimal learning occurs if the task is practised using various 
recall schema's already present in the memory such as e.g. raising eyebrows (functional task) or looking 
astonished (emotional task). The patient will then become more adept in generating various strategies for 
searching the appropriate motor programs in the memory. Such various task conditions enable patients to 
facilitate the appropriate muscles, using various recall schémas, present in diverse memory regions. 
The recognition schema is used for feedback and correction of errors in the response (e g the patient feels 
that the movement, for instance raising eyebrows is asymmetrical). Simultaneously, the physiotherapist 
gives information and external feedback regarding the outcome and execution of the movement 
(knowledge of result and performance). 
Furthermore a mirror can be used for environmental feedback. Within this perspective, releaming specific 
mimic movements is the effect of repeated stimulation of the impaired facial nerve According to this 
view, releaming is an ongoing process which intensifies by using many variations in the motor programs, 
repetitions of movements and by the use of positive feedback (reinforcement of the adequate movement) 
by the physiotherapist, the environment and the patient's own intrinsic feedback 
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A second possible framework to understand Mime therapy are the three releaming stages of motor skills 
as defined by Fitts and Posner." 
These three learning stages, when extrapolated to Mime therapy are: 
1. The first or cognitive stage. 
The first sessions of Mime therapy provide explanations and examples of which movements the 
patient has to perform. Examples demonstrated by the physiotherapist and imitation by the patient 
are important. E.g. learning to smile can commence with abduction of the mouth comers, the 
patients being told how he can realise such a movement. Important at this stage is that the patient 
knows exactly how to execute the movement. 
2. The second or associative stage. 
In subsequent sessions of Mime therapy, the patient leams to perform the movement 
independently (homework) with the aid of a mirror, searching for the appropnate sensory 
association. There is as yet no differentiation between e.g. grimacing, smirking and smiling. This 
diversity of movement has to be learnt by frequently practising in differing conditions. 
3. Third or autonomous phase. 
The last stage of Mime therapy is used for consolidation and refinement of movement, thereby 
stimulating an automatic process. In our example, the patient must not only be able to feign a 
smile, but also to be able to give a broad smile in a pleasant situation (without cognitive aid). 
When this stage is reached during Mime therapy, the benefits of the therapy will be preserved, and 
automatically incorporated into daily life. 
When considering the physiological basis of motor learning, one also has to consider the relationship 
between the plasticity of the neural system and motor learning. The general "laws" for peripheral nerve 
regeneration are also applicable to the facial nerve.12 However, in the chronic phase (when spontaneous 
recovery has taken place) there is little known about the process of recovery of the nerve. 
Research concerning the neuro-physiological basis of (re)leaming suggests that the plasticity of the brain 
is enormous e.g. in realising new synaptic connections. However, there is not yet much known regarding 
the effect of reinforcement on already existing weak pathways or development of new pathways. 
In experimental studies in rats, Van Meeteren13 found that moderate exercise training with positive 
reinforcement is effective in acute and chronic neuropathy. Assuming that recovery of nerve function in 
rats and humans is more or less analogous, the processes ongoing in the training program of Mime 
therapy are comparable to processes in the experimental reinforcement training. 
Further studies are required to discover the physiological basis of nerve recovery while receiving Mime 
therapy. 
Recommendations for future research and work: 
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1. Replication of this study in other patients groups, e g. patients with duration of paresis for less 
than nine months and patients with a dynamic reconstruction following the facial nerve paresis. 
2. A process study to provide further clues to the working mechanisms underlying the effectiveness 
of Mime therapy. 
3. Documentation and production of guidelines in the training of physiotherapists in Mime therapy. 
4. Promotion of Mime therapy as a treatment of choice for patients with facial nerve paresis. 
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Mime therapy: rehabilitation of facial expression 
Physiotherapy for patients with facial nerve paresis has not provoked much attention of researchers. This 
dissertation covers many aspects of a specific modality of physiotherapy, Mime therapy; integration of 
mime in physiotherapy. The dissertation consists of three parts. Part I reports on preparatory studies 
which concern the origin and development of Mime therapy, on the practice of Mime therapy in 
Nijmegen and its outcomes, on the literature search for a comparison treatment and on the reliability of an 
instrument to measure an important outcome variable 'facial asymmetry'. Part II reports on the design 
and results of the Nijmegen Mime Therapy Study (NMTS), an intervention study that began on April 1st, 
1999. Five chapters report on empirical results of the effectiveness of Mime therapy, and on the stability 
of the benefits. In part III the results are discussed. 
Part I. Preparatory studies 
Chapter 1. Introduction 
Approximately half of the cases of peripheral facial nerve paralysis are Bell's palsies; the incidence being 
20:100.000 adults per year in western countnes. Other cases are due to trauma, operative trauma, herpes 
zoster, diabetes mellitus, tumour growth or otitis media, etc. Complete spontaneous recovery of facial 
function in Bell's palsy is observed in 70 % of the cases. The literature does not provide exact figures for 
the other aetiologies. However, complete spontaneous recovery in these cases is described as less than 70 
%. Not much is known about the prevalence of peripheral facial nerve paresis. Of the estimated 8 million 
adults in the Netherlands, approximately 1600 patients a year will face a Bell's palsy, 30 % (480) will 
remain with a facial nerve paresis, varying from mild to very severe. It is generally believed that 
spontaneous recovery of the facial nerve starts within the first weeks, and can continue until about nine 
months or even more. When there is no complete recovery after this period of nine months, we refer to 
the affliction as longstanding facial nerve paresis. 
Sequelae of longstanding facial nerve paresis consist of facial disfigurement (asymmetry at rest, during 
movement, and synkinesis), disabilities in eating, drinking and speaking, and psychosocial problems. 
Facial nerve paresis maligns not only the face, but also the life and social environment of the patient. 
Surgical and non-invasive treatments for sequelae of longstanding facial nerve paresis are available. 
Surgical treatments consist of gold weight implants in the upper eyelid and static or dynamic surgical 
reconstructions Non-invasive possibilities for longstanding sequelae of facial nerve paresis are limited. 
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For more than fifty years physiotherapy has been given to patients with peripheral facial nerve paralysis, 
but only few scientific data from well designed studies are available. A review of the literature shows a 
variety of treatments, four of which were frequently used: exercise therapy, massage, low frequency 
electrotherapy and biofeedback Until 2003 there was no randomised controlled trial (RCT) published 
which demonstrated clear effects of any of the above mentioned modalities of physiotherapy 
Mime therapy, a modality of physiotherapy, has been applied in the treatment of patients with facial nerve 
paresis in the Netherlands for more than 25 years. The main purpose of the NMTS is to determine, under 
controlled conditions, whether Mime therapy, as practised in the outpatient departments of two university 
hospitals is an effective treatment. 
Our central hypothesis is that facial asymmetry improves as a consequence of Mime therapy in patients 
with longstanding peripheral facial nerve paresis, and that this results in improvements in secondary 
sequelae: facial stiffness, reduced emotional readability, problems in eating, drinking, speaking, rinsing 
and lacrimation, lack of well-being and psychosocial problems. 
Chapter 2. From mime to Mime therapy. The genesis of a rehabilitation method for 
patients with facial nerve paresis 
The objective of this chapter was to give an extended and detailed description of the origin of Mime 
therapy and its development throughout the years. 
Mime therapy is originally developed in Amsterdam in 1974 by Jan Bronk, mime actor, teacher and 
director of the Dutch Mime Institute (t 1985) together with Pieter Devricse, otolaryngologist and 
specialised in facial nerve paralysis. Jan Bronk conceived the idea of using the principles of mime for 
patients suffering from either lack of facial movements or uncontrolled and involuntary movements. He 
developed an analysis of the face, specifically of the emotions, based on mime in order to help these 
patients. 
Mime therapy is a non-conventional method of rehabilitation for patients with facial nerve paresis of 
various aetiologies. Mime therapy was initially based upon principles of mime and at a later stage also on 
principles of physiotherapy, aiming at rehabilitation of facial expression or in other words improved 
symmetry of the face. When in 1980 physiotherapists were trained in Mime therapy by Jan Bronk, the 
content of the treatment changed from mime to a combination of mime and physiotherapy. Specific items 
were elaborated such as stretching of the facial muscles and inhibiting synkineses (involuntary movement 
in one area when another area is moving) by counteracting movements. The medical history and 
examination were improved by the introduction of standardised intakes and measurements of the 
asymmetry of the face at rest and dunng movements. 
Present day Mime therapy includes: 
a. information about treatment and prognosis; 
b. auto-massage of face and neck; 
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c. breathing and relaxation exercises, 
d. specific exercises for the face to co-ordinate both halves and to decrease synkineses; 
e. exercises for eye closure and lip closure, necessary for eating, dnnking and rinsing of the mouth; 
f. letter and word exercises; 
g. expressive exercises 
From 1980 until now, more than 1000 patients with facial nerve paresis have been treated with Mime 
therapy at the University Medical Centre Nijmegen. The positive results reported by patients contrast with 
the lack of scientific 'hard' evidence. This is one reason for performing a RCT; another reason is the 
increasing need for evidence based treatments, also in the field of physiotherapy. 
In preparation of this RCT two studies will next be reported. Firstly (chapter 3), the archive records, 
collected over a decade, will be inspected to see whether patients' reported satisfaction is backed up by 
positive results Secondly (chapter 4), the empirical literature will be reviewed to discover eventually 
comparable treatments. 
Chapter 3. Description of outcomes in patients with facial nerve paresis referred for 
physiotherapy 
This descriptive study was performed to describe sequelae in patients with facial nerve paresis and their 
changes and stability in time following physiotherapy, based on archive data. 
Physiotherapy files of 175 patients with facial nerve paresis treated between 1987 and 1998 were 
collected. The files contained a letter from the general practitioner or referring specialist, the general 
history and state of well-being prior to and following treatment, and observations made by the 
physiotherapist prior to and following treatment. All patients were treated by means of Mime therapy. 
Outcome measures were: (a) impairments: facial asymmetry in rest and during movements and 
synkineses, (b) disabilities: difficulties with eating, drinking and speaking, (c) quality of life. 
Patients were treated over a period of three to five months with Mime therapy. The results were: (a) facial 
asymmetry at rest decreased significantly, asymmetry in all facial movements decreased and the severity 
of synkineses decreased for six movements; however the number of synkineses per patient increased for 
three out of eight movements (b) Substantially fewer patients reported difficulties in eating, dnnking and 
speaking, (c) Quality of life improved. According to the House Brackmann Facial Grading System (HB-
FGS) almost all patients improved on average by one level after 8 to 10 sessions. Age, sex and affected 
side were not predictive of any of the observed changes and a high degree of stability of inter-individual 
differences was observed 
The conclusion of the study was that sequelae of longstanding peripheral facial nerve paresis improved in 
patients receiving Mime therapy. This outcome encouraged setting up a RCT to assess the effectiveness 
of Mime therapy under controlled conditions in the 'real-world' setting of the outpatient clinic. 
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Chapter 4. Literature review of evidence based physiotherapy in patients with facial nerve 
paresis 
An earlier review of the literature was updated to gain information regarding the efficacy of several 
modalities of physiotherapy in use for treating patients with peripheral facial nerve paresis This 
information serves to identify a "standard" treatment with which Mime therapy could be compared in a 
RCT 
A variety of physiotherapy interventions during the past 35 years have attempted to decrease the sequelae 
of patients with facial nerve paresis. An earlier literature review of the penod 1966 - mid 1991 described 
a variety of physiotherapy modalities, mainly exercise therapy, massage, electrotherapy, biofeedback, 
ultra sound, short-wave diathermy, infrared and hot packs. Of the 17 articles in this review aiming to 
study the effectiveness of physiotherapy in facial nerve paresis, 14 were based on a pre-expenmental 
design, two on a quasi-experimental design and only one was a RCT. This RCT from Mosforth & 
Tavemer however did not show differential outcomes for two forms of physiotherapy (electrotherapy + 
infrared versus massage therapy). 
This supplementary review only deals with RCTs and documents the expansion of evidence based 
physiotherapy in patients with facial nerve paresis between mid 1991- end 2002, the studies being 
identified by computerised searches of biomedical databases, reference lists, and by contacting 
investigators. To assess the trials the PEDro scale was applied by two independent reviewers Only three 
randomised controlled studies using physiotherapy were identified in reviewing a time period of more 
than forty years. Interventions in the included studies were massage, infrared, electrotherapy, biofeedback 
and exercise therapy. None of the RCTs revealed scientific based evidence that proved that the 
physiotherapy group scored better than a control group. Two of the studies described nevertheless 
benefits of the interventions used in the studies (biofeedback and small-movement exercises). The 
conclusion of this review is that the number of RCTs has hardly increased since mid-1991. The 
methodological quality of the included trials is moderate. None of the included trials showed a significant 
treatment effect when the experimental group was properly compared with the control group. This implies 
in our study of the effectiveness of Mime therapy, that a 'no-treatment' group can serve as a control group 
in the RCT design of the NMTS. 
Chapter 5. Contralateral reinnervation of midline muscles in facial paralysis 
A case study serves to remind physiotherapists of the need for electromyogram information in cases of 
patients with severe facial nerve paresis This study contains the report of a patient with recovery of 
voluntary activity of ipsilateral midline muscle three months after a complete left sided facial nerve 
paralysis as a result of resection of a vestibular schwannoma of the left cerebellopontine angle. As the 
patient was able to voluntarily contract the orbicular oris and nasalis muscles he started Mime therapy. 
There was however no improvement at all during therapy, a consequence being that a dynamic correction 
with a hypoglossal-facial nerve jump anastomosis was postponed. Electrodiagnostic studies showed that 
stimulation of the affected side evoked no responses in contrast with contralateral facial nerve 
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stimulation. Needle electromyography revealed abnormal spontaneous activity in the left orbicular oris 
muscle. Contralateral reinnervation is probably due to sprouting of terminal nerve branches crossing the 
midline of the face and innervating bundles of muscle fibres on the affected side. Contralateral 
reinnervation in facial paralysis is a phenomenon unknown to most clinicians. Knowledge regarding this 
phenomenon is relevant for the interpretation of the mechanisms underlying renewed facial muscle 
activity and consequently for the prognosis and treatment possibilities. 
When treating patients with a very severe facial nerve paresis, physiotherapists are advised to gain 
information regarding electromyogram results prior to commencing treatment. 
Chapter 6. Reliability of the Sunnybrook Facial Grading System when performing optimal 
facial movements 
Accurate grading of asymmetry in patients with facial nerve paresis is important so that treatment can be 
assessed for its effectiveness. Several grading systems for facial nerve paresis are available, the most 
widely used being the House-Brackmann Facial Grading System (HB-FGS). The HB-FGS scale has 
shown to have good interrater reliability; however, its sensitivity to change is low. A more recently in 
Canada developed facial grading scale by Ross, Fradet and Nedzelski (1996), the Sunnybrook Facial 
Grading System (SB-FGS) has been translated into Dutch, the SB-FGS Dutch Language Version (SB-
FGS-DLV). 
The purpose of this study was to examine the subscales and composite scale of the SB-FGS-DLV for its 
intra- and interrater reliability, enabling the SB-FGS to be used to more accurately measure aspects of 
facial asymmetry in our patient population. Besides this, the reliability of the SB-FGS-DLV was 
investigated when patients performed optimal symmetrical movements (with respect to synkinesis), other 
than maximal movements required in the original Canadian version. 
In this study, 25 patients with a mean severity of III according to the HB-FGS were videotaped. These 
video tapes were independently scored by two physiotherapists and one student using the SB-FGS-DLV. 
The infrarater reliabilities of the composite scale as estimated by the intraclass correlation coefficient 
(ICC) were: 0.98, 0.89 and 0.95, and the m/errater reliabilities were (ICC): 0.95, 0.90 and 0.93, 
respectively. Intrarater reliabilities for the subscales varied between 0.81 and 0.99, interrater reliabilities 
between 0.82 and 0.97. The conclusion of this study was that the SB-FGS-DLV has a very good intra-
and interrater reliability as a measurement instrument in patients with facial nerve paresis referred to the 
physiotherapy department of the UMC Nijmegen The SB-FGS-DLV is reliable when optimal 
symmetrical movements are requested. 
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Part II The Nijmegen Mime Therapy Study 
The design of the Nijmegen Mime Therapy Study (NMTS) 
Patients with peripheral facial nerve paresis show a wide range of sequelae, asymmetry of the face being 
the most important one Evidence based physiotherapeutic treatments of patients with facial nerve paresis 
are absent. Experiences from the outpatient department and the archive records show that Mime therapy 
is a valuable treatment and has the potential to be an effective therapy. 
The RCT design of the NMTS is explained according to the CONSORT statement (Consolidated 
Standards of Reporting Trials). 
To evaluate the effectiveness of Mime therapy in patients with longstanding peripheral facial nerve 
paresis, a randomised controlled trial was started in April 1999. The treatment group received Mime 
therapy for three months, the control group formed a waiting list Considerations of power and desired 
effect size led to a design with 50 patients equally divided over treatment and control group. 
The wide range of sequelae is reflected in a wide range of dependent variables, which can be classified 
according to the three (WHO) levels of Functioning, Disability and Health. 
Imposed on the immediate post-treatment measurement in the RCT design are two follow-up 
measurements after three and twelve months. Companson of measurements at these three time points 
allows the study of the stability of eventual benefits of Mime therapy. 
Chapter 7. Effectiveness of Mime therapy: improvement of facial disfigurement in patients 
with facial nerve paresis 
The objective of this study was to assess the effectiveness of Mime therapy in improving facial 
asymmetry for patients with longstanding, unilateral, peripheral facial nerve paresis 
50 patients, 21 male and 29 female adults, with a facial nerve paresis lasting more than nine months, were 
included in this RCT at the physiotherapy outpatient departments of two university medical centres, 
Nijmegen and Amsterdam. Assessments were made at baseline and post-treatment. The median seventy 
of the paresis corresponded to a grade IV HB-FGS. The treatment group received Mime therapy for three 
months and the control group formed a waiting list. The main outcome measures were resting asymmetry, 
symmetry of voluntary movement, and synkinesis measured by blinded scoring of video recordings using 
the Sunnybrook Facial Grading System (SB-FGS) and the HB-FGS. Of the 50 patients, 48 completed the 
trial. Results at post-test showed Mime therapy to have effects on the HB scores and on all the SB scores, 
except that of eye asymmetry. The HB scores improved significantly by one grade The SB composite 
score and all three components improved significantly and substantially due to Mime therapy (Hedges' g 
> 1.50). These results are unchanged when the missing scores were estimated on the basis of a "worst 
case" scenario. The therapy effect was independent of age, sex and duration of paresis. 
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Chapter 8. Positive effects of Mime therapy on sequelae of facial nerve paresis: stiffness, lip 
mobility and social & physical aspects of facial disability 
The objective of this study was to evaluate the effects of Mime therapy for patients with longstanding 
sequelae of facial nerve paresis upon stiffness of the face, lip (im)mobility (both lip and pout-length) and 
the physical and social index of the Facial Disability Index (FDl). 
50 Patients, 21 male and 29 female adults, with longstanding facial nerve paresis and a mean House-
Brackmann score of grade IV were included in the study. At impairment level, stiffness and lip 
(im)mobility were measured respectively with the stiffness scale and a sliding calliper, disability was 
indicated by the physical subscale of the FDl, the social subscale of the FDI indicating the degree of 
handicap. For all indices, patients in the treatment group scored at post-test significantly and substantially 
more favourably when compared to the waiting list group. 
Chapter 9. Stability of benefits of Mime therapy in sequelae of facial nerve paresis over a 
one year period 
The aim of this study was to assess the stability of benefits from Mime therapy over time periods of three 
and twelve months. The design was a prospective follow-up which was built upon a RCT in which a 
treatment group was compared with a control group. 48 patients completed the RCT and were available 
for follow-up at three and twelve months following therapy. Sequelae of facial nerve paresis were 
measured using the same measurements as in the RCT. Asymmetry of the face was a blinded assessment 
with the Sunnybrook Facial Grading System and the House Brackmann Facial Grading System. The lip 
mobility was assessed by the physiotherapist using a sliding calliper. The stiffness-scale and the Facial 
Disability Index are self reported by the patients. Two types of stability are analysed; stability of outcome 
level, (repeated measures analysis of co-variance and testing for trends, and individual's time course 
based analysis of level stability) and stability of inter-patient differences in outcomes 
Of the 48 patients completing the trial, 46 were available for follow-up. Repeated measures analyses of 
co-variance showed no significant differences (p < 0.05) in the average scores, nor were there significant 
trends in the three post-therapy measurements, except for the pout index and FDI-social, which showed 
continuous improvements. 
Analysis of the individual sequel-trajectones showed long-term stability after therapy in 45 % of all 
sequelae of all patients Other patterns are short/long-term continuous improvements (35 %) or 
deterioration during or after therapy (20 %) 
Chapter 10. Psychosocial sequelae in patients with facial nerve paresis: does Mime therapy 
have an impact that lasts? 
Mime therapy has been promoted in the Netherlands in the past 25 years as an effective means to generate 
lasting benefits for patients with facial nerve paresis This study reports the evidence basis for this claim 
with regards to psychosocial sequelae. The literature reports a variety of psychosocial sequelae attributed 
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to longstanding facial disfigurement· depressed mood and anxieties, a feeling of shame and associated 
withdrawal from social contacts, especially strangers; lack of disfigurement-adapted social skills and 
distorted contact behaviours; socially unusual coping behaviours e.g avoidance of eye contact, and low 
self-esteem. 
The objectives of this study were 1) to provide information regarding the presence of psychosocial 
sequelae of longstanding facial nerve paresis, 2) to demonstrate the effectiveness of Mime therapy in 
improving these sequelae and 3) to show the stability of eventual benefits achieved. 
Fitly patients with sequelae of longstanding facial nerve paresis were included in the study, 48 patients 
completed the first section of the RCT and 46 of these completed the follow-up At pre- and post-tests and 
at both follow-ups, patients answered a set of questionnaires tapping several aspects of psychosocial 
functioning. Three areas were covered. The first area (A) 'feeling tense in social contacts' consists of the 
component feelings of relaxation in contact with friends, family and strangers The second area (B) covers 
moods and feelings. Three questionnaires were used in this area, each covering a different time track to be 
overseen by the patient. In the Moods questionnaire the patient indicated the extent to which each of 20 
moods had been present in the past week. The Well-being questionnaire consists of 24 items requesting 
subjective evaluation of indicators of (absence of) quality-of-life in the past month. The experience of 
depression symptoms in the past three months, and in the past 24 hrs was assessed with Depnscope. The 
ten variables in area Β turned out to measure a single dimension: depressivity. The third area of 
psychosocial functioning (C) in patients with longstanding facial nerve paresis is involved with 
behavioural tendencies: avoiding confrontations with own facial nerve paresis in social contact, 
impressions of'being supported', and/or 'deterioration of relations'. 
Inspection of the pre-therapy scores makes clear that not every patient is relaxed with friends, or at ease 
with strangers. Depressivity is present in moderate to severe degrees; forty percent of patients are 
'depression-disordered' at pre-test on the basis of the D-Intrusions score. The prevalence of sequelae area 
C at pre-test is high for some items, e g 52% of the patients feel their intelligence as being 
underestimated. It was observed that the supposed cause (facial disfigurement) and supposed 
(psychosocial) sequel are unrelated. 
None of the variables showed significant between-group differences at pre-test. Between group 
comparisons at post-test revealed that Mime therapy had significant effects in the expected direction on 
all target variables in all areas and effect sizes were large, Hedges' g > 0.8. Furthermore, for most patients 
the benefits achieved could be sustained over a period of 12 months. 
Chapter 11. Improving emotional readability in patients with facial nerve paresis 
A multitude of facial muscles are involved in generating facial action patterns which convey emotional 
expressions, the muscles providing the basis for display of emotions, readability and empathy Normally both 
halves of the face are symmetric, non-deliberate asymmetry is perceived as uncanny 
The above mentioned considerations led to the following four hypotheses to be tested: 
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1. Correctly reading emotions from faces of patients with longstanding facial nerve paresis is more difficult 
than those of non-impaired faces. 
2. Emotional readability of the face of an individual patient with longstanding facial nerve paresis is 
negatively correlated with the extent of facial impairment. 
3. Mime therapy is effective in improving emotional readability of faces of patients with longstanding facial 
nerve paresis. 
4. The benefits of Mime therapy on improved facial readability are stable. 
These four hypotheses are tested in two empirical studies. Study 1 compared "normal" faces with faces of 
patients with facial nerve paresis. Study 2 is a RCT combined with follow-ups, where improvements in 
emotional readability are the aim and the sustainability of benefits achieved is investigated. Both studies 
make use of an especially designed instrument: the Facial Emotional Readability Stories (FERS) test. A core 
story was constructed comprising a series of connected events familiar to everybody. Six basic emotions 
(sadness, fear, anger, happiness, disgust and surprise) occur twice, dispersed throughout the story. The subject 
has to facially express each emotion as the story unwinds. These facial displays are videotaped. 
The intra- and interrater agreement of the FERS turned out to be high in study 1. Furthermore it was 
shown that patients produced emotional displays of much lower quality than the normal individuals and that 
some emotions are more easily readable than others, e.g. happiness versus fear. 
In study 2, two dependent variables are used from FERS: a) the amount of correctly recognised facial 
displays by each individual and b) emotion specific readability (ER^,) estimated on group level. 
The treatment group scored significantly higher than the control group for the amount of correctly 
recognised emotions; effect size g = 1 3. For the index ER<C) the treatment group was substantially better 
than the control group with regard to emotional readability (except "surprise"), effect size g = 2.7. 
Remarkable is that at pre-test there were no correlations between "the amount of correctly recognised 
emotions" with facial disfigurement as measured by the SB-FGS and HB-FGS. These correlations were 
however found at post-test. 
As regards to stability, no significant difference between the three time points was found for "the amount 
of correctly recognised emotions" at post-therapy and three and twelve months follow-ups, implying 
stability of the benefits. 
Chapter 1. General discussion and conclusions 
Aspects of the design and specific results are discussed. Future research and work in the area of care for 
patients with facial nerve paresis is suggested. 
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Conclusions: 
1. This is the first study that demonstrates effectiveness of Mime therapy in alleviating sequelae in 
patients with longstanding facial nerve paresis 
2. Mime therapy induces substantial improvements on all three levels of the International 
Classification of Functioning, Disability and Health (WHO): 
Functioning level: 
- facial disfigurement: 
- asymmetry at rest (excepting resting asymmetry of the eye); 
- asymmetry during voluntary movements; 
- synkinesis; 
- stiffness; 
- lip (im)mobility; 
- low emotional readability. 
Disability level: 
- eating, drinking, rinsing difficulties; 
- speaking difficulties; 
- lacrimation difficulties . 
Health level: 
- tension in social contact; 
- depressivity; 
- avoidance of confrontation with own facial nerve paresis in social contacts. 
3. These benefits of Mime therapy are stable to a large extent, over a period of one year. 
Recommendations: 
1. Mime therapy is a treatment of choice for patients with facial nerve paresis 
2. Replication of this study in a different clinical setting is desirable. 
3. Research into mechanisms underlying the effectiveness of Mime therapy is needed. 
The co-operation between a performance art and a medical profession has led to an 
important step forward in the treatment of patients with facial nerve paresis. 
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Nederlandse samenvatting 
Mimetherapie: revalidatie van de gelaatsexpressie 
Fysiotherapie voor patiënten met restverschijnselen van een aangezichtsverlamming, veroorzaakt door 
een nervus faciahsuitval, heeft in het verleden weinig aandacht getrokken van onderzoekers. Dit 
proefschrift omvat een onderzoek naar de effectiviteit van een specifieke behandelvorm van fysiotherapie 
voor deze patiëntengroep: mimetherapie, een combinatie van mime en fysiotherapie. 
Het proefschrift bestaat uit drie delen. Deel I geeft een beschrijving van medische aspecten van een 
aangezichtsverlamming, van het ontstaan en de inhoud van mimetherapie tegen de achtergrond van 
andere behandelvormen van fysiotherapie voor patiënten met een aangezichtsverlamming, van gegevens 
van een jarenlange toepassing van mimetherapie in Nijmegen die werden geanalyseerd en van een 
meetinstrument voor asymmetrie van het gelaat, dat werd getoetst op betrouwbaarheid 
Deel II beschrijft het onderzoeksdesign en de empirische resultaten van de Nijmegen Mimetherapie 
Studie (NMTS), een interventiestudie gestart op 1 apnl 1999. In deel III worden deze resultaten 
bediscussieerd. 
Deel l. Voorbereidende studies 
Hoofdstuk 1. Inleiding 
De incidentie van de verlamming van Bell, de meest voorkomende oorzaak van een 
aangezichtsverlamming, is in de westerse wereld 20:100.000 volwassenen per jaar. Omdat ongeveer de 
helft van het aantal nieuwe gevallen per jaar een verlamming van Bell is, mag worden verondersteld dat 
de totale incidentie van aangezichtsverlammingen ongeveer 40:100.000 is. Andere oorzaken van een 
aangezichtsverlamming zijn o.a. trauma (schedeltrauma, extratemporaal), operatietrauma, herpes zoster, 
diabetes mellitus, tumorgroei en otitis media. De verlamming van Bell geneest in 70% van alle gevallen 
spontaan, bij oorzaken anders dan de verlamming van Bell is de spontane genezing minder dan 70%. 
Over de prevalentie van aangezichtsverlammingen is minder bekend. Van de geschatte acht miljoen 
volwassenen in Nederland zullen er per jaar ongeveer 1600 te maken krijgen met de verlamming van 
Bell, 30 % hiervan wordt geconfronteerd met blijvende restverschijnselen. Het wordt algemeen 
aangenomen dat het spontaan herstel binnen de eerste weken start en zeker negen maanden kan doorgaan. 
Als er geen volledig herstel na deze penode van negen maanden is spreken we over een 
aangezichtsverlamming met (blijvende) restverschijnselen. 
Restverschijnselen van een aangezichtsverlamming bestaan naast asymmetrie van het gelaat uit 
beperkingen in eten, drinken, praten en uit psychosociale problemen. Een aangezichtsverlamming heeft 
dus niet alleen impact op het gelaat van de patiënt, maar ook op kwaliteit van leven en sociale contacten. 
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Restverschijnselen van een aangezichtsverlamming kunnen chirurgisch of met-invasief behandeld 
worden Chirurgische behandelmethodes bestaan b.v. uit het plaatsen van een goudgewichtje in het 
bovenooghd en uit statische of dynamische reconstructies. Niet-invasieve mogelijkheden zijn b.v. 
botuline-toxine injecties en fysiotherapie Alhoewel een literatuuroverzicht een scala aan 
fysiotherapeutische behandelvormen laat zien zijn er slechts weinig wetenschappelijke data voorhanden. 
Tot 2003 is er geen gerandomiseerd effectonderzoek gevonden dat de effectiviteit van fysiotherapie 
bewijst. 
Mimetherapie wordt in Nederland meer dan 25 jaar toegepast Het belangrijkste doel van de NMTS is 
om, onder gecontroleerde condities, vast te stellen of mimetherapie zoals toegepast in twee universitaire 
centra, positieve effecten heeft op de asymmetrie van het gelaat en op andere rcstverschijnsclen van 
patiënten met een aangezichtsverlamming. 
De centrale hypothese is dat de gelaatsasymmetne van patiënten met restverschijnselen na een 
aangezichtsverlamming verbetert door mimetherapie, en dat dit resulteert in verbeteringen van secundaire 
restverschijnselen: stijfheid van het gelaat, verminderde emotionele afleesbaarheid, problemen met eten, 
drinken, praten, mondspoelen en tranen van het oog, verminderde kwaliteit van leven en psychosociale 
problemen. 
Hoofdstuk 2. Van mime tot mimetherapie, het ontstaan van een revalidatiemethode voor patiënten 
met restverschijnselen van een aangezichtsverlamming 
Dit hoofdstuk geeft een uitgebreide beschrijving van het ontstaan, de ontwikkeling door de jaren heen en 
de inhoud van mimetherapie 
De oorsprong van mimetherapie ligt in Amsterdam in 1974 bij Jan Bronk, mime acteur, docent en 
directeur van het Nederlands Mime Centrum en Pieter Devriese, KNO-arts, gespecialiseerd in 
aangezichtsverlammingen. Jan Bronk gebruikte principes uit de mime voor patiënten met asymmetrische 
mimische bewegingen en/of ongecontroleerde bewegingen. Hij ontwierp een analyse van het gezicht, met 
name van de emoties, gebaseerd op 'mime corporel' om deze patiënten te helpen. 
Mimetherapie is het revalideren van patiënten met een aangezichtsverlamming met als doel de 
asymmetrie van het gelaat en de expressiemogehjkheden te verbeteren. Nadat in 1980 fysiotherapeuten 
door Jan Bronk werden getraind veranderde de inhoud van de therapie van uitsluitend mime naar een 
combinatie van mime en fysiotherapie. Toegevoegd zijn rekoefeningen van de aangezichtsmusculatuur en 
inhibitie van synkinesen middels contrabewegingen. Het onderzoek van de patiënt werd verbeterd met de 
invoer van een gestandaardiseerde intake en metingen van de asymmetne van het gelaat in rust en bij 
bewegen. 
Mimetherapie, zoals tegenwoordig toegepast, bestaat uit: 
a informatie over de behandeling en prognose; 
b. automassage van gelaat en hals; 
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c. ademhalings- en ontspanningsoefeningen; 
d. coördinatieoefeningen en inhibitie van synkinesen; 
e. oefeningen voor de oogsluiting en lipsluiting; 
f. letter- en woordoefeningen, 
g. expressie oefeningen. 
Vanaf 1980 tot nu zijn in het Universitair Medisch Centrum Nijmegen (UMCN) meer dan 1000 patiënten 
met een aangezichtsverlamming behandeld met mimetherapie. De positieve resultaten die patiënten 
rapporteerden contrasteerden met gebrek aan wetenschappelijk bewijs. Dit was een van de redenen om 
een 'Randomised Controlled Trial' (RCT) op te zetten; een andere reden was de toenemende noodzaak 
voor 'evidence-based' behandelen, ook op fysiotherapeutisch gebied. 
Ter voorbereiding van dit RCT zal eerst het dossieronderzoek (hoofdstuk 3), worden beschreven waarin 
van 10 jaar verzamelde gegevens zijn geanalyseerd om aan te tonen dat de tevredenheid van de patiënten 
kon worden gestaafd met positieve resultaten. Vervolgens (hoofdstuk 4) wordt een literatuuronderzoek 
beschreven, uitgevoerd om eventuele vergelijkbare behandelmethodes te vinden. 
Hoofdstuk 3. Beschrijving van uitkomstmaten van patiënten met een aangezichtsverlamming 
verwezen voor fysiotherapie 
Deze beschrijvende studie, gebaseerd op een dossieronderzoek, is uitgevoerd om restverschijnselen van 
patiënten met een aangezichtsverlamming te beschrijven, evenals hun veranderingen en stabiliteit in de 
tijd na behandeling met mimetherapie. 
Fysiotherapeutische dossiers van 175 patiënten met een aangezichtsverlamming, behandeld tussen 1987 
en 1998, werden verzameld. De dossiers bevatten een brief van de verwijzer, de anamnese en observaties 
uitgevoerd door de fysiotherapeut voor en na de behandeling Alle patiënten zijn behandeld met 
mimetherapie gedurende een periode van drie tot vijf maanden 
Uitkomstmaten waren (a) op functieniveau: asymmetrie van het gelaat in rust en tijdens bewegen en 
synkinesen, (b) op beperkingenniveau: problemen met eten, drinken, praten en (c) kwaliteit van leven. 
De resultaten waren: (a) de asymmetrie in rust verbeterde significant, de asymmetrie bij alle bewegingen 
verminderde en de emst van de synkinesen verminderde voor zes van de acht bewegingen. Het aantal 
synkinesen steeg echter voor drie bewegingen, (b) Substantieel minder patiënten rapporteerden 
problemen met eten, drinken en praten en (c) de kwaliteit van leven verbeterde. Volgens de Housc-
Brackmann-schaal (HB) verbeterden bijna alle patiënten gemiddeld een niveau na acht tot tien 
behandelsessies Leeftijd, geslacht en aangedane zijde waren niet voorspellend voor de geobserveerde 
verandenngen en daarnaast werd een hoge interindividuele stabiliteit gezien. 
Deze uitkomst stimuleerde de uitvoering van een RCT om de effectiviteit van mimetherapie te 
onderzoeken onder gecontroleerde condities op de polikliniek 
Hoofdstuk 4. Literatuuroverzicht van 'evidence-based' fysiotherapie voor patiënten met een 
aangezichtsverlamming 
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Een update van een eerder literatuuroverzicht is uitgevoerd om inzicht te krijgen in behandelvormen van 
fysiotherapie, effectief voor patiënten met een aangezichtsverlamming. Deze behandelvormen zouden 
kunnen dienen als 'standaard' behandeling waarmee mimetherapie vergeleken kon worden in een RCT. 
Verschillende behandelvormen van fysiotherapie zijn gedurende de afgelopen 35 jaar toegepast om te 
proberen restverschijnselen van een aangezichtsverlamming te verminderen. Een eerder uitgevoerde 
literatuurstudie over de periode tussen 1966 en midden 1991 beschrijft een grote verscheidenheid aan 
fysiotherapeutische behandelvormen, met name: oefen-, massage-, elektro-, myofeedback-, 
ultrageluidtherapie en warmtepakkingen. Van de 17 artikelen in dit overzicht, die claimden de effectiviteit 
van fysiotherapie te bestuderen, hadden er 14 een pre-experimenteel design, twee een quasi-
expenmenteel design en werd slechts één RCT gevonden. Dit RCT van Mosforth & Tavemer liet geen 
verschil in uitkomst zien tussen elektro- en infraroodtherapie versus massagethcrapie. 
Het aanvullende literatuuroverzicht, uitgevoerd tussen midden 1991 en eind 2002 bevat alleen RCTs met 
betrekking tot fysiotherapie voor patiënten met een aangezichtsverlamming. Slechts dne RCTs zijn 
gevonden in een tijdsbestek van meer dan 40 jaar. Om de studies te beoordelen is door twee 
onafhankelijke reviewers gebruik gemaakt van de PEDro schaal. Interventies in de geincludeerde studies 
waren massage-, infrarood-, elektro-, myofeedback- en oefentherapie. Twee van de studies beschrijven 
voordelen van de gebruikte interventies (myofeedback- en oefentherapie). De methodologische kwaliteit 
van de geiïcludeerde tnals is matig Conclusies van het literatuuroverzicht zijn dat het aantal RCTs 
nauwelijks is toegenomen sinds midden 1991 en dat geen van de geincludeerde trials een significant 
behandeleffect toonde als de behandelgroep werd vergeleken met de controlegroep. Dit had als 
consequentie voor onze effectiviteitstudie dat een "geen-behandelmg-groep" kon dienen als de 
controlegroep in het RCT design van de NMTS 
Hoofdstuk 5. Contralaterale reïnnervatie van spieren in de middellijn bij aangezichtsverlammingen 
Deze studie beschrijft een patiënt met herstel van willekeurige activiteit van middellijn spieren aan de 
ipsilaterale zijde, drie maanden na een complete hnkszijdige aangezichtsverlamming ten gevolge van de 
resectie van een vestibulair schwannoma van de linker cerebellopontinehoek. Omdat de patiënt in staat 
was de m. orbiculains ons en m. nasahs willekeurig aan te spannen werd gestart met mimetherapie, 
echter zonder enig resultaat. Een andere consequentie was dat een dynamische correctie middels een 
hypoglossus-faciahs anastomose werd uitgesteld. Electrodiagnostiek toonde aan dat stimulatie van de 
aangedane zijde geen respons opwekte in tegenstelling tot stimulatie van de contralaterale zijde. 
Naaldelectromyografie liet abnormale spontane activiteit in de linker m. orbicularis ons zien. 
Contralaterale innervatie komt waarschijnlijk door sprouting van terminale zenuwtakjes welke over de 
middellijn van het gelaat lopen en spiervezels innerveren aan de aangedane zijde. Kennis betreffende dit 
fenomeen is relevant voor de interpretatie van mechanismen die ten grondslag liggen aan hernieuwde 
activiteit van de mimische musculatuur en heeft consequenties voor de prognose en 
behandelmogelijkheden. Fysiotherapeuten die patiënten behandelen met een ernstige 
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aangezichtsverlamming worden geadviseerd informatie in te winnen omtrent de resultaten van het 
electromyogram, voorafgaande aan de behandeling. 
Hoofdstuk 6. Betrouwbaarheid van de Sunnybrookschaal bij het uitvoeren van optimale mimische 
bewegingen 
Kwalificering van de gelaatsasymmetne is belangrijk om behandelingen te kunnen beoordelen op hun 
effectiviteit. Er zijn verscheidene scoringssystemen voorhanden, de meeste gebruikte is de HB schaal De 
HB schaal laat een goede interbeoordelaarsbetrouwbaarheid zien; de sensitiviteit voor veranderingen is 
echter laag. Een meer recent ontwikkelde schaal om aangezichtsverlammingen te kwalificeren is de 
Sunnybrook (SB) schaal, ontwikkeld in Canada door Ross, Fradet en Nedzelski in 1996. Deze schaal is 
vertaald in het Nederlands: de 'SB Dutch Language Version' (SB-DLV). 
Het doel van deze studie was de inter- en intrabeoordelaarsbetrouwbaarheid van de subschalen en de 
samengestelde score van de SB-DLV te onderzoeken om de schaal te kunnen gebruiken voor accuraat 
meten van de aangezichtsasymmetne in onze patiëntenpopulatie. Daarnaast is de betrouwbaarheid van de 
SB-DLV onderzocht als patiënten optimaal-symmetrische bewegingen uitvoerden (ter preventie van 
synkinesen) in plaats van maximale bewegingen zoals in de originele Canadese versie. 
In deze studie zijn 25 patiënten met een gemiddelde HB score van III op video gezet. De videobanden 
zijn onafhankelijk gescoord door twee fysiotherapeuten en een fysiotherapiestudent, allen gebruikmakend 
van de SB-DLV. De intrabeoordelaarsbetrouwbaarheid van de samengestelde score was, zoals berekend 
met behulp van de 'intraclass correlation coefficient' respectievelijk 0.98, 0.89 en 0.95 en de 
interbetrouwbaarheid 0.95, 0.90 en 0.93. 
De SB-DLV heeft een hoge intra- en interbeoordelaarsbetrouwbaarheid als meetinstrument voor patiënten 
met restverschijnselen van een aangezichtsverlamming, ook als patiënten optimaal- symmetrische 
bewegingen uitvoeren. 
Deel II De Nijmegen Mimetherapie Studie 
Inleiding. Design van de Nijmegen Mimetherapie Studie 
Het design van de NMTS is opgezet volgens het "CONSORT statement (Consolidated Standards of 
Reporting Trials)". Om de effectiviteit te onderzoeken van mimetherapie bij patiënten met een 
aangezichtsverlamming is 1 april 1999 een RCT gestart, waarbij de therapiegroep drie maanden 
mimetherapie kreeg en de controlegroep dne maanden op een wachtlijst werd geplaatst. 
Powerberekeningen en gewenste effectgrootte hebben geleid tot een design met 50 patiënten, gelijk 
verdeeld over beide groepen. De veelheid aan restverschijnselen wordt gereflecteerd in een grote 
verscheidenheid aan onafhankelijke vanabelen, geclassificeerd volgens de drie niveaus van de WHO, 
respectievelijk functie-, activiteiten- en participatieniveau. 
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Naast de directe posttherapie metingen zijn follow-up metingen uitgevoerd na 3 en 12 maanden. 
Vergelijking van metingen op deze dne tijdstippen maakt het mogelijk de stabiliteit van eventuele baten 
van mimetherapie te bestuderen. 
Hoofdstuk 7. Effectiviteit van mimetherapie: verbetering van de gelaatsasymmetrie bij patiënten 
met een aangezichtsverlamming 
De effectiviteit van mimetherapie is onderzocht met betrekking tot de aangezichtsasymmetrie in patiënten 
met een aangezichtsverlamming Vijftig volwassen patiënten, 21 mannen en 29 vrouwen met een 
enkelzijdige aangezichtsverlamming, langer bestaande dan negen maanden werden ge'includeerd in een 
RCT, uitgevoerd op de Afdeling Fysiotherapie van het UMC Nijmegen en de Vnje Universiteit MC van 
Amsterdam. Patiënten werden na randomisatie of aan de experimentele groep toegewezen en kregen drie 
maanden mimetherapie, of aan de controlegroep en werden dne maanden op een wachtlijst geplaatst. 
Metingen werden verricht pre- en posttherapie. De belangrijkste uitkomstvariabelen, asymmetrie van het 
gelaat in rust en bij bewegen en synkinesen, zijn gemeten door middel van een geblindeerde sconng van 
video-opnames, gebruikmakend van de SB en de HB schalen. Van de 50 patiënten hebben er 48 de trial 
voltooid. Een vergelijking van de therapie- en de controlegroep laat positieve resultaten van mimetherapie 
bij de posttest zien op de scores van de HB en de SB schalen, behalve voor asymmetrie van het oog in 
rust. De HB score verbeterde significant met één niveau, de SB score verbeterde significant en 
substantieel door mimetherapie (effectgrootte g > 1.50). Het therapie-effect was onafhankelijk van 
leeftijd, geslacht en duur van de aangezichtsverlamming. 
Hoofdstuk 8. Positieve effecten van mimetherapie op restverschijnselen van een 
aangezichtsverlamming: stijfheid, lip(im)mobiliteit en fysieke en sociale aspecten van 
aangezichtsbeperkingen 
Effecten van mimetherapie bij patiënten met een aangezichtsverlamming zijn op functieniveau 
geëvalueerd op stijfheid van het gelaat en lip(im)mobiliteit (zowel lip- als tuitlengte) met respectievelijk 
de stijfheidschaal van het gelaat en een schuifmaat. Beperkingen werden gemeten met de fysieke index 
van de Faciale Beperkingen Index (FBI) vragenlijst en de sociale index van de FBI gaf de graad van 
handicap aan. Patiënten in de mimetherapiegroep scoorden na de therapie, in vergelijking met de 
controlegroep, op alle uitkomstvariabelen significant en substantieel beter. 
Hoofdstuk 9. Stabiliteit van baten van mimetherapie bij restverschijnselen van een 
aangezichtsverlamming over een periode van 12 maanden 
De stabiliteit van baten van mimetherapie over een periode van 3 en 12 maanden is onderzocht door 
middel van een prospectief follow-up design, toegevoegd aan een RCT, waarbij een mimetherapiegroep 
werd vergeleken met een controlegroep Achtenveertig patiënten voltooiden de RCT en waren 
beschikbaar voor follow-up. De restverschijnselen van aangezichtsverlammingen werden bij de follow-up 
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met dezelfde meetinstrumenten gemeten als in de RCT. Asymmetrie van het gelaat werd, evenals in het 
RCT geblindeerd gemeten, gebruikmakend van de HB en SB schalen. 
Twee soorten stabiliteit zijn geanalyseerd: stabiliteit van behaalde resultaten (m.b.v covanantie analyse 
van herhaalde metingen, het testen van trends en op individuele tijdcurves gebaseerde analyses van 
niveaustabiliteit) en stabiliteit van intenndividuele verschillen in uitkomstmalen. Van de 48 patiënten 
waren er 46 beschikbaar voor follow-up Covanantie-analyse van herhaalde metingen liet geen significant 
verschil zien (p < 0.05) op de gemiddelde scores tussen de 3 posttestmetingen van alle uitkomstmaten, 
behalve voor de tuitindex en de sociale index van de FBI, welke een lichte continue verbetering lieten 
zien. Analyses van de individuele trajecten van de restverschijnselen toonden een stabiliteit op de posttest 
metingen in 45 % van alle restverschijnselen van alle patiënten. Andere patronen lieten een verbetering 
zien op korte of lange termijn (35 %) of een verslechtering tijdens of na de therapie (20 %). 
Hoofdstuk 10. Psychosociale restverschijnselen na een aangezichtsverlamming: heeft mimetherapie 
een blijvend effect? 
Er is in de literatuur een grote variëteit te vinden aan psychosociale restverschijnselen na een 
doorgemaakte aangezichtsverlamming, depressieve gevoelens en angsten, gevoelens van schaamte 
geassocieerd met afzondering tijdens sociale contacten, gebrek aan sociale vaardigheden om met de 
gezichtsasymmetrie om te gaan, sociaal ongebruikelijk copinggedrag (b v. vermijden van oogcontact) en 
een laag gevoel van eigenwaarde. 
Doelen van deze studie waren: 1) informatie verschaffen met betrekking tot het voorkomen van 
psychosociale restverschijnselen na een aangezichtsverlamming, 2) het aantonen van effecten van 
mimetherapie bij deze restverschijnselen en 3) het aantonen van stabiliteit van deze eventuele baten van 
mimetherapie 
Vijftig patiënten met restverschijnselen na een aangezichtsverlamming zijn geïncludeerd in deze studie, 
48 patiënten voltooiden de RCT waarvan 46 de follow-ups voltooiden. Patiënten hebben bij de pretest, de 
posttest en bij beide follow-ups vragenlijsten ingevuld met betrekking tot verschillende aspecten van 
psychosociaal functioneren Het onderzoek bestond uit drie gebieden, het eerste gebied (A) omvatte 'zich 
gespannen voelen in sociale contacten'. Het tweede gebied (B) bestond uit 'gemoedstoestanden en 
gevoelens' waarin dne vragenlijsten werden gebruikt, elk een verschillend tijdsbestek omvattend. In de 
gemoedstoestandenvragenlijst geeft de patiënt aan in welke mate elk van de 20 gemoedstoestanden de 
afgelopen week aanwezig zijn geweest. De welbevindenvragenlijst bestaat uit 24 items die vragen naar de 
subjectieve evaluatie van indicatoren van kwaliteit van leven in de afgelopen maand. De ervaring van 
depressieve symptomen in de afgelopen drie maanden en in de afgelopen 24 uur is onderzocht met de 
depnscope. De vanabelen in het gebied Β bleken één enkele dimensie te meten, namelijk depressiviteit. 
Het derde gebied (C) heeft betrekking op gedragtendensen om bepaalde situaties te vermijden (b.v. 
vermijden van confrontaties van de eigen aangezichtsverlamming in sociale contacten) en impressies van 
"ondersteuning" en "verslechtcnng van relaties met intimi". 
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Inspectie van de pretest scores maakte duidelijk dat niet iedere patiënt ontspannen is tijdens sociale 
contacten (A). Depressiviteit is in matige tot ernstige mate aanwezig; 40 % van de patiënten heeft een 
stoornis van depressive aard bij de pretest op basis van metingen met de depnscope (B) De prevalentie 
van restverschijnselen in gebied C op de pretest is hoog voor sommige items, b v. 52 % van de patiënten 
merkt dat hun intelligentie wordt onderschat. Opmerkelijk is dat de veronderstelde oorzaak 
(aangezichtsasymmelne) en het veronderstelde (psychosociale) restverschijnscl niet samenhangen. Geen 
van de variabelen toonde significante verschillen tussen de groepen bij de pretest. Vergelijking van de 
groepen bij de posttest het zien dat mimetherapie een significant effect had in de verwachte richting op 
alle uitkomstvanabelen in alle gebieden en dat de effecten groot waren (g > 0.8). Voor de meeste 
patiënten bleven de baten van mimetherapie behouden over een penode van 12 maanden 
Hoofdstuk 11. Verbetering van de emotionele afleesbaarheid na een aangezichtsverlamming door 
mimetherapie 
Een veelvoud van aangezichtsspieren, aangestuurd door de nervus facialis, is betrokken in het genereren 
van mimische bewegingspatronen welke emotionele expressies transporteren. De afleesbaarheid van 
emoties op het gezicht is met name belangrijk in sociale contacten. Normaliter zijn beide gezichtshelften 
symmetrisch, niet-doelbewuste asymmetrie wordt gezien als abnormaal, eng en soms zelfs afstotend. 
De bovengenoemde beschouwingen leiden tot de volgende vier hypothesen: 
1. Het correct lezen van emoties van gezichten van patiënten met een aangezichtsverlamming is 
moeilijker dan van met-aangedane gezichten 
2. De emotionele afleesbaarheid van het gezicht van de individuele patiënt met een 
aangezichtsverlamming is negatief gecorreleerd met de uitgebreidheid van de stoornis. 
3. Mimetherapie is effectief in het verbeteren van de emotionele afleesbaarheid van gezichten van 
patiënten met een aangezichtsverlamming. 
4. De baten van mimetherapie met betrekking tot een verbeterde emotionele afleesbaarheid zijn 
stabiel. 
Deze vier hypothesen zijn getest in twee empirische studies Studie 1 heeft 'met-aangedane' gezichten 
vergeleken met gezichten van patiënten met een aangezichtsverlamming In studie 2 is een RCT 
gecombineerd met follow-ups, waarbij verbetering van de emotionele afleesbaarheid en de stabiliteit van 
deze baten zijn onderzocht. Beide studies hebben gebruik gemaakt van een speciaal ontworpen 
meetinstrument: de "Facial Emotional Readability Stories (FERS)" test. Een verhaal is geconstrueerd met 
een serie aan elkaar gekoppelde gebeurtenissen, bekend voorkomend voor iedereen Zes basis emoties 
(verdoet, angst, boosheid, blijdschap, afkeer en verbazing) komen verspreid, twee keer gedurende het 
verhaal, voor. De patiënt moet elke emotie uitdrukken op zijn gezicht. Dit geheel is op video opgenomen. 
De intra- en interbeoordelaarsbetrouwbaarheid van de FERS waren hoog. Verder bleken de getoonde 
emoties van patiënten van veel lagere kwaliteit dan van 'met-aangedane' individuen en bleken sommige 
emoties beter afleesbaar dan andere, b.v. blijdschap beter dan angst. 
181 
Samenvatting 
In studie 2 zijn twee afhankelijke variabelen gebruikt van de FERS test: a) het aantal correct herkende 
emoties en b) de emotie specifieke afleesbaarheid (ERJ geschat op groepsniveau. 
De mimetherapiegroep scoorde significant hoger dan de controlegroep voor het aantal correct herkende 
emoties (effectgrootte g = 1.3). Ook voor de index (ER )^ scoorde de mimetherapiegroep substantieel beter 
dan de controlegroep met betrekking tot de emotionele afleesbaarheid, met uitzondering van 'verbaasd' 
(effectgrootte g = 2.7). 
Opmerkelijk is dat er bij de pretest geen correlaties waren tussen het aantal correct herkende emoties en 
de aangezichtsasymmetne, gemeten met de SB- en HB-schalen. Deze correlaties zijn echter wel 
gevonden bij de posttest. 
Met betrekking tot de stabiliteit zijn er geen significante verschillen gevonden tussen de drie posttherapie 
tijdstippen voor het aantal correct herkende emoties, hetgeen een stabiliteit van de baten inhoudt. 
Hoofdstuk 13. Algemene discussie en conclusies 
Aspecten van het design en specifieke resultaten worden bediscussieerd. Suggesties worden gegeven voor 
verder onderzoek en werkzaamheden op het gebied van zorg voor patiënten met een 
aangezichtsverlamming. 
182 
Samenvatting 
Conclusies: 
1. Dit is de eerste studie die aantoont dat een speciale behandelvorm van fysiotherapie, 
mimetherapie, effectief is bij patiënten met restverschijnselen van een aangezichtsverlamming. 
2. Mimetherapie leidt tot substantiële verbeteringen van alle hieronder genoemde restverschijnselen, 
ingedeeld volgens de drie niveaus van de internationale classificatie van de WHO: 
Op functieniveau: 
Aangezichtsasymmetrie: 
asymmetrie in rust (behalve van het oog); 
asymmetrie tijdens bewegen; 
synkinesen; 
stijfheid van het gelaat; 
lipimmobihteit; 
lage emotionele afleesbaarheid. 
Op activiteitenniveau: 
problemen bij eten, drinken, mondspoelen, 
problemen met praten; 
gestoorde traansecretie. 
Op participatieniveau: 
spanningen tijdens sociale contacten; 
depressiviteit; 
vermijding van de confrontatie met eigen aangezichtsverlamming tijdens sociale contacten. 
3. Deze baten van mimetherapie zijn grotendeels stabiel over een periode van een jaar. 
Aanbevelingen: 
1. Mimetherapie is een goede behandelkeuze voor patiënten met restverschijnselen van een 
aangezichtsverlamming. 
2. Herhaling van dit onderzoek in een andere klinische setting. 
3. Onderzoek naar de werkingsmechanismen van mimetherapie 
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Prof.dr. Aditi Lahiri and Joanne Postma. Thanks dear friends for correcting my misspellings, 
misleadings and nonsense, and for more than this "English" support. 
Medewerkers van de Afdeling Fysiotherapie, voor jullie collegialiteit, belangstelling, tijd en 
flexibiliteit die het mij mogelijk hebben gemaakt het onderzoek uit te voeren en dit proefschrift te 
schrijven. 
De leden van de manuscriptcommissie voor hun snelle beoordeling en waardevolle opmerkingen 
Prof dr. JJ Manm en Prof.dr. J-PA Nicolai. Beste Hans en Jean-Philippe, dank voor de voortdurende, 
zeer plezierige samenwerking op facialisgebied. Ik vind het een voorrecht met jullie het "Xth 
International Facial Nerve Symposium" in Maastricht te organiseren, in september 2005. 
Alle lieve vrienden, want zonder vrienden kan ik niet (Boudewijn de Groot). 
Luud Roos. Dierbare "uilzendzus", dank voor het, onder het genot van een glaasje witte wijn, bijna 
wekelijks aanhoren van "dips", vorderingen, afwegingen en overwegingen Er komen nu weer tijden 
om de wereld te ontdekken! 
Mijn ouders. Jammer genoeg heeft mijn moeder deze dag niet mogen meemaken. Lieve papa, dank 
voor jullie nooit aflatende vertrouwen en positieve instelling. Jij zei niet voor niets vaak: "ut kump 
waal good". 
Last but not least, Jan. Lieve Jan, dank dat je regelmatig op de rem trapte en me liet beseffen dat er 
meer in de wereld is dan promoveren! 
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Mime therapy: rehabilitation of facial expression 
1. Mimetherapie helpt, omdat het werkt. 
2. Vijftigplussers doen niet onder voor jongvolwassenen met betrekking tot de 
effectiviteit van mimetherapie. 
3. De kans dat een blije gezichtsuitdrukking van een patiënt met een aangezichtsver-
lamming wordt aangezien voor een verbaasde is significant lager na mimetherapie. 
4. Bij aanwezigheid van synkinesen dienen optimaal-symmetrische bewegingen te 
worden geoefend en niet maximaal-symmetrische bewegingen. 
5. Bij depressies volgen na mimetherapie opklaringen. 
6. De samenwerking tussen een theaterkunst en een medische professie heeft geleid 
tot een belangrijke stap voorwaarts in de behandeling van patiënten met een aange-
zichtsverlamming. 
7. Een burka verhult óók een aangezichtsverlamming (eigen waarneming). 
8. Bij het ontwerpen van een meetinstrument voor wetenschappelijk onderzoek is het 
belangrijker om maat te houden dan om in de maat te lopen. 
9. Vriendelijkheid ten opzichte van de patiënt kost weinig en levert de gezondheids-
zorg veel op. 
10. Kijken naar sport op televisie kan wel de hartslag verhogen, maar niet de conditie. 
11. Een oneerlijke verdeling geeft scheve gezichten. 
Carien Beurskens 
27 augustus, 2003 



